Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,clathrin adaptor activity (GO:0035615),-0.7627511222673731,-2.1587577314470656,0.0,0.00338928530799738,0.003,6/15,5.83%,DAB2;HIP1;AP2A2;AP2B1;HIP1R;LDLRAP1
prerank,lipoprotein particle binding (GO:0071813),-0.6277494693963632,-1.9275884157997552,0.0,0.13952557851255878,0.203,8/20,10.39%,MSR1;CD36;THBS1;HSPD1;PLTP;LDLR;LPL;STAB2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.6571365293902709,-1.902771192761276,0.0,0.09320534596992794,0.259,5/16,4.12%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.6571365293902709,-1.902771192761276,0.0,0.09320534596992794,0.259,5/16,4.12%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5713934006419981,-1.8620047955514996,0.0,0.11704331930284284,0.374,6/24,5.60%,OSBPL8;GOLPH3L;SESTD1;OSBP;PLA2G4E;PLEKHA3
prerank,death domain binding (GO:0070513),-0.7240452733111908,-1.8588588499712353,0.0,0.10111367835525517,0.389,6/11,13.53%,BCL2;BCL2L1;MCL1;BAX;RIPK1;RACK1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6304464979813135,-1.8433705108020146,0.0,0.100710192009065,0.438,6/16,10.39%,MSR1;CD36;THBS1;PLTP;LDLR;STAB2
prerank,hyaluronic acid binding (GO:0005540),-0.7327882322605908,-1.805423358215403,0.0091324200913242,0.13430043032939618,0.579,5/10,11.26%,LYVE1;CD44;IMPG2;STAB2;CHODL
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6962509079161474,1.7969105431131214,0.005244755244755245,0.875164821053066,0.571,5/14,3.78%,KCNJ3;KCNH2;KCNA5;KCNE2;KCNJ8
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7465802915482862,1.7628434837626847,0.0,0.6487494238429276,0.707,6/10,16.42%,CACNB4;CACNB2;CACNA1S;CACNA1D;CACNA1B;CACNA1A
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3919051551490563,-1.7445244725486033,0.0,0.21791849239568337,0.786,21/100,8.39%,IQGAP1;IQGAP2;OSBPL8;DENND1A;HIP1;KIF16B;GOLPH3L;SNX24;SESTD1;DENND1B;OSBP;PLA2G4E;SH3PXD2B;GBF1;ZFYVE16;HIP1R;PLEKHA3;ARAP1;CYTH3;GAB2;RACGAP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.6573067086464823,1.7372655119463305,0.008680555555555556,0.5726615284539422,0.799,6/14,12.53%,NUDT12;FHIT;NUDT17;NUDT10;NUDT3;ENPP4
prerank,voltage-gated calcium channel activity (GO:0005245),0.5300966362360932,1.7362941645943641,0.0,0.4345789409717047,0.804,16/37,17.26%,CACNB4;CACNG5;CACNG2;CACNB2;CACNA1S;CACNA2D3;PKD2;CACNA1G;CACNA2D2;CACNG7;CACNA1D;CACNA1B;CACNA2D1;CACNA1A;OPRM1;CACNG3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6679649650880441,1.6908213516876776,0.01592920353982301,0.5574439493761452,0.925,5/12,10.08%,B3GNT9;B3GNT6;B4GAT1;B3GALT2;B3GALNT1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4773516553768528,-1.6863966903612533,0.005420054200542005,0.3272919845756136,0.914,11/34,8.39%,IQGAP1;IQGAP2;KIF16B;PLA2G4E;GBF1;ZFYVE16;HIP1R;ARAP1;CYTH3;GAB2;RACGAP1
prerank,protein tyrosine kinase binding (GO:1990782),-0.40704918624944536,-1.6836736773015792,0.003663003663003663,0.3043167384120071,0.915,35/71,30.36%,NEDD9;CBLB;GAS6;ITGAX;CASS4;CRK;PTPN1;PCNA;NCK1;BLNK;BANK1;SOCS5;CBL;CEACAM1;RACK1;SHC1;ELMO2;SQSTM1;CD247;PITPNM3;ACVR1;DUSP3;NOX4;ANGPT1;RNF41;BMPR2;PHYHIP;PIK3R2;PTPN14;HSP90AA1;SHC4;DUSP22;ANGPT4;LRP4;CD4
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.6877822304181407,1.678239816129565,0.014388489208633094,0.5227577266198709,0.944,4/11,3.78%,KCNJ3;KCNH2;KCNE2;KCNJ8
prerank,sequence-specific mRNA binding (GO:1990825),-0.672953903934191,-1.667902179848741,0.02097902097902098,0.3209464893045296,0.944,6/10,20.95%,ETF1;SHFL;LARP6;SSB;TYMS;DHFR
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6737592482784338,1.66244464384165,0.02054794520547945,0.5239899192577492,0.962,2/11,7.89%,HCN1;CNGB1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.6267302487132507,1.6604128218941507,0.010434782608695653,0.46727055189541344,0.963,5/15,11.14%,SLC4A8;SLC26A4;CFTR;SLC26A7;SLC39A8
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.638145622426046,1.65994704146877,0.016129032258064516,0.41668647704251344,0.963,6/13,9.82%,GLRA3;GABRG1;GABRG2;GLRB;GABRA2;GLRA2
prerank,GABA receptor activity (GO:0016917),0.5728787315354984,1.650069177132489,0.008077544426494346,0.4087491028001807,0.969,9/21,15.13%,GABRQ;GABBR1;GABRG1;GABRD;GABRG2;GABRA2;GABBR2;GABRB1;GABRR2
prerank,protein phosphatase regulator activity (GO:0019888),-0.42172128274133197,-1.6451114331638408,0.0182370820668693,0.35370233855254707,0.973,20/53,14.91%,PPP2R5C;PPP2R1B;PPP2R2A;ENSA;PPP2R5A;PPP4R1;PPP6R1;PTPA;SHOC2;LMTK2;PPP6R3;BOD1;CABIN1;PPP2R2C;PPP4R2;CALM3;CALM2;PTN;ARPP19;PPP1R2
prerank,chloride transmembrane transporter activity (GO:0015108),0.6147885264129785,1.640760340775827,0.01415929203539823,0.4086398857254596,0.975,6/16,10.39%,SLC4A8;SLC1A1;SLC26A4;CLCN6;CFTR;SLC26A7
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.4663864510375034,-1.6250756405375333,0.0111731843575419,0.38282784526522784,0.988,11/34,14.93%,IQGAP1;STK3;ETAA1;FAM20A;CAB39L;SPRY2;CALM3;IGF2;CALM2;MTCP1;INCENP
prerank,chemokine receptor activity (GO:0004950),0.545243708927484,1.6163933766843832,0.014040561622464899,0.4601469382076795,0.988,10/24,16.08%,ACKR4;ACKR3;CCR1;GPR17;CXCR6;CX3CR1;CXCR4;CCR6;ACKR2;CCR9
prerank,phosphotyrosine residue binding (GO:0001784),-0.43235612227954656,-1.6040264008352214,0.0136986301369863,0.41582764856563403,0.995,12/37,10.70%,SH3BP2;STAP1;ABL2;CRK;RASA1;LDLRAP1;CRKL;SYK;BCAR3;HCK;LCK;GRB2
prerank,C-C chemokine binding (GO:0019957),0.5529352774085476,1.6021158594886253,0.011400651465798045,0.4808394809197416,0.997,9/22,16.08%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;CXCR4;CCR6;ACKR2;CCR9
prerank,fatty acid synthase activity (GO:0004312),0.6662251540785447,1.5951982302787167,0.02486678507992895,0.4754063238214045,0.997,5/10,20.59%,CBR4;ELOVL6;OXSM;ELOVL4;ELOVL5
prerank,phosphatase inhibitor activity (GO:0019212),-0.510587635157325,-1.5870529324302611,0.04488778054862843,0.4370765845104954,0.998,8/20,14.91%,ENSA;LMTK2;BOD1;CABIN1;PTN;TESC;ARPP19;PPP1R2
prerank,voltage-gated cation channel activity (GO:0022843),0.40986087990261083,1.5819374855790915,0.001349527665317139,0.49688168122442655,0.999,25/97,17.26%,HCN1;KCNMA1;CACNB4;CACNG5;CACNG2;KCNH2;KCND2;KCNA5;CACNB2;CACNA1S;KCNH7;KCNC1;CACNA2D3;PKD2;GRIN1;GRIN2B;CACNA2D2;CACNG7;CACNA1D;CACNA1B;CACNA2D1;KCNC3;CACNA1A;OPRM1;CACNG3
prerank,GTPase inhibitor activity (GO:0005095),-0.5850265999618571,-1.5815271921966112,0.04938271604938271,0.42804679742766905,0.998,2/13,0.11%,IQGAP1;IQGAP2
prerank,double-stranded RNA binding (GO:0003725),-0.3859627239130949,-1.578600701564644,0.0,0.4124885748918292,0.998,26/70,17.50%,RFTN1;DDX60;OAS2;MBNL1;IFIH1;ACTN1;EIF4B;ZBP1;DHX33;TLR7;MSN;OASL;ZNF346;HSPD1;TFRC;ILF2;TLR8;VIM;RC3H1;AGO2;OAS3;LRRFIP1;PRKRIP1;RC3H2;DUS2;SLC3A2
prerank,C-C chemokine receptor activity (GO:0016493),0.5507453330708109,1.5714715299332886,0.027331189710610933,0.505969101928779,1.0,9/21,16.08%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;CXCR4;CCR6;ACKR2;CCR9
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.4719592460509779,-1.5671793554143614,0.018229166666666668,0.42086598964921845,1.0,9/26,15.27%,ENSA;LMTK2;BOD1;CABIN1;PTN;PPP1R1A;ARPP19;PPP1R2;PPP1R14C
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4328401061684827,1.5613929063726224,0.01037037037037037,0.5170860163896368,1.0,20/55,18.79%,ATP2A3;TRPC3;ATP2A2;ITPR2;CACNB2;SLC24A5;PKD1L1;TRPM2;PKD2;GRIN1;ATP2C1;PANX1;CACNA1D;PKD1;ATP2B3;SLC24A3;CHRNA7;SLC24A4;TRPV6;PKD2L2
prerank,copper ion binding (GO:0005507),0.46170556815820907,1.547965038899635,0.01199400299850075,0.5450398768215036,1.0,15/42,18.25%,LACC1;ANG;COA6;GPC1;PRNP;COMMD1;S100A13;AOC2;MOXD1;DCT;ACR;AOC1;ATOX1;IL1A;SNCB
prerank,O-acyltransferase activity (GO:0008374),0.495570951247977,1.5403313524949531,0.02702702702702703,0.5465585002041519,1.0,7/30,11.35%,PRDX6;DGAT2;AWAT2;PLA2G4C;SOAT2;LPCAT1;LPCAT2
prerank,ligand-gated anion channel activity (GO:0099095),0.5633107141941218,1.540011806120178,0.04013961605584642,0.5206167919115573,1.0,8/17,14.53%,GLRA3;GABRG1;GABRG2;GLRB;GABRA2;GLRA2;CFTR;GABRB1
prerank,inward rectifier potassium channel activity (GO:0005242),0.514230447174547,1.5347422944052143,0.025210084033613446,0.5173448803891912,1.0,9/24,16.52%,KCNJ3;KCNH2;KCNE2;KCNJ8;KCNJ13;KCNK6;ABCC8;KCNJ5;KCNN3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4826055851988974,-1.5323443259314198,0.026634382566585957,0.5006539280796796,1.0,7/23,5.30%,HIP1;KIF16B;SESTD1;PLA2G4E;SH3PXD2B;GBF1;HIP1R
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5318475353645401,1.525335877349942,0.027331189710610933,0.5308369897114138,1.0,6/21,10.75%,FGF10;FGF16;FGF9;KLB;FGF7;FGF2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5668658788905391,1.5228764401715447,0.045871559633027525,0.5174405475194612,1.0,4/15,12.08%,HS3ST6;HS3ST5;HS6ST3;HS6ST1
prerank,myosin V binding (GO:0031489),0.5795567021313558,1.5199434730329466,0.050335570469798654,0.5063926681480496,1.0,4/15,10.82%,RAB6B;RAB3A;RAB8A;RAB3D
prerank,protein phosphatase activator activity (GO:0072542),-0.5545631056714724,-1.5190921888196316,0.04926108374384237,0.5199594047903916,1.0,6/13,17.80%,PPP2R5C;PPP2R5A;PTPA;CALM3;CALM2;PPP1R15A
prerank,GABA-A receptor activity (GO:0004890),0.5484098808587297,1.5186915692638427,0.03636363636363636,0.490942512709853,1.0,7/18,15.13%,GABRQ;GABRG1;GABRD;GABRG2;GABRA2;GABRB1;GABRR2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.5756310568711773,-1.5143780244324159,0.055288461538461536,0.5112685534306349,1.0,6/12,23.56%,STAT1;TNF;TRAF1;TRAF4;TRIM37;BABAM2
prerank,calcium channel activity (GO:0005262),0.3967424626503792,1.513792687985401,0.011428571428571429,0.491040614200638,1.0,28/84,18.79%,CACNB4;CACNG5;CACNG2;TRPC3;CACNB2;SLC24A5;CACNA1S;PKD1L1;CACNA2D3;TRPM2;PKD2;GRIN1;CACNA2D2;CACNG7;TRPC6;PANX1;CACNA1D;PKD1;CACNA1B;CACNA2D1;SLC24A3;CACNA1A;OPRM1;CACNG3;CHRNA7;SLC24A4;TRPV6;PKD2L2
prerank,transmitter-gated ion channel activity (GO:0022824),0.4915062585903863,1.5097346855700648,0.024916943521594685,0.48726373313432086,1.0,10/29,9.82%,GLRA3;GABRG1;GRIA2;GABRG2;GRIK5;GRIK2;GABRA2;GRID2;GRIA4;GLRA2
prerank,protein kinase activator activity (GO:0030295),-0.37653839744389805,-1.5033616259649674,0.006369426751592357,0.5213604965084665,1.0,24/60,22.65%,IQGAP1;STK3;GAS6;MARK2;ETAA1;FAM20A;CD24;PRKAG2;CAB39L;GPRC5B;SPRY2;AGAP2;CALM3;IGF2;CALM2;MTCP1;INCENP;RGCC;TPX2;AFAP1L2;LTF;EPO;DUSP19;PARP16
prerank,voltage-gated potassium channel activity (GO:0005249),0.3962741534587284,1.4897546212408703,0.01272984441301273,0.5403604785895609,1.0,20/80,19.18%,HCN1;KCNMA1;KCNJ3;KCNH2;KCND2;KCNA5;KCNE2;KCNJ8;KCNH7;KCNC1;KCNJ13;PKD2;KCNK6;KCNJ5;KCNC3;KCNT2;KCNN3;KCNT1;KCNQ4;KCNK2
prerank,poly(A) binding (GO:0008143),0.5108816163427824,1.4894416789398952,0.0528,0.5229064395244424,1.0,12/21,30.10%,PABPC1L;PABPC4L;ZC3H14;DDX1;KHDRBS2;RBMS3;TIA1;HNRNPDL;DDX3X;PABPC4;ELAVL4;RBMS2
prerank,adenylate cyclase binding (GO:0008179),-0.6049141276976829,-1.488205123427458,0.056179775280898875,0.5476520176839099,1.0,5/10,17.20%,AKAP12;ADCY5;CALM3;CALM2;AKAP5
prerank,ligand-gated cation channel activity (GO:0099094),0.3925145972649902,1.47819808145809,0.008595988538681949,0.5482025045920579,1.0,17/75,10.58%,KCNJ3;KCNH2;SCNN1A;KCNE2;KCNJ8;GRIA2;TRPM2;GRIK5;GRIK2;GRIA1;KCNJ13;GRIN1;GRIA4;GRIN2B;ASIC1;ASIC2;KCNK6
prerank,cadherin binding (GO:0045296),-0.2849441779463038,-1.477282135916649,0.0,0.5643385990169504,1.0,82/315,15.93%,IQGAP1;EHD4;AHNAK;SLK;CDH12;EIF2A;CHMP4B;STK38;PDLIM1;FXYD5;RPS26;TRIM25;MARK2;OLA1;PDLIM5;AFDN;P2RX4;STX5;RAB1A;DHX29;PTPN1;ATIC;ENO1;SNX1;SH3GLB1;IDH1;CTNNA1;NCK1;STK24;CLINT1;ARHGAP18;CRKL;TBC1D2;PICALM;DIAPH3;ASAP1;PLEC;RPL6;SNX9;EPS15;ANXA1;GAPVD1;HNRNPK;PAICS;GLOD4;PSEN1;RPL15;DDX6;USP8;EEF1D;FMNL2;LDHA;ARVCF;CEMIP2;MAPRE1;STAT1;RAB10;RPL14;TMPO;CTNNB1;TES;SHTN1;RPL23A;CBL;TBC1D10A;PACSIN2;KDR;VASP;LRRFIP1;LARP1;RACK1;TAGLN2;YKT6;VCL;EGFR;STXBP6;CDH2;CDH24;MYH9;EPHA2;CAPZB;PI4KA
prerank,cation channel activity (GO:0005261),0.3792993777508045,1.4717602746702383,0.015193370165745856,0.5538904648011026,1.0,27/94,18.79%,HCN1;TMEM63C;TRPC3;CACNB2;SLC24A5;PKD1L1;TRPM3;TRPM2;KCNK3;TMEM63A;PKD2;GRIN1;TMEM63B;TRPC6;PANX1;CACNA1D;PKD1;UNC80;ABCC8;SLC24A3;ASIC3;KCNK9;CHRNA7;KCNQ4;SLC24A4;TRPV6;PKD2L2
prerank,sodium channel activity (GO:0005272),0.4460112714459763,1.4635113804901816,0.04047976011994003,0.5671070350785065,1.0,18/37,28.45%,HCN1;SCNN1A;GRIK5;GRIK2;PKD2;CACNA1G;ASIC1;ASIC2;SCN2A;ASIC3;SCN1B;SCN8A;GRIK3;GRIK4;SCN7A;KCNK1;CACNA1H;SCN1A
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5282798278587629,1.4590664091964198,0.05501618122977346,0.5655204120298748,1.0,7/18,19.35%,TGFBR3;TGFBR1;ACVR1B;AMHR2;ENG;LTBP4;BMPR1B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.5256045363909999,-1.458055147725078,0.0801781737193764,0.6085505222885038,1.0,7/14,25.68%,CYBB;KMO;CYBA;MICAL1;CYB5R4;NOX4;AIFM1
prerank,glycerophospholipid flippase activity (GO:0140333),0.5985852841302415,1.456970223973363,0.0625,0.5573950240802293,1.0,9/11,29.07%,ATP8A2;ABCB4;ATP11A;ATP8B1;ATP8A1;ATP8B2;ATP10B;ABCA3;ABCA4
prerank,outward rectifier potassium channel activity (GO:0015271),0.5993705664097171,1.4547651854531036,0.07325383304940375,0.5497075398854664,1.0,6/11,19.18%,KCND2;KCNA5;PKD2;KCNT2;KCNT1;KCNK2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4035676413149254,-1.4427190767469127,0.04087193460490463,0.637269323960495,1.0,12/35,14.21%,NR3C1;POU2F1;SMARCA4;TAF1;H3-3A;STAT1;AGO2;HDAC1;FOS;NPM1;UBTF;FOXP1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.4307130390939702,-1.4416022500973276,0.03608247422680412,0.6188673577864738,1.0,13/28,25.80%,RIPK1;PIDD1;STAT1;EDA;SIVA1;TNF;TRAF1;TRAF4;TRIM37;MYD88;BABAM2;FADD;TMBIM1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.4093657737022295,-1.4413189587523407,0.037940379403794036,0.5985010366294683,1.0,15/35,20.17%,PEAK1;ABL2;CSK;TEC;DYRK1A;SYK;LYN;FYN;HCK;LCK;FRK;PTK2B;ZAP70;PKDCC;MELK
prerank,phospholipase C activity (GO:0004629),0.4815804198226029,1.4344649920255297,0.05194805194805195,0.6129388253045893,1.0,5/25,7.57%,PLCH1;PLCL1;PLCD1;PLCG1;CCR1
prerank,poly-purine tract binding (GO:0070717),0.46664413971960705,1.432021781252944,0.038834951456310676,0.6061888240805363,1.0,14/27,30.10%,PABPC1L;PATL1;PABPC4L;ZC3H14;DDX1;KHDRBS2;RBMS3;TIA1;HNRNPDL;DDX3X;MCRS1;PABPC4;ELAVL4;RBMS2
prerank,glycine binding (GO:0016594),0.5914038169751026,1.429978109606294,0.07536764705882353,0.5988456220088562,1.0,5/11,9.82%,GLRA3;GLRB;GRIN1;GRIN2B;GLRA2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.4775145065478709,-1.4242270679413351,0.08133971291866028,0.6403113121319939,1.0,6/18,19.59%,PDLIM1;PDLIM5;ANXA1;RAB10;STXBP6;TRIM29
prerank,SUMO transferase activity (GO:0019789),-0.4955596324579357,-1.42418170433234,0.06683168316831684,0.6197654402989616,1.0,9/16,28.25%,NSMCE2;RANBP2;EGR2;PIAS2;MUL1;HDAC4;PIAS4;PIAS3;MDM2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.54101130306143,1.419834853993387,0.0812603648424544,0.6234657787541554,1.0,7/15,16.08%,ACKR4;CCR1;GPR17;CX3CR1;CCR6;ACKR2;CCR9
prerank,steroid hydroxylase activity (GO:0008395),0.5298068658385914,1.4173345269884372,0.07142857142857142,0.6170974754574285,1.0,4/16,15.42%,CYP2S1;CYP2U1;CYP39A1;CYP27A1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3743863462062922,-1.413587436346411,0.04285714285714286,0.6373621631799656,1.0,13/42,10.70%,SH3BP2;STAP1;ABL2;CRK;FBXW7;RASA1;LDLRAP1;CRKL;SYK;BCAR3;HCK;LCK;GRB2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3891246144990223,-1.4107066550943184,0.037463976945244955,0.627462839646222,1.0,6/38,4.21%,DENND1A;HIP1;KIF16B;SESTD1;PLA2G4E;SH3PXD2B
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.549589137983705,1.409344394791242,0.08963093145869948,0.6326783259623074,1.0,4/14,8.48%,ATP2A3;EBAG9;BCL2L13;NOD1
prerank,beta-tubulin binding (GO:0048487),0.4509678495083256,1.408159404614468,0.055031446540880505,0.6226973509277862,1.0,14/31,24.87%,DLEC1;PDCD5;MAP1S;EMD;LRPPRC;FGF13;PEX14;UXT;TAOK1;EML4;TTLL7;GABARAP;SPAST;TBCD
prerank,active ion transmembrane transporter activity (GO:0022853),0.43320457641983645,1.4069210377084604,0.052050473186119876,0.6126862974529311,1.0,12/37,24.47%,SLCO2B1;UQCRC1;SLC22A8;NDUFA4;UQCR11;SLC22A4;COX4I1;COX6B1;UQCR10;SLCO4A1;COX10;SLC16A7
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4901885435693425,-1.404744047775787,0.11455847255369929,0.6293437620928468,1.0,8/15,26.62%,SESTD1;PLA2G4E;SH3PXD2B;LANCL2;PLEKHF1;VEPH1;SAP30L;SNX3
prerank,kinase inhibitor activity (GO:0019210),-0.3998596481670151,-1.4022281602162003,0.055408970976253295,0.6197227488403971,1.0,15/33,23.28%,GMFG;NCK1;TAOK3;SMCR8;NPM1;QARS1;PRKRIP1;SPRY4;DUS2;LRP6;SOCS1;WARS1;GSKIP;DUSP19;ITPRIP
prerank,chloride channel activity (GO:0005254),0.39485395082568436,1.4021399516050053,0.05037037037037037,0.61724449844263,1.0,17/59,16.61%,GABRQ;GLRA3;GABRG1;GABRD;GABRG2;GLRB;GABRA2;ANO2;CLCN6;GLRA2;CFTR;SLC26A7;SLC1A4;CLCC1;GABRB1;GABRR2;ANO3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5511069394272088,-1.4008145360768778,0.10361445783132531,0.6074038623730489,1.0,5/11,25.88%,IQGAP1;SH3RF1;MAPK8IP3;DUSP19;KSR1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.35122994167086685,-1.3963315632406155,0.045454545454545456,0.604025603268506,1.0,16/56,16.83%,CBLB;GAS6;STAP1;ITGAX;FRS2;PTPN1;PCNA;NCK1;GAB2;BLNK;SOCS5;CBL;RACK1;SHC1;ELMO2;SQSTM1
prerank,phosphatase activator activity (GO:0019211),-0.5026554430962746,-1.39529364767682,0.1100244498777506,0.5913410945269112,1.0,7/14,17.80%,PPP2R5C;PPP2R5A;FRS2;CALM3;CALM2;BMP2;PPP1R15A
prerank,semaphorin receptor activity (GO:0017154),-0.5402415680587762,-1.3948163876790949,0.10514018691588785,0.5774241371308698,1.0,3/11,0.72%,PLXNC1;NRP1;NRP2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.572620011987665,1.3893283196776383,0.1001788908765653,0.6535139020427236,1.0,5/11,11.86%,TRPC3;CYTH2;ITPR2;TRPC6;ITPR3
prerank,growth factor activity (GO:0008083),0.372555223405703,1.3855207832121894,0.043835616438356165,0.6538322184741756,1.0,16/74,16.98%,FGF10;FGF16;FGF9;FGF7;IL6;AREG;IL2;CLCF1;FGF2;NRG3;PDGFB;INHA;THPO;IL7;AGT;ANGPTL3
prerank,amino acid:sodium symporter activity (GO:0005283),0.5811878186934436,1.3850886469856316,0.10215053763440861,0.6419461474699611,1.0,4/11,14.20%,SLC38A2;SLC1A1;SLC1A3;SLC6A1
prerank,calcium activated cation channel activity (GO:0005227),0.5099984621492561,1.3844686505680728,0.10157618213660245,0.63101740166346,1.0,6/17,16.27%,KCNMA1;TMEM63C;TMEM63A;TMEM63B;KCNN4;KCNMB3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4904409596857999,-1.382944657373175,0.08396946564885496,0.5986325175250371,1.0,9/15,23.37%,SETD3;PRDM9;WDR82;KMT2C;KMT2D;RBBP5;KMT2B;SETD1A;KMT2A
prerank,voltage-gated ion channel activity (GO:0005244),0.536082639296421,1.377517359280085,0.10380622837370242,0.6446190638271824,1.0,4/14,8.99%,HCN1;KCND2;VDAC1;PKD2
prerank,syntaxin-1 binding (GO:0017075),0.4806213269214564,1.377161334139355,0.0903010033444816,0.63313138215782,1.0,9/22,19.11%,SNAP25;SYT1;SYNPR;UNC13B;CPLX2;STXBP2;VAMP3;STXBP5;UNC13C
prerank,ligand-gated ion channel activity (GO:0015276),0.44038526715106124,1.3756985828789305,0.07644305772230889,0.6260444624420229,1.0,9/30,9.58%,GRIA2;GRIK5;GRIK2;GRIA1;CNGB1;GRID2;GRIN1;GRIA4;GRIN2B
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.38071900879040005,-1.37526394300911,0.06868131868131869,0.6084731558633996,1.0,12/38,15.65%,STAP1;DLG5;FRS2;NCK1;LDLRAP1;GAB2;BLNK;SORBS1;LRRK2;MAPK8IP3;SHC1;NUP62
prerank,protein kinase inhibitor activity (GO:0004860),-0.3774060516690862,-1.374739747719781,0.06353591160220995,0.5957341406049045,1.0,22/42,27.81%,GMFG;NCK1;CIT;CIB1;TAOK3;SMCR8;SPRY2;RACK1;NPM1;QARS1;PRKRIP1;SPRY4;DUS2;INKA1;INKA2;SOCS1;GSKIP;DUSP19;ITPRIP;CAMK2N2;SPRED1;DNAJC3
prerank,mechanosensitive ion channel activity (GO:0008381),0.5516204807236175,1.3747115066827256,0.11754684838160136,0.6175417756874327,1.0,4/12,10.84%,TMC3;TMC8;TMEM63A;TMEM63B
prerank,potassium channel activity (GO:0005267),0.35945013230896417,1.3736435449514104,0.0407055630936228,0.6095866219843237,1.0,22/89,19.18%,HCN1;KCNMA1;KCNK12;KCNH2;KCND2;KCNA5;KCNH7;KCNC1;KCNK3;GRIK5;GRIK2;PKD2;KCNK6;KCNN4;ABCC8;KCNC3;KCNMB3;KCNT2;KCNT1;KCNK9;KCNQ4;KCNK2
prerank,titin binding (GO:0031432),0.5367721760434638,1.372609288357915,0.10906040268456375,0.6020630138966496,1.0,4/13,9.01%,CAPN3;TRIM63;MYBPC3;ACTN2
prerank,ligand-gated channel activity (GO:0022834),0.4403912629840285,1.3702446145752785,0.08878504672897196,0.5996857533528641,1.0,9/29,9.58%,GRIA2;GRIK5;GRIK2;GRIA1;CNGB1;GRID2;GRIN1;GRIA4;GRIN2B
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.48403770292144827,1.3649182760746923,0.07931034482758621,0.6073444506942222,1.0,6/19,7.92%,GABRG1;GABRG2;GRIK5;GRIK2;GABRA2;GRID2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.56474043899027,1.3632598077793834,0.11904761904761904,0.6026556913496641,1.0,3/11,6.31%,RDH14;AKR1C1;AKR1B1
prerank,chemoattractant activity (GO:0042056),0.4585164872300658,1.357023655903137,0.0875796178343949,0.6148747486516006,1.0,8/26,19.32%,FGF10;FGF7;BMP4;FGF2;PDGFB;HMGB1;CCL15;CCL5
prerank,kinase binding (GO:0019900),-0.25718575213629546,-1.3540828244795393,0.0,0.6471958526503834,1.0,113/435,17.80%,IQGAP1;SASH1;SP100;MAP3K1;NR3C1;PTPN22;STAP1;AP2A2;BCL2L1;CRK;PTPN23;TPCN2;PTPRC;CDK5RAP2;PPP2R5A;CNOT9;TRIM14;ATG13;PRKAB1;LYST;KIF11;PRKACA;PTPN1;EEF1A1;IFNAR2;ESR1;BORA;LIMS1;TUBA4A;PRC1;CEP250;PPP1R12A;MSN;UTRN;RPS7;SMAD3;FAS;NOD2;ERCC6L2;TFRC;BCAR3;CCND1;CAV1;UBQLN1;PDCD10;CD24;KIF13B;TEX14;CIT;PRKAG2;EIF4ENIF1;BLNK;HIF1A;CD226;HSF1;RACGAP1;CDKN2C;SIKE1;SMCR8;WDCP;MAPRE1;CENPJ;ADCY6;GPRC5B;PGAM1;SPRY2;LCK;AGAP2;GRB2;CTNNB1;GHR;ATF5;BARD1;CALM3;CCNA2;CSPG4;SKAP1;CEACAM1;IRAK4;FAM83H;EMP2;CCND2;TRIM5;CEP68;CALM2;RB1;PTN;MTCP1;SIK1;NPM1;QARS1;PRKRIP1;EGFR;SHC1;PRKAB2;HSPB1;TNS2;CDC25A;CHP1;RELB;PLK1;KIF20A;PEBP1;BCAR1;SQSTM1;SLC12A7;PFKL;MAP2K7;GSN;RGCC;DCTN2;FLNA;PPP1R15A
prerank,vinculin binding (GO:0017166),-0.5312237950640526,-1.3535122621485252,0.14418604651162792,0.6345923211148123,1.0,6/11,10.50%,PXN;ACTN1;CTNNA1;UTRN;DAG1;SORBS3
prerank,anion channel activity (GO:0005253),0.38088472823686936,1.3533237926541304,0.0734632683658171,0.6170309057280517,1.0,17/61,16.61%,GABRQ;GLRA3;GABRG1;GABRD;VDAC1;GABRG2;GLRB;GABRA2;ANO2;GLRA2;CFTR;SLC26A7;SLC1A4;CLCC1;GABRB1;GABRR2;ANO3
prerank,semaphorin receptor binding (GO:0030215),0.4476758600977246,1.3423388698032763,0.11409395973154363,0.6466855011744814,1.0,10/23,19.02%,SH3BP1;SEMA7A;SEMA6C;SEMA6B;RIT2;SEMA3D;SEMA4F;SEMA4B;SEMA3C;PLXNB1
prerank,phospholipase A2 activity (GO:0004623),0.44342819310791354,1.3373831791858666,0.1266025641025641,0.6550972359159317,1.0,5/26,6.61%,PRDX6;PLAAT5;PLA2G3;PLA2G4C;PNPLA3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.505252693790768,-1.3362002632114394,0.12561576354679804,0.6774302627088392,1.0,6/12,14.04%,POU2F1;TAF1;H3-3A;STAT1;HDAC1;FOS
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.536562246184518,1.3361850077781465,0.12207357859531773,0.6490624405210982,1.0,5/12,19.35%,TGFBR3;TGFBR1;ENG;LTBP4;BMPR1B
prerank,P-type ion transporter activity (GO:0015662),0.5373335479697822,1.3335945040012378,0.12931034482758622,0.6489107824026497,1.0,4/12,12.76%,ATP2A3;ATP2A2;ATP2C1;ATP2B3
prerank,sterol transfer activity (GO:0120015),-0.46195862597534887,-1.3287763935659747,0.14563106796116504,0.6871161961003094,1.0,7/17,16.15%,NPC2;OSBP;PLTP;OSBPL2;ABCG1;GRAMD1C;GRAMD1B
prerank,glutamate receptor activity (GO:0008066),0.46822747113188473,1.3258939186635545,0.1272430668841762,0.666596964082196,1.0,7/19,9.38%,GRIA2;GRM3;GRIK5;GRIK2;GRIA1;GRID2;GRIA4
prerank,protein kinase binding (GO:0019901),-0.2521143997398172,-1.324515763414109,0.0,0.6864865185184196,1.0,118/480,17.42%,IQGAP1;NEDD9;SASH1;MAP3K1;NR3C1;DUSP16;STAP1;AP2A2;BCL2L1;CASS4;CSK;CRK;PTPN23;STK38;NBR1;TPCN2;PTPRC;PDLIM5;CDK5RAP2;PJA2;TRIM14;ATG13;PRKAB1;LYST;KIF11;PRKACA;RARA;PTPN1;EEF1A1;IFNAR2;TOP2A;MAPKAPK2;ESR1;BORA;LIMS1;TUBA4A;PRC1;CEP250;ADAM9;PPP1R12A;MSN;UTRN;RPS7;SMAD3;NOD2;ERCC6L2;TFRC;CCND1;CAV1;PDCD10;CD24;KIF13B;TEX14;RNF13;CIT;PRKAG2;BLNK;HIF1A;YWHAG;CD226;HSF1;BANK1;RACGAP1;CDKN2C;SIKE1;SMCR8;MAPRE1;CENPJ;MAD2L2;MAP3K11;ADCY6;GPRC5B;PGAM1;SPRY2;LCK;AGAP2;GRB2;GHR;MAPKAPK3;CALM3;CCNA2;CSPG4;SKAP1;PRKCSH;CEACAM1;IRAK4;FAM83H;CAVIN3;EMP2;CCND2;TRIM5;MAPK8IP3;CEP68;CALM2;PTN;RACK1;MTCP1;DUSP1;SIK1;NPM1;QARS1;PRKRIP1;SHC1;PRKAB2;HSPB1;CDC25A;RELB;PARD6A;MAPK7;PLK1;KIF20A;PEBP1;BCAR1;SQSTM1;SLC12A7;MAP2K7;RGCC;DCTN2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2812527223620306,-1.3232840073407277,0.01838235294117647,0.6759505886137275,1.0,29/147,10.13%,VAV3;FGD4;DENND1A;ITSN1;FGD6;RIC1;RCC1L;DENND4C;DENND1B;DOCK2;RIC8A;LAMTOR5;CCDC88C;ARHGEF18;ARHGEF6;RASGRP4;HPS1;DENND6B;GAPVD1;CYTH3;FGD1;EIF2B2;SMCR8;RASGRP2;EEF1D;DENND2A;RABGEF1;ABR;CYTH1
prerank,cyclic nucleotide binding (GO:0030551),0.4557597477456471,1.3228023397121522,0.13365539452495975,0.6670759197301407,1.0,10/21,31.67%,HCN1;PDE4A;CNGB1;SLC19A1;POPDC3;PDE11A;RAPGEF2;KCNH1;RAPGEF4;PDE10A
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5331909770681096,1.3214046218737527,0.13854351687388988,0.6615614268390486,1.0,3/12,8.48%,ATP2A3;BCL2L13;NOD1
prerank,protein phosphatase binding (GO:0019903),-0.2912223423033391,-1.3208717237426777,0.03875968992248062,0.6694645455987205,1.0,34/117,17.80%,IQGAP1;PXN;KIF3A;VCP;ENSA;MET;TBK1;PPP6R1;PTPA;AP3B1;SHOC2;PPP6R3;BOD1;MTMR4;AKAP11;CDC27;LCK;CTNNB1;FOXO1;PPP1R3C;SKAP1;CEACAM1;PPP1R3F;PPP1R3E;RACK1;ARPP19;EGFR;LILRB1;ITGA1;MTMR3;RPA2;AKAP5;MAP2K7;PPP1R15A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.49944687612834626,1.3175651837113107,0.11467116357504216,0.656360025429823,1.0,4/16,4.66%,PTPRD;PTPRT;PTPRU;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.49944687612834626,1.3175651837113107,0.11467116357504216,0.656360025429823,1.0,4/16,4.66%,PTPRD;PTPRT;PTPRU;PTPRO
prerank,mRNA 5'-UTR binding (GO:0048027),-0.40914862961220677,-1.3166660369819405,0.1095890410958904,0.6706491815111348,1.0,8/24,13.81%,RPL5;RPS14;RPS13;RPS7;LARP6;SYNCRIP;LARP1;RPL41
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3867574509911229,1.3158978607014036,0.1015625,0.653450506624398,1.0,18/46,23.38%,HEXB;B3GNT9;B3GNT6;B4GAT1;B3GALT2;PIGQ;PIGP;OGT;B3GALNT1;MGAT5B;MGAT4B;POMGNT1;GCNT7;GCNT4;GCNT1;LARGE1;EXT2;RFNG
prerank,chemokine receptor binding (GO:0042379),-0.3707843707959045,-1.313180639920769,0.09776536312849161,0.6699044248310376,1.0,6/35,15.58%,ITCH;CXCL16;CCL25;PF4;CCRL2;CCL28
prerank,ionotropic glutamate receptor activity (GO:0004970),0.48495433174135866,1.3130014955952554,0.14597315436241612,0.6539774411779254,1.0,7/17,9.58%,GRIA2;GRIK5;GRIK2;GRIA1;GRIN1;GRIA4;GRIN2B
prerank,poly-pyrimidine tract binding (GO:0008187),0.44103670413934365,1.3087972161095789,0.1206611570247934,0.6597870931061754,1.0,5/23,6.03%,PABPC1L;PATL1;PABPC4L;HNRNPH1;PTBP1
prerank,neuropeptide binding (GO:0042923),0.4729386776640229,1.3083372298712759,0.12714776632302405,0.6522021302969825,1.0,5/18,22.73%,NMUR1;MC4R;OPRM1;OPRD1;SSTR2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5379150955654217,1.3043460755995764,0.14160839160839161,0.6578769330063892,1.0,3/10,7.88%,GABRG1;GABRG2;GABRA2
prerank,chemokine binding (GO:0019956),0.4178335962821302,1.3032726391282545,0.13853503184713375,0.6525708861455365,1.0,11/30,16.08%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;FGF2;CXCR4;CCR6;HMGB1;ACKR2;CCR9
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.47944761670705727,-1.3014627247510708,0.12686567164179105,0.6955856309028469,1.0,5/13,8.67%,TARBP1;TRMT10C;THUMPD3;WDR4;TRMT1L
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5520693880516249,1.2995835824235507,0.15384615384615385,0.6569927925903334,1.0,4/10,17.85%,IGSF11;SHANK3;GNAS;SHANK1
prerank,actin monomer binding (GO:0003785),-0.41640559848974235,-1.2955124127905007,0.1362397820163488,0.7045023863478829,1.0,9/22,21.28%,MTSS1;ABL2;PRKCE;ABITRAM;COBL;PFN2;LIMA1;TMSB4X;MYL4
prerank,water transmembrane transporter activity (GO:0005372),-0.5102650055304209,-1.292677115794333,0.18009478672985782,0.7005150615288658,1.0,5/11,36.42%,AQP11;PDPN;AQP1;SLC5A1;SLC4A11
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.36724089997422316,-1.2913213249028628,0.10704225352112676,0.6927904580777433,1.0,13/34,16.38%,UBE2D3;UBE2K;BIRC6;TAF1;UBE2Q1;CDC34;UBE2L3;UFC1;UBE2Q2;AKTIP;UBE2E3;UBE2L6;UBE2C
prerank,Tat protein binding (GO:0030957),-0.5006441916244427,-1.2879919237086304,0.15753424657534246,0.6908291476294897,1.0,2/10,3.30%,MDFIC;SMARCA4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.37241380158842874,-1.2844905293571673,0.1335149863760218,0.689927674187607,1.0,12/31,16.38%,UBE2D3;UBE2K;BIRC6;TAF1;UBE2Q1;CDC34;UBE2L3;UBE2Q2;AKTIP;UBE2E3;UBE2L6;UBE2C
prerank,poly(U) RNA binding (GO:0008266),0.44533119389856024,1.2803794939322581,0.16440677966101694,0.7181575380897305,1.0,4/20,3.76%,PABPC1L;PATL1;PABPC4L;HNRNPH1
prerank,DNA secondary structure binding (GO:0000217),-0.37648658395216933,-1.2780689962888794,0.13227513227513227,0.6981148588426787,1.0,11/31,20.30%,RAD51B;RBBP8;LIN54;HMGB2;CLSPN;YY1;HMGA2;FANCM;XPC;NEIL3;HMGA1
prerank,adenylyltransferase activity (GO:0070566),-0.41517082561858165,-1.2739625619574195,0.14173228346456693,0.6985182980250645,1.0,9/21,19.82%,OAS2;OASL;FLAD1;TENT2;OAS3;FICD;NMNAT3;TENT4B;TENT4A
prerank,ion channel activity (GO:0005216),0.33558903158629133,1.2724366559639884,0.10623229461756374,0.7394115977377267,1.0,19/80,12.64%,TMC3;TMC8;GRIA2;TRPM3;TRPM2;KCNK3;TMEM63A;GRIK5;GRIK2;GRIA1;CNGB1;GRID2;PKD2;GRIN1;GRIA4;GRIN2B;TMEM63B;TRPC6;UNC80
prerank,CXCR chemokine receptor binding (GO:0045236),-0.5079157368408407,-1.2723448105901387,0.17433414043583534,0.6921673773443537,1.0,2/11,5.70%,ITCH;PF4
prerank,cAMP binding (GO:0030552),0.520224290726738,1.2698285844153017,0.17353951890034364,0.7397421109477871,1.0,2/11,4.42%,HCN1;PDE4A
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.47126749362857545,1.2679739039255336,0.17123287671232876,0.7282258489860782,1.0,7/17,20.52%,EFNA4;EFNB3;EPHA1;EFNA3;EPHA4;EPHB2;EPHA5
prerank,ephrin receptor activity (GO:0005003),0.47126749362857545,1.2679739039255336,0.17123287671232876,0.7282258489860782,1.0,7/17,20.52%,EFNA4;EFNB3;EPHA1;EFNA3;EPHA4;EPHB2;EPHA5
prerank,voltage-gated sodium channel activity (GO:0005248),0.438417808143392,1.2651123111548879,0.15726495726495726,0.7298003173567005,1.0,10/22,28.45%,HCN1;PKD2;CACNA1G;SCN2A;SCN1B;SCN3B;SCN8A;SCN7A;CACNA1H;SCN1A
prerank,platelet-derived growth factor binding (GO:0048407),0.5173632211125215,1.2639377300562054,0.175,0.7251153139124098,1.0,5/11,21.50%,COL5A1;COL2A1;PDGFB;PDGFRB;COL6A1
prerank,chemokine activity (GO:0008009),-0.36448438353862145,-1.2622766534888774,0.13192612137203166,0.7129537591877548,1.0,11/31,37.19%,CXCL16;CCL25;PF4;CCL28;CXCL12;CCL7;CCL24;CKLF;CCL8;CXCL9;CXCL1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4013348419605364,-1.2600024396092437,0.16112531969309463,0.7086521807957962,1.0,5/22,4.12%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.36951306355754365,-1.256376544390891,0.1475,0.7095083238672821,1.0,18/29,39.56%,DUSP16;NBR1;MAPKAPK2;MAPKAPK3;DUSP1;MAPK7;TNIP1;DUSP7;GCH1;PPM1D;PRMT1;DUSP4;DUSP8;DUSP9;NFATC1;DUSP6;PTPRJ;MAPK14
prerank,SH2 domain binding (GO:0042169),-0.3639036020874989,-1.253780602603568,0.15942028985507245,0.7072308676021198,1.0,14/31,21.10%,CRK;SH3PXD2B;BLNK;DAG1;LCK;SKAP1;SLAMF1;RACK1;NLK;LILRB1;NUP62;SQSTM1;AFAP1L2;LAX1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.324659069873349,-1.2516692913558283,0.1,0.7031637252325229,1.0,16/49,17.30%,VCP;ZRANB3;TNIP3;UBL7;UBQLN1;EPS15;BAG6;ABRAXAS1;ATRIP;RAD23B;WDR81;FAAP20;OPTN;SQSTM1;UIMC1;BRCC3
prerank,ribosome binding (GO:0043022),-0.33332823703631703,-1.2488665069516984,0.15056818181818182,0.7022154100503863,1.0,21/46,25.81%,EIF2A;ETF1;SHFL;IGHMBP2;NAA10;NAA16;BAG6;CPEB4;ZC3H12A;EIF2S1;SRP72;SEC61A1;RACK1;GTPBP6;NOMO1;CPEB2;EFL1;CPEB3;PYM1;MRPS27;SERBP1
prerank,calcium-activated potassium channel activity (GO:0015269),0.5060066905843693,1.248310492481689,0.20379965457685664,0.7757246483221221,1.0,5/11,22.48%,KCNMA1;KCNN4;KCNMB3;KCNN3;KCNN2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.48122345444717063,-1.2481746348264977,0.19854721549636803,0.6940109686893341,1.0,4/12,7.43%,XDH;CIAPIN1;SDHB;CISD2
prerank,GTPase activator activity (GO:0005096),-0.24254745340072,-1.2472247713570235,0.03571428571428571,0.6872606669148019,1.0,60/313,12.63%,IQGAP1;VAV3;ARHGAP15;IQGAP2;FGD4;DENND1A;ITSN1;ARHGAP10;FGD6;RIC1;NRP1;TBC1D1;STARD8;ARHGEF10L;RCC1L;DENND4C;DENND1B;ARHGAP17;DOCK2;ARHGAP19;RANBP2;RIC8A;RASA4;LAMTOR5;CCDC88C;ARHGEF18;RASA1;ARHGEF6;RABGAP1;RASGRP4;ARHGAP18;TBC1D2;ASAP1;ARAP1;ARHGAP30;HPS1;DENND6B;GAPVD1;CYTH3;FGD1;RACGAP1;ARHGAP24;EIF2B2;SMCR8;RASGRP2;EEF1D;DENND2A;RABGEF1;SEC23A;ABR;CYTH1;AGAP2;RALGAPA2;RANBP3;ARHGAP39;ARHGAP28;TBC1D10C;LRRK2;TBC1D10A;DENND5A
prerank,gated channel activity (GO:0022836),0.4746389067706101,1.2469362925946492,0.19435215946843853,0.7717046463512126,1.0,4/14,10.84%,TMC3;TMC8;TMEM63A;TMEM63B
prerank,leak channel activity (GO:0022840),0.4443776025131114,1.2435894296128058,0.15309446254071662,0.7757160028883056,1.0,6/18,19.18%,KCNK12;KCNK3;KCNK6;PANX1;KCNK9;KCNK2
prerank,exoribonuclease activity (GO:0004532),-0.4644593720981751,-1.2403045686118057,0.21323529411764705,0.6988804545244451,1.0,6/12,24.37%,EXOSC8;ZC3H12A;EXOSC10;EXOSC9;EXOSC1;EXOSC7
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4753505462551483,1.239804978003659,0.18537414965986396,0.781106255709908,1.0,4/15,12.99%,GPR34;P2RY12;P2RY1;GPR171
prerank,DNA replication origin binding (GO:0003688),-0.3860061799705052,-1.2389860252124634,0.18253968253968253,0.693318658385483,1.0,9/23,15.38%,ORC5;HSPD1;ORC2;GRWD1;MCM2;ORC4;MCM9;MCM8;KAT7
prerank,ribosomal small subunit binding (GO:0043024),-0.42939439819015846,-1.238937292186648,0.1836734693877551,0.6836809039596967,1.0,7/17,18.10%,EIF4B;DHX29;PIM1;LARP1;NPM1;CPEB2;EIF1B
prerank,potassium ion leak channel activity (GO:0022841),0.4561868670650775,1.23892406330905,0.1986970684039088,0.775569664391454,1.0,5/15,19.18%,KCNK12;KCNK3;KCNK6;KCNK9;KCNK2
prerank,DNA polymerase binding (GO:0070182),-0.4150464467569163,-1.2351879661016438,0.17632850241545894,0.6851063662860258,1.0,7/18,19.26%,SMARCA4;PCNA;RTEL1;CDT1;FANCI;SMG6;NAT10
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.45926352778324886,1.2332094431401117,0.20431893687707642,0.7891878796356541,1.0,3/16,4.32%,IDO2;ALOX12;BCO2
prerank,cAMP response element binding (GO:0035497),-0.4973358781919328,-1.2331436490419818,0.2136150234741784,0.68212848965887,1.0,5/10,28.34%,CREB5;CREB3L1;HMGA2;ATF2;CREB1
prerank,hydro-lyase activity (GO:0016836),0.370011472383494,1.2276887939236634,0.17061611374407584,0.8018562815298568,1.0,6/41,4.80%,IREB2;CYP2S1;ECHDC1;CA1;CA3;CA4
prerank,NAD binding (GO:0051287),-0.37151826995643883,-1.2237197753723283,0.18508997429305912,0.7022538089966824,1.0,11/26,22.41%,HSD17B8;CRYZ;SORD;PARP9;ALDH1A1;NUDT6;ZC3HAV1;GRHPR;SIRT2;ALDH2;ALDH1B1
prerank,"DNA binding, bending (GO:0008301)",0.47842345461773306,1.2226278170829061,0.21122112211221122,0.8130417755600349,1.0,6/14,15.28%,HHEX;TFAM;FOXD1;FOXC1;HMGB1;HMGB3
prerank,heme binding (GO:0020037),0.33023224308933763,1.2221195830798135,0.14852941176470588,0.8060774047166421,1.0,14/65,17.33%,CYP2S1;CYP2U1;SLC48A1;HEBP2;ABCB6;PGRMC2;FLVCR1;SDHC;PXDN;HEBP1;CYP27A1;PGRMC1;BACH1;CYB5B
prerank,phosphatase binding (GO:0019902),-0.27489329192782486,-1.2217367174249534,0.08455882352941177,0.6988555670188019,1.0,28/105,17.21%,IQGAP1;PXN;KIF3A;VCP;MET;TBK1;PPP6R1;AP3B1;SHOC2;PPP6R3;PPP3R1;SMAD3;MTMR4;CRY2;CDC27;LCK;CTNNB1;PPP1R3C;SKAP1;CRY1;CEACAM1;PPP1R3F;RACK1;EGFR;ITGA1;MTMR3;RPA2;MAP2K7
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.42014549636946347,1.2208526600384093,0.19218241042345277,0.8018259206523908,1.0,4/23,7.57%,PLCH1;PLCD1;PLCG1;CCR1
prerank,chloride channel inhibitor activity (GO:0019869),0.5071005835505016,1.2162904829534984,0.25,0.8110808668459919,1.0,7/10,35.74%,CFTR;WNK1;VTI1B;WNK4;STX8;WNK3;STX7
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4250251716323335,1.215412875972657,0.23421926910299004,0.805794997226981,1.0,6/20,14.01%,DGAT2;PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5
prerank,N-acyltransferase activity (GO:0016410),0.38464601925018993,1.2140205297492739,0.1949579831932773,0.8028967228415035,1.0,11/32,17.18%,PLAAT5;SAT2;TLCD3B;SMARCE1;NAT8L;CERS4;CERS5;CERS6;CERS1;ESCO1;NMT1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.39656929012255676,1.2134018990701378,0.20903010033444816,0.7969976005876611,1.0,7/26,19.66%,B3GNT9;B3GNT6;B3GALT2;B3GALNT1;CSGALNACT1;B4GALNT3;CHSY1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3240028500000655,1.2096666776584313,0.1661721068249258,0.8032625697278014,1.0,21/70,23.38%,HEXB;B3GNT9;B3GNT6;B4GAT1;B3GALT2;GXYLT1;OGT;B3GALNT1;CSGALNACT1;MGAT4B;POMGNT1;GCNT7;B3GAT3;B4GALNT3;GCNT4;CHSY1;GCNT1;LARGE1;UGT1A6;EXT2;RFNG
prerank,endopeptidase inhibitor activity (GO:0004866),0.3186992617423593,1.2086228739988207,0.13714285714285715,0.7987908809445733,1.0,10/82,7.99%,GAPDH;SPOCK3;BIN1;CST3;SPOCK2;PRNP;PSMF1;SERPINH1;SPINT2;UBE2Z
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5067262989140058,1.2076712224120207,0.23333333333333334,0.7946148947481275,1.0,1/10,0.83%,SLCO2B1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.46140799870265514,-1.2032189595124514,0.2132701421800948,0.7495969339520872,1.0,2/11,2.72%,PRPF19;UBE2K
prerank,insulin-like growth factor I binding (GO:0031994),0.4705717616780263,1.2012590224360054,0.22126929674099485,0.8111216086993412,1.0,5/13,16.97%,IGFBP6;LRP2;IGFBP2;INSR;ITGA6
prerank,acetylcholine receptor activity (GO:0015464),-0.3775685779033675,-1.1988587335235765,0.21158690176322417,0.7535951168370624,1.0,9/22,35.54%,CHRM2;CHRNB2;CHRNA4;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3725835955014865,1.1972360598929364,0.20707070707070707,0.8188377575967876,1.0,12/33,23.51%,MAF1;CTR9;SMYD2;ELP2;RRN3;SPTY2D1;CCAR2;PAF1;ELOF1;SCAF8;ELP4;GTF2B
prerank,cysteine-type peptidase activity (GO:0008234),0.31957526292053035,1.193958762882293,0.16502115655853314,0.8232134049825204,1.0,23/73,21.54%,USP10;CAPN3;USP35;OTULINL;LGMN;USP11;USP50;USP30;ATG4A;GGH;USP12;CASP3;SFRP1;CASP4;USP33;CASP7;OTUD7B;CTSK;USP48;CASP8;USP49;CASP2;CTSS
prerank,nuclear import signal receptor activity (GO:0061608),-0.427078105510094,-1.1908051866583422,0.23880597014925373,0.7696864156708579,1.0,5/15,21.12%,KPNB1;KPNA2;HIKESHI;KPNA3;RANBP6
prerank,snoRNA binding (GO:0030515),-0.34458948120960237,-1.1891182472609512,0.18489583333333334,0.7649917256569781,1.0,11/30,19.48%,UTP6;BYSL;NOP58;NUDT5;TSR1;WDR3;TBL3;DDX21;NOP10;NUDT7;DKC1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.24657468408285504,-1.1877966797561492,0.07650273224043716,0.7598777660530125,1.0,49/188,18.14%,ARID4B;SOX6;LIN54;ATF3;GABPB2;CDK5RAP2;HMGB2;TCF12;PPARG;CIITA;SOX11;AHR;PROX1;NFKB1;ETV5;YY1;SMAD3;SP1;CEBPB;PRDM9;EGR2;BCOR;YAP1;TBL1X;BRCA1;HSF1;CRY2;HINFP;MZF1;CTCF;ATF5;SMAD6;FOXJ1;TCF7;NR1H3;AHRR;CREB3L1;ZBTB20;FOS;KMT2D;TNF;FOXK2;KLF11;ARID5B;SMAD4;GATA3;HMGA2;GLIS2;PER2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4483971306482959,1.1865927527863778,0.23711340206185566,0.8439323265934466,1.0,5/15,11.61%,SLC1A1;SLC25A18;SLC38A7;SLC1A3;SLC1A4
prerank,insulin-like growth factor binding (GO:0005520),0.44643260725489964,1.1863534097084192,0.2341880341880342,0.8368572552221043,1.0,6/15,16.97%,IGFBP6;LRP2;IGFBP2;INSR;IGFALS;ITGA6
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.39022141485467565,1.185787112984091,0.2353870458135861,0.8311931466327802,1.0,13/27,27.31%,POLR2L;POLR2F;POLR3F;POLR2G;POLR3A;POLR1F;PRIM1;POLR3B;POLR2C;POLR3K;POLR2D;POLR1A;POLRMT
prerank,carboxypeptidase activity (GO:0004180),-0.3370050704012674,-1.185585632484498,0.2,0.7574703971470028,1.0,8/35,9.95%,CPD;CPA6;PEPD;AGTPBP1;CPE;AGBL5;CTSA;CPM
prerank,alpha-tubulin binding (GO:0043014),0.37949026385971557,1.1852032714580847,0.2396825396825397,0.8255051328548009,1.0,9/31,18.29%,DIP2B;DLEC1;BEX4;ARL4C;TBCE;DNAL1;TAOK1;EML4;TTLL7
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4637544130822048,1.1840230532748464,0.25752508361204013,0.8223331222266531,1.0,5/13,15.55%,ARHGDIG;ARHGDIA;ITGB1BP1;GDI1;SH3BP4
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4547065211679853,-1.1824277170498525,0.24311926605504589,0.758951912505462,1.0,8/12,35.07%,GPR88;OPN3;RRH;GPR52;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,histone acetyltransferase activity (GO:0004402),-0.3452219744380098,-1.1814938911562287,0.18181818181818182,0.7528432975904702,1.0,9/30,15.38%,BAZ1A;EPC1;KAT6B;EPC2;TAF1;EP300;HAT1;KAT5;KAT7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.37708628114098475,-1.1806708712259137,0.21666666666666667,0.7466783827146449,1.0,10/22,25.31%,DUSP16;MTMR2;DUSP18;CDKN3;DUSP1;MTMR3;PPM1F;DUSP19;DUSP3;DUSP7
prerank,RNA cap binding (GO:0000339),0.4371369167775898,1.179834097930994,0.2542372881355932,0.830403712103473,1.0,7/16,18.83%,LSM1;NCBP3;SNUPN;CYFIP1;GEMIN5;EIF4A1;EIF3D
prerank,RNA methyltransferase activity (GO:0008173),-0.3931568713287807,-1.1757571640202096,0.22391857506361323,0.753524517514884,1.0,8/19,16.76%,FTSJ3;MRM2;LCMT2;METTL8;TRDMT1;TRMT13;TRMT9B;FBL
prerank,sterol binding (GO:0032934),-0.297347246371429,-1.1753435067806075,0.1786743515850144,0.7459055030546171,1.0,19/56,21.48%,OSBPL8;NPC2;OSBP;STARD3NL;OSBPL9;OSBPL1A;GPR183;CAV1;ERLIN2;OSBPL2;ABCG1;OSBP2;NR1H3;GRAMD1C;GRAMD1B;SULT2B1;VDAC2;INSIG1;PTCH1
prerank,phosphatidylinositol binding (GO:0035091),-0.2694805768610743,-1.1742233715602406,0.1263537906137184,0.7408380337978947,1.0,14/91,6.79%,DENND1A;HIP1;SNX24;SESTD1;DENND1B;SNX8;PLEKHF2;SNX1;FCHO2;ZFYVE16;HIP1R;PICALM;ITPR1;SNX9
prerank,metallocarboxypeptidase activity (GO:0004181),-0.36233951951747906,-1.168273172563552,0.23115577889447236,0.7514969878368735,1.0,7/26,9.95%,CPD;CPA6;PEPD;AGTPBP1;CPE;AGBL5;CPM
prerank,cholesterol transfer activity (GO:0120020),-0.409472158256012,-1.1670473771663763,0.2755344418052256,0.7473437573896543,1.0,6/16,16.15%,NPC2;PLTP;OSBPL2;ABCG1;GRAMD1C;GRAMD1B
prerank,diacylglycerol kinase activity (GO:0004143),0.47930698473386707,1.163542011018741,0.27474402730375425,0.8865682552132472,1.0,5/11,20.70%,DGKI;DGKQ;DGKZ;DGKE;DGKH
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3736656388024354,1.1626209113623602,0.23178807947019867,0.8821211085814517,1.0,6/28,7.92%,GABRG1;GABRG2;GRIK5;GRIK2;GABRA2;GRID2
prerank,carboxylic acid binding (GO:0031406),0.3573111189989708,1.1617945680449704,0.2543720190779014,0.8776541832066175,1.0,8/38,11.49%,GLRA3;AKR1C1;EPDR1;GLRB;GRIN1;GRIN2B;GLRA2;MAG
prerank,mRNA binding (GO:0003729),-0.23119503507487826,-1.1616638474604666,0.09202453987730061,0.756024023128734,1.0,68/249,20.95%,RBM47;HNRNPLL;NOVA2;SRSF4;EIF2A;CELF1;NOCT;RPS26;ZC3H12D;HNRNPM;RPL5;NCBP1;ETF1;PURB;RBM8A;RPS14;DHX33;SAMD4A;PUM2;EIF2S2;RPS13;SLC4A1AP;SHFL;RPS7;RPS5;HNRNPAB;LUC7L;HNRNPK;EIF4ENIF1;DDX6;LARP6;CPEB4;AQR;ZC3H12A;CRYZ;SSB;DCP1B;RC3H1;ZC3H12B;RBPMS;HNRNPA2B1;LUC7L2;CSTF2;AGO2;SYNCRIP;TYMS;NSRP1;LARP1;RPL41;PCF11;RC3H2;RBMX;LARP4B;FXR2;UPF3B;CPEB2;EIF3A;CELF3;RNF20;SNRNP35;SRBD1;CELF2;RPL26;HNRNPC;HNRNPU;PUM1;PTBP3;DHFR
prerank,anion:anion antiporter activity (GO:0015301),0.42414458151056605,1.1577053083195414,0.26353790613718414,0.8864360831736582,1.0,5/17,14.50%,SLC25A4;SLC26A4;SLC26A7;SLC25A5;SLC19A1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4574022392967111,1.1577042600370628,0.25259515570934254,0.8785996943356472,1.0,4/13,14.97%,DNASE1;DNASE1L2;FAN1;FEN1
prerank,metalloaminopeptidase activity (GO:0070006),0.4381645222353206,1.1573243231982118,0.27823240589198034,0.8723518549652781,1.0,7/16,18.17%,MMP16;RNPEPL1;XPNPEP1;XPNPEP3;TRHDE;ENPEP;MMP17
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.49341478976788383,1.1540710717740195,0.2826086956521739,0.8772702632560495,1.0,4/10,6.07%,LACC1;ADARB2;APOBEC2;ADA
prerank,3'-5' DNA helicase activity (GO:0043138),0.42384751490904116,1.1536134575735286,0.27303754266211605,0.8716355451570742,1.0,2/16,1.07%,NAV2;MCM5
prerank,aspartic-type peptidase activity (GO:0070001),0.483294768439674,1.1532159886171287,0.26287744227353466,0.8656469227925316,1.0,2/10,6.03%,ASPRV1;BACE1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2803841416524155,1.1520279774842697,0.17757009345794392,0.862759356190359,1.0,40/134,24.72%,SLC4A8;SLC35A1;SLCO2B1;SLC25A2;SLC5A12;SLC38A2;SLC1A1;SLC2A2;SLC38A9;SLC25A18;SLC38A7;SLC26A4;SFXN1;CFTR;SLC26A7;MFSD10;SLC1A3;SLC39A8;CTNS;SLC1A4;SLC66A1;SFXN2;SLC3A1;SLC6A1;SLC19A1;MPC1;SLC25A23;SLC16A12;SLC35B2;SLC13A3;ABCG2;SLC25A38;SLC6A9;SLC38A3;SLC19A2;SLC6A7;SLC35B1;SLCO4A1;SLC16A7;SLC25A1
prerank,carboxy-lyase activity (GO:0016831),0.39271090670103026,1.151924081477957,0.2766990291262136,0.855959700926135,1.0,8/23,19.79%,ECHDC1;PPCDC;CSAD;AZIN2;UXS1;UROD;FAHD1;BCKDHA
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3067951531999048,-1.150167764854316,0.225,0.7850602800410781,1.0,6/47,4.50%,SLC38A6;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4460266429226267,-1.1478569781572463,0.2989010989010989,0.7841160680128866,1.0,6/11,35.21%,CHRNB2;CHRNA4;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.30229712475180914,-1.1473075828283374,0.2034383954154728,0.7774826128929758,1.0,19/44,23.99%,NSD2;SETDB2;SETD7;DOT1L;SETD3;PRDM9;WDR82;KMT2C;EHMT1;KMT2D;RBBP5;SMYD3;EED;KMT2B;SETD2;SETD1A;MECOM;KMT2A;EZH2
prerank,four-way junction DNA binding (GO:0000400),-0.39358800779637015,-1.1464128271875862,0.27941176470588236,0.7720719819164669,1.0,3/17,5.48%,RAD51B;HMGB2;YY1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4884536025135161,1.1458306383328531,0.2743362831858407,0.8723692840058797,1.0,6/10,34.47%,APEX1;FEN1;EXD2;TATDN1;POLD1;MGME1
prerank,FMN binding (GO:0010181),0.47375129409387284,1.14235688267106,0.2679509632224168,0.878594084448153,1.0,2/11,4.44%,PPCDC;NDOR1
prerank,syntaxin binding (GO:0019905),0.3196888707717383,1.1422700883560801,0.23839009287925697,0.8716954917816628,1.0,17/61,19.11%,SNAP25;SCFD2;SYT1;NAPB;SYT6;STX16;SYNPR;UNC13B;CPLX2;STXBP2;VAMP3;BAIAP3;PTPN2;CACNA1A;STXBP4;STXBP5;UNC13C
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.35473262067081035,-1.1418331146841254,0.25906735751295334,0.77875073371544,1.0,6/25,7.70%,HIP1;KIF16B;SESTD1;PLA2G4E;HIP1R;GAB2
prerank,aminopeptidase activity (GO:0004177),0.38228983943276584,1.1389632253781112,0.2878787878787879,0.8769379763124519,1.0,9/26,18.17%,MMP16;RNPEPL1;XPNPEP1;METAP1D;XPNPEP3;TRHDE;LAP3;ENPEP;MMP17
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45382677633798396,1.1387435000130959,0.2920203735144312,0.8706037208854358,1.0,3/12,6.73%,PDE8B;PDE4A;PDE3B
prerank,nucleosomal DNA binding (GO:0031492),-0.36817049098798954,-1.1372916681562788,0.2793017456359102,0.7864083382695032,1.0,10/21,21.96%,GATAD2B;SMARCA4;MBD2;H3-3A;H1-0;HDAC2;HDAC1;HMGA2;HNRNPC;RCC1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.43134027347188786,1.1303380952252347,0.2822719449225473,0.8955625379805036,1.0,4/14,11.08%,SLC1A1;SLC25A18;SLC38A7;SLC1A3
prerank,omega peptidase activity (GO:0008242),0.2963555495443644,1.1287934351041344,0.2683578104138852,0.8940877794204829,1.0,25/89,21.47%,MPND;OTUD7A;USP32;USP10;GGT7;USP35;GGT5;USP11;USP50;USP30;USP51;GGH;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;COPS5;CYLD;USP49;APEH
prerank,aspartic-type endopeptidase activity (GO:0004190),0.44672505079484065,1.1283283191381888,0.30849220103986136,0.8886122147231397,1.0,4/12,15.40%,ASPRV1;BACE1;SPPL2B;HM13
prerank,Toll-like receptor binding (GO:0035325),-0.4440054752244065,-1.1280623894589874,0.28465346534653463,0.8083969575858492,1.0,4/11,19.81%,TLR2;CD36;TLR1;MYD88
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.410453511156624,-1.127303437538744,0.31797235023041476,0.8026496243854339,1.0,6/14,15.83%,MTMR14;MTMR2;MTMR4;MTM1;MTMR12;MTMR3
prerank,tropomyosin binding (GO:0005523),0.4216688303340757,1.119830850550265,0.3087248322147651,0.9143615427193237,1.0,4/16,12.95%,NEBL;LMOD1;TMOD2;LMOD3
prerank,histone deacetylase binding (GO:0042826),0.2932871204712855,1.1197624755907123,0.24601063829787234,0.9075528612614835,1.0,24/88,20.80%,YWHAE;NACC2;PKN1;HIC1;RELA;SP2;BEX4;ZMYND15;MEF2C;AKAP8L;PHF6;NCOR2;HDAC5;PRKN;AKAP8;USF1;NUDT21;PRDM1;BHLHE41;HDAC3;DHX36;GLI3;HSP90AB1;YWHAB
prerank,microtubule motor activity (GO:0003777),-0.2883982179415146,-1.118315876627314,0.24842767295597484,0.8243837395613828,1.0,17/51,20.56%,KIF3A;KIF16B;KIF23;KIF11;KIFC2;KIF20B;KIF13B;KIFC1;KIF24;KIF21A;KIF4A;KIF20A;DNAH8;KIF18B;KIF19;KIF27;KIF7
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3501849336119854,-1.1177866372930627,0.2864321608040201,0.8179701162320876,1.0,12/25,31.93%,HIP1;CNOT9;SNX1;GRB2;SHC1;TGFA;PLSCR1;EGF;SNX2;CCDC88A;FAM83B;EFEMP1
prerank,ephrin receptor binding (GO:0046875),0.3886953559055788,1.1176730958374559,0.30689655172413793,0.9089174209260248,1.0,7/21,12.45%,CHN1;EFNA4;EFNB3;PIK3CG;ANKS1B;EFNA1;EFNA3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4804280657103108,1.1173506642308364,0.3477508650519031,0.9032912640715058,1.0,6/10,23.45%,CASP3;CASP4;CASP7;CASP8;CASP2;CFLAR
prerank,3'-5' exonuclease activity (GO:0008408),0.3275901902105158,1.1148877342893977,0.2958579881656805,0.9059276304328233,1.0,15/45,22.38%,ERI3;REXO2;POLG;ANGEL1;EXD1;ERI2;EXOSC5;CNOT8;APEX1;ANGEL2;WRN;REXO4;APLF;DIS3L;EXD2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.32929556431842477,-1.11411471087281,0.2636363636363636,0.8221869240717209,1.0,14/29,27.43%,PKIB;CIT;PRKAG2;CIB1;YWHAG;CDKN2C;SPRY2;HSPB1;CDKN2A;INKA1;INKA2;KAT2B;SPRED1;INCA1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.35158183728495224,1.113687070865983,0.3080568720379147,0.9039383720687845,1.0,4/32,5.60%,KCNH2;KCNA5;KCNE2;KCNC1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4336810634064458,1.112638100556076,0.3268892794376098,0.9009994868449996,1.0,5/13,24.72%,PIK3C2G;PIK3CG;PIK3C2A;PIP4K2B;PIP4K2A
prerank,calcium channel inhibitor activity (GO:0019855),-0.4293668520792576,-1.1126028772473,0.2860635696821516,0.8189443696167001,1.0,5/11,18.12%,MCUB;ITPR1;PHPT1;CALM2;SLC30A1
prerank,nucleotidyltransferase activity (GO:0016779),-0.3724840650047298,-1.1124408864972872,0.29009433962264153,0.8113883215980523,1.0,9/19,25.05%,PAPSS2;TENT2;NUDT5;YRDC;TENT4B;TENT4A;THG1L;DNTT;TERT
prerank,tubulin binding (GO:0015631),0.2518116727966041,1.1119715610390133,0.20512820512820512,0.8969951672874767,1.0,87/296,22.80%,TPPP;STMN4;GAPDH;STMN3;MAP6;DIP2B;DST;IFT81;BLOC1S2;DLEC1;PAK1;MID2;PSRC1;STMN2;REEP2;BEX4;PRNP;NAV3;PDCD5;MAP1S;ARL4C;CLASP2;CCDC181;TBCE;PHF6;MAPRE2;KIF26A;FSD1;MAP4K4;CKAP5;PRKN;EMD;RAE1;LRPPRC;FGF13;PEX14;RMDN3;TTLL6;DNAL1;CAMSAP1;DNM1L;DCTN1;KIF1C;MTCL1;VASH2;SYBU;TTLL12;HOOK2;KIF2A;NEFM;RCC2;NDRG1;APC2;UXT;TUBGCP2;AGBL4;MAP9;CLIP1;KIF14;TAOK1;HDGFL3;STARD9;ALMS1;EML4;MAST2;TTLL7;HOOK1;ABRAXAS2;EML6;TPGS1;ALDOA;GABARAP;CEP57;TTLL1;TTLL5;KIF1B;KIF9;TUBGCP6;MAP2;KIF17;MAPRE3;DRG1;SPAST;MAP7D3;TOGARAM2;KIF21B;TPPP3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.44859536350601414,-1.107447573555765,0.33260393873085337,0.8199137409990969,1.0,2/10,11.95%,CYBB;CYBA
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4272023126291751,1.107151508444571,0.33500837520938026,0.9086106969554761,1.0,6/14,22.65%,IREB2;NDUFS1;CIAO3;ISCU;EXO5;NUBPL
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3079762813093733,1.1070115923232378,0.30057803468208094,0.9024439471164595,1.0,18/60,20.52%,MERTK;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;ACVR1B;TEK;EPHA4;INSR;EPHB2;NTRK2;FLT3;BMPR1B;PDGFRB;ROR1;EPHA5
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.33462096800852464,1.1031504438280222,0.31332357247437775,0.9106305395867808,1.0,12/40,17.70%,LRTOMT;METTL2A;METTL2B;TPMT;MEPCE;METTL4;METTL9;FBLL1;COMT;N6AMT1;ASMT;PCMT1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.31862647620701234,1.1029933643488306,0.2986217457886677,0.904664310626444,1.0,9/49,8.84%,SYT4;ANXA8;SYT13;SYT1;SYT6;PLA2G4C;ESYT2;DOC2B;CPNE6
prerank,Hsp90 protein binding (GO:0051879),-0.31621677384765556,-1.1007469540604222,0.2918918918918919,0.8348186300853991,1.0,9/33,13.33%,NR3C1;AHR;ERN1;NOD2;HIF1A;HSF1;PACRG;KDR;CYP1A1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3751724818288419,-1.0996177917191527,0.3260340632603406,0.8306200374470433,1.0,10/16,33.57%,CD38;ADPRH;BST1;NTHL1;NEIL3;TDG;DNPH1;RPS3;MACROD1;SMUG1
prerank,tRNA binding (GO:0000049),-0.2982258191872319,-1.0984597734583823,0.29577464788732394,0.8266055083878469,1.0,15/43,16.11%,XPOT;EIF2A;EEF1A1;AIMP1;TRNAU1AP;TRMT10C;FARS2;IGHMBP2;PSTK;YARS2;ALKBH8;SSB;NSUN2;TRMT9B;YRDC
prerank,calcium-release channel activity (GO:0015278),-0.3689000536495884,-1.0980293453849832,0.3383458646616541,0.8204162596778349,1.0,4/17,6.44%,MCOLN2;TPCN2;TPCN1;ITPR1
prerank,gamma-tubulin binding (GO:0043015),-0.3539687511121499,-1.0974844228747094,0.3089005235602094,0.8147758962130704,1.0,12/22,23.75%,CDK5RAP2;GIT1;DIXDC1;RACGAP1;CENPJ;TUBGCP4;RAB11FIP5;TUBGCP3;B9D2;OFD1;MARK4;BRSK1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4230043092815807,-1.0954822694461,0.3486238532110092,0.8136236145886195,1.0,4/12,7.82%,STAP1;FRS2;GAB2;BLNK
prerank,cell adhesion mediator activity (GO:0098631),0.36478771544106453,1.0950396223141174,0.3044189852700491,0.9275638129788409,1.0,9/24,19.51%,ROBO4;MYPN;CNTN2;DSCAM;BSG;DSCAML1;JAM3;NTNG1;LRRC4C
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4281595739808301,-1.0940508048542288,0.3235955056179775,0.811382689093823,1.0,4/11,16.99%,RPA1;HNRNPA2B1;TERF2;RPA2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4233895201075106,-1.0927454844666518,0.33573141486810554,0.8084655918612321,1.0,3/11,9.74%,SASH1;STK38;MAP3K11
prerank,regulatory RNA binding (GO:0061980),-0.3065639780643039,-1.0922999589078695,0.3047091412742382,0.8028207107577627,1.0,10/38,15.12%,TLR7;PUM2;ZNF346;ZC3H12A;RC3H1;PIWIL2;HNRNPA2B1;AGO2;DDX21;TRIM71
prerank,actinin binding (GO:0042805),-0.3475180906056302,-1.0921479732491133,0.3333333333333333,0.7962045620325306,1.0,6/21,8.30%,PDLIM5;PPARG;RARA;NFKB1;SYNPO2;DAG1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.33848004502840073,1.0914205994883752,0.3377926421404682,0.9348278507477799,1.0,5/33,6.32%,CTR9;SMYD2;DRAP1;ELP2;AR
prerank,channel activity (GO:0015267),-0.29398137860338835,-1.0908945997607256,0.28191489361702127,0.7928275136559784,1.0,18/41,35.57%,BCL2;MCUB;BAX;TMEM120B;TRPV2;TRPV3;AQP11;TMEM120A;TMEM266;ASIC4;PDPN;AQP1;MPV17;SLC14A1;TRPV4;PANX3;CHRNB3;TRPM5
prerank,death receptor activity (GO:0005035),-0.4192783612695367,-1.090667446061106,0.3395784543325527,0.7868303757120697,1.0,4/11,17.62%,FAS;TNFRSF19;TNFRSF1B;TNFRSF25
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4557434572260207,1.0902771730038308,0.3642611683848797,0.9326179721473777,1.0,6/11,23.45%,CASP3;CASP4;CASP7;CASP8;CASP2;CFLAR
prerank,hexosyltransferase activity (GO:0016758),0.27646082328582844,1.088951503661483,0.3022284122562674,0.9309236920999926,1.0,29/101,23.38%,HEXB;B3GNT9;B3GNT6;B4GAT1;B3GALT2;TMTC4;ALG1;DPY19L4;PIGB;POFUT1;OGT;DPY19L3;B3GALNT1;CSGALNACT1;MGAT4B;POMGNT1;ALG5;GCNT7;B3GAT3;B4GALNT3;GCNT4;B4GALT2;CHSY1;GCNT1;LARGE1;UGT1A6;EXT2;GBA2;RFNG
prerank,phosphate ion binding (GO:0042301),0.4516609656291013,1.0889235396837034,0.3562091503267974,0.9246258036578999,1.0,2/10,7.30%,RELA;PNP
prerank,secondary active transmembrane transporter activity (GO:0015291),0.31453374757508845,1.0887406412674143,0.3267175572519084,0.9189374022786603,1.0,9/51,14.81%,SLC35A1;SLCO2B1;SLC5A12;SLC22A8;SLC46A2;SLC20A1;SLC35C1;TMEM241;SLC22A4
prerank,organic cation transmembrane transporter activity (GO:0015101),0.40702307574199725,1.0882835463328744,0.3711340206185567,0.9142573984410957,1.0,6/16,29.22%,SLC44A2;SLC22A4;SLC18A3;SLC22A5;SLC25A26;SLC5A7
prerank,chloride channel regulator activity (GO:0017081),0.41061850518443094,1.088160443478455,0.3431034482758621,0.9084906025499686,1.0,7/14,32.39%,CFTR;CHRNA7;WNK1;VTI1B;WNK4;STX8;WNK3
prerank,histone demethylase activity (GO:0032452),-0.3285627868206783,-1.0872719016252355,0.3259668508287293,0.7912194818726646,1.0,8/27,15.26%,RIOX2;KDM7A;JMJD6;KDM8;KDM6A;HR;RIOX1;KDM5C
prerank,RNA binding (GO:0003723),-0.19338509791240216,-1.0855615169723751,0.15384615384615385,0.7898470905476266,1.0,316/1321,18.61%,APOBEC1;RFTN1;ASCC3;MYO5A;AHNAK;DDX42;RBM47;UTP6;DDX60;PSMA6;HNRNPLL;NOL11;XPOT;ANKRD17;ZCCHC7;MECP2;OAS2;NOVA2;SRSF4;EIF2A;KPNB1;FAM120A;CELF1;NOCT;RCC1L;VCP;SCAF4;RPS26;FTSJ3;MBNL1;TRIM25;RPL39;ZNFX1;MARK2;ZC3H12D;IFIH1;RPS23;HNRNPM;RPL5;CCT6A;HMGB2;RPS24;FAM98B;PPHLN1;GOLGB1;IFIT2;ACTN1;RPS16;SNRPA;TRUB2;EIF4B;RBM34;FAU;WDR43;GNL3L;AGFG1;LGALS1;NCBP1;FAM98A;ZBP1;DHX29;PTPN1;RPL28;EEF1A1;ETF1;ENO1;MKI67;RPGR;TOP2A;AIMP1;SNTB2;PURB;KPNA2;GPATCH1;FNDC3A;RBM8A;RPS14;SNRNP40;DHX33;TLR7;TCOF1;IFIT1;CTNNA1;RPS20;TRNAU1AP;SAMD4A;CLNS1A;DDX49;SLTM;RPL35A;ZCCHC17;FIP1L1;PUM2;RPS12;NOL7;MSN;EIF2S2;SREK1;TRMT10C;RPL18A;OASL;ZNF346;RPS13;GANAB;SLC4A1AP;SNRPD1;RPL27;RPL21;YY1;BAG4;SHFL;RPS7;EIF3I;BST2;DDX52;CRKL;RPF1;RPS5;HSPD1;TBCA;UBAP2L;JMJD6;TFRC;HNRNPAB;LUC7L;FARS2;DDX41;RPL30;PRPF6;PLEC;RPF2;RPL6;DHX38;IFIT3;MBNL3;ILF2;RPL37A;RO60;RRP12;RPP38;SRRT;ACAA2;FNDC3B;HNRNPK;CISD2;UBC;BYSL;TLR8;IGHMBP2;KMT2C;EIF4ENIF1;PSTK;YWHAG;BRCA1;DQX1;RAVER2;EIF3G;TXN;UTP4;RPL10;RPL15;FAM133B;SNRPB;DDX6;ALG13;CAPRIN1;TPT1;S100A4;TRMT1L;DEK;LARP6;CPEB4;AQR;UBE2L3;NOSIP;HNRNPUL2;SNW1;ZC3H12A;MAPRE1;H1-0;DNAJC21;GNL2;UTP11;UTP15;EXOSC10;VIM;MRPL1;RPP21;GDI2;NUSAP1;MRPS30;YARS2;DDX27;RPS10;FASTKD1;ALKBH8;EIF2S1;SSB;RPL14;DCP1B;XRN2;IBA57;GRWD1;SEC63;RPL9;RC3H1;GRB2;ZC3H12B;TENT5A;SPEN;BARD1;RPL32;RPL36;CCT3;TES;NOP58;MTO1;HDAC2;SRP72;RPL31;NUDT5;RBPMS;HNRNPA2B1;RPL23A;CPSF4;LTA4H;TSR1;RPN1;LUC7L2;CSTF2;AGO2;CS;NSUN2;CHCHD1;SLC25A11;LSM2;YLPM1;OAS3;POLR2B;SYNCRIP;LRRFIP1;NSRP1;LRP1;LARP1;RACK1;LSM5;IMMT;CPSF2;UTP18;RPL41;PRPF40A;RPL3;EXOSC9;NPM1;UBTF;NMD3;FRG1;PCF11;PRKRIP1;WDR3;TBL3;PURG;DDX21;TRMT9B;HSPB1;RC3H2;PHF5A;HMGN2;RBM7;RPL8;MYH9;MKRN1;SAP18;DDX20;ZC3H18;RBM27;RBMX;LARP4B;YRDC;PEBP1;FXR2;UPF3B;CCDC9B;ANKHD1;NOP10;SEC23IP;FBL;DUS2;USO1;NOP53;HADHB;CPEB2;POP1;SLC3A2;CCDC59;EIF3A;KRI1;CELF3;HELZ2;FLNA;ZC3HAV1;HNRNPD;EIF1B;SMG6;NUDT7;SNRPC;RPL37;SCAF11;MRPL4;PRPF3;COL14A1;EMG1;TENT4B;MAGOH;MAGOHB;MEX3D
prerank,transition metal ion binding (GO:0046914),0.24203028806971744,1.0854795343847707,0.25112107623318386,0.9122867056756329,1.0,110/397,22.59%,POLR2L;QPCTL;LACC1;NUDT12;TYW5;TET1;ANG;IKZF4;MMP16;MYCBP2;COA6;AFP;NSD1;GPC1;XPNPEP1;PRNP;ZFPM2;ADA;KDM1B;MTPAP;GALT;XPNPEP3;COMMD1;S100A13;ZNF205;SHANK3;WDFY1;ENPP2;PHEX;MPPED2;CHORDC1;MPPE1;GRIN2B;TRHDE;PRKN;AOC2;KLF7;NEK4;ITGB1BP2;MOXD1;KDM2B;SUV39H2;THAP1;RNF8;USP33;PHF8;CHMP1A;MGAT5B;PITRM1;TIMM13;DCT;SEC24D;FBXL19;TRIM8;SEC24B;KDM4A;MSRB3;PGGT1B;ACR;ZBTB32;RNF2;AOC1;ENPEP;FEN1;RPS27;TRAF7;NAPEPLD;POMGNT1;SIAH1;EPRS1;SEC24C;CLIP1;ATOX1;TK1;ESCO1;MT2A;ISCU;ZEB1;PHF2;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;IL1A;SNCB;WRN;ADAMTS3;ALAD;ARG2;RABGGTB;CDADC1;GALNT4;GALNT2;PLA2G15;CYLD;CALB1;COX17;FDX1;MDM4;PTGR2;LANCL1;CXXC5;LARGE1;TIMP2;EXD2;ZDHHC15
prerank,microtubule plus-end binding (GO:0051010),0.37782015702314115,1.0839046555294236,0.34348561759729274,0.9119197215836038,1.0,5/20,16.37%,DST;CLASP2;MAPRE2;DCTN1;CLIP1
prerank,histone methyltransferase binding (GO:1990226),-0.4249513256656745,-1.0836629238398432,0.35096153846153844,0.7889059978673901,1.0,4/11,13.36%,LCOR;LCORL;CTNNB1;PRDM4
prerank,lysine N-methyltransferase activity (GO:0016278),0.3887747989390235,1.0827752355092224,0.3495798319327731,0.9099989069258857,1.0,6/20,10.50%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4
prerank,general transcription initiation factor binding (GO:0140296),0.3557976725471268,1.082726882880774,0.3495297805642633,0.9041499087997134,1.0,4/25,6.32%,HHEX;DRAP1;RELA;AR
prerank,PDZ domain binding (GO:0030165),0.30011916108339665,1.0825397630383164,0.3247863247863248,0.8988946624953639,1.0,24/61,26.40%,F11R;CADM1;TGFBR3;GRIA1;GRID2;PRKN;CFTR;ATP2B3;ACOX1;SLC22A4;DOCK4;KIF14;CXADR;SDC2;LLGL2;PLEKHA2;PLEKHA1;SLC22A5;SSTR2;PDZK1;CXXC4;RAPGEF2;SRR;DLG4
prerank,RNA polymerase binding (GO:0070063),0.387021666197566,1.0814409718901437,0.3406408094435076,0.8972174451750939,1.0,3/18,2.11%,YTHDC2;BIN1;PPIB
prerank,calcium:sodium antiporter activity (GO:0005432),0.4544350572092581,1.0799370282983496,0.375,0.8967621975322414,1.0,5/10,18.64%,SLC24A5;SLC8A1;SLC8A3;SLC24A3;SLC24A4
prerank,small GTPase binding (GO:0031267),0.2571366049438817,1.0792399891810789,0.2921760391198044,0.8935642395070618,1.0,43/170,16.06%,IFT20;TSC2;RIN3;SRGAP2;GGA3;RAB11FIP3;SGSM2;MYCBP2;PKN1;PAK1;SGSM3;AP3M1;NCKAP1;CHM;PEX5;FGD2;CDC42EP5;RAB8A;CDKL5;MYO1C;OCRL;UNC13B;RAP1GAP;EHD1;RIMS1;KCTD13;ANKRD27;BICD2;USP33;DNM1L;AKAP13;RAB34;HACE1;MICALL1;RALBP1;CYFIP1;FMNL1;EXOC5;RCC2;NDRG1;SH3BP4;RNF152;DOCK4
prerank,metallopeptidase activity (GO:0008237),0.27095633612911724,1.0778499824054617,0.32526881720430106,0.892486606020163,1.0,28/113,21.27%,ADAM2;MPND;MMP16;MEP1B;ADAMTS20;METAP1D;PSMD7;PHEX;ADAMTSL1;ADAMTS15;ADAM15;LAP3;ADAM12;ADAMTS19;THSD4;PSMD14;CHMP1A;ADAMTS14;PITRM1;MMP1;COPS6;THOP1;ADAMTS4;MMP17;ADAMTS3;COPS5;OMA1;METAP2
prerank,protein tyrosine kinase activity (GO:0004713),-0.23969528412620716,-1.0772227428129948,0.2835820895522388,0.8023003204914464,1.0,28/108,19.08%,PEAK1;AXL;ABL2;CSK;TEC;BAZ1B;MET;LMTK2;FLT1;DYRK1A;SYK;LYN;FYN;HCK;RET;WEE1;HIPK1;LCK;FRK;KDR;EGFR;PTK2B;EPHA2;EPHB4;HIPK2;ZAP70;PDGFRA;PKDCC
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3516411121777522,-1.075406716809321,0.3375959079283887,0.8016640125197108,1.0,4/18,11.76%,GAS6;TNFAIP8;BIRC5;BIRC2
prerank,alpha-actinin binding (GO:0051393),-0.3248302029029417,-1.0748202000999412,0.3424657534246575,0.7971858333996241,1.0,6/24,8.30%,PDLIM1;PDLIM5;PPARG;RARA;SYNPO2;DAG1
prerank,glucuronosyltransferase activity (GO:0015020),0.3785790544683132,1.073687586059094,0.3557377049180328,0.9017001287515791,1.0,8/19,22.46%,B4GAT1;CSGALNACT1;B3GAT3;CHSY1;B3GAT2;LARGE1;UGT1A6;EXT2
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.2148990572960559,-1.07310328755827,0.23391812865497075,0.7962340508934332,1.0,68/232,24.19%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;NSMCE2;TRIM14;DTX3L;SIAH2;SMURF2;TRIM17;UHRF2;RNF216;HECW1;EGR2;ARIH2;TRIM62;RNF13;NHLRC3;ZNRF3;RNF14;RNF150;RNF6;RNF157;SH3RF1;RNF220;RC3H1;TRIM44;TRIP12;PIAS2;BIRC2;CBL;RNF38;PELI1;TRIM5;FBXO2;TRIM71;RC3H2;MKRN1;MUL1;TRAF3IP2;DTX4;TRIM3;RNF144A;RNFT1;RNF130;TRIM37;RNF121;RNF24;TRIM21;RNF125;NEURL4;ASB12;KCMF1;BFAR;MEFV;NEURL2;TRIM72;XIAP;TRIM69;PIAS4;PIAS3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.34056009766818957,1.0727100293195384,0.37161084529505584,0.8994440851661968,1.0,8/31,18.57%,HCN1;SLC12A2;KCNK3;PKD2;SLC12A6;ABCC8;KCNK9;KCNQ4
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.22067721395714462,-1.0705358074984688,0.25116279069767444,0.7980855802132754,1.0,55/173,24.60%,ZEB2;TRPS1;NR3C1;MITF;TGIF1;ATF3;PPARG;PEG3;ETV6;TFEC;MNT;ERF;ENO1;PATZ1;PROX1;NFKB1;YY1;PPARD;CEBPB;HSF1;MZF1;CTCF;FOXP4;ZBTB18;ZNF148;ZBTB5;LRRFIP1;E2F8;FOXP2;CREB3L1;ZBTB20;FOXP1;DACH1;ZBTB2;FOXK2;DEAF1;HEY2;ZBTB39;SATB1;GATA3;HES1;MYT1L;MXI1;BHLHE40;NFATC3;ZFP90;HEYL;HOXD9;TFAP2C;ZNF3;SKIL;BCL6;MAFK;PLAGL1;IRX2
prerank,GTPase binding (GO:0051020),0.2517459971400493,1.0701035745237615,0.2997601918465228,0.90287753094648,1.0,49/195,16.29%,IFT20;TSC2;RIN3;SRGAP2;GGA3;RAB11FIP3;SGSM2;MYCBP2;PKN1;PAK1;GNB3;SGSM3;AP3M1;NCKAP1;CHM;PEX5;FGD2;CDC42EP5;RAB8A;ATG16L1;GNB2;CDKL5;MYO1C;OCRL;UNC13B;RAP1GAP;EHD1;RIMS1;KCTD13;BECN1;ANKRD27;BICD2;USP33;DNM1L;AKAP13;RAB34;HACE1;MICALL1;RALBP1;CYFIP1;FMNL1;SPTBN1;EXOC5;RCC2;NDRG1;SH3BP4;RNF152;DOCK4;EPRS1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.25518030781442713,-1.066356220674659,0.31690140845070425,0.8049417035081456,1.0,22/74,15.98%,PIK3C3;FCSK;PAPSS2;FAM20A;DGKK;NADK;PANK1;GALK2;FAM20B;IPPK;PIK3CA;HK1;PANK3;SHPK;FAM20C;GK;SPHK2;GK5;PGM2L1;DGKA;PI4KA;POMK
prerank,NADPH binding (GO:0070402),-0.3941861836356151,-1.0662104692085228,0.36930455635491605,0.7990195281787579,1.0,8/13,20.95%,DECR1;CRYZ;CBR3;MTRR;DUS2;KCNAB1;GRHPR;DHFR
prerank,voltage-gated anion channel activity (GO:0008308),-0.36911037083173315,-1.0651985802771924,0.35784313725490197,0.795752594898398,1.0,7/15,22.45%,CLCN1;CLCN5;VDAC3;ANO1;VDAC2;GPR89A;GPR89B
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3781531333724333,-1.0651985320386084,0.35853658536585364,0.7895357777507542,1.0,6/15,13.63%,SESTD1;ZFYVE16;PICALM;SNX9;WDFY3;EEA1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.20365534815668823,-1.0645582287423756,0.18181818181818182,0.7856836267469275,1.0,64/346,13.02%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;KLHL20;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;PJA2;TRIM14;CUL4A;UBE2K;DTX3L;BIRC6;FBXL14;SIAH2;RNF213;OBI1;SMURF2;TRIM17;UHRF2;RNF214;TAF1;RNF216;UBE2Q1;RNF146;HECW1;RMND5B;CDC34;ARIH2;TRIM62;BCOR;RNF13;NHLRC3;ZNRF3;BRCA1;RNF14;TTC3;RNF150;LMO7;RNF6;RNF157;UBE2L3;SH3RF1;RNF220;RC3H1;KLHL21;UBE2Q2;BARD1;TRIM44;TRIP12;AKTIP;BIRC2;RNF103;CBL;RNF38;PELI1;UBE2E3;FBXO3;TRIM5
prerank,amyloid-beta binding (GO:0001540),-0.25164398668000043,-1.064310991312857,0.2867383512544803,0.7803699064536735,1.0,12/79,6.88%,FCGR2B;CD74;APOE;ITM2B;MSR1;TM2D1;TLR2;CD36;LDLRAP1;PICALM;LDLR;PFDN5
prerank,endopeptidase regulator activity (GO:0061135),0.3207235407647498,1.0640534101726609,0.37059724349157736,0.9188248717548884,1.0,8/40,13.97%,CST3;VSIR;PSMF1;SPINT2;PSME3;PSENEN;PSMD14;ABCA2
prerank,receptor ligand activity (GO:0048018),0.24661078076810813,1.062479461514042,0.33252720677146314,0.9186283116773574,1.0,42/245,16.98%,FGF10;WNT4;SEMA7A;FGF16;GDF11;FGF9;IL17F;SLURP1;SEMA6C;WNT3;FGF7;IL6;AREG;DAND5;SEMA6B;NDP;IL2;PPY;SEMA3D;BMP4;TNFRSF11B;SST;TGFB1;TAFA2;WNT8B;CLCF1;FGF2;NRG3;SEMA4F;GREM2;PDGFB;INHA;HMGB1;THPO;TAFA1;WNT7A;SEMA4B;SEMA3C;GDF1;IL7;AGT;ANGPTL3
prerank,Hsp70 protein binding (GO:0030544),-0.30640985644538843,-1.0609846250225856,0.36666666666666664,0.7841581575444523,1.0,15/31,28.03%,DNAJC8;ERN1;NOD2;PACRG;DNAJC10;HIKESHI;CYP1A1;FICD;SPN;DNAJB1;GPR37;DNAJB14;RNF207;DNAJB12;TSC1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.42200023776472606,1.0608706304676296,0.39168110918544197,0.9186224299204592,1.0,4/12,14.53%,GABRG1;GABRG2;GABRA2;GABRB1
prerank,nuclear receptor binding (GO:0016922),-0.23809974440289766,-1.0588570001060995,0.314410480349345,0.78473081321807,1.0,25/111,12.60%,MED13;STAT5B;SMARCA4;MED16;ESR1;PROX1;NCOA7;TAF1;OASL;LCOR;NCOA1;SMAD3;PRPF6;HIF1A;RNF14;RNF6;SNW1;STAT1;EP300;CTNNB1;PRMT2;TRIP12;CRY1;ZNHIT3;HMGN3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.41904208022283834,-1.0566517060927463,0.39285714285714285,0.7854902298642248,1.0,7/10,37.91%,DSEL;DSE;RENBP;FUOM;GALM;GLCE;GNE
prerank,GTPase activity (GO:0003924),0.2513122063361323,1.0563598285965068,0.35286783042394015,0.928595112859961,1.0,54/192,25.30%,TPPP;RAB6B;RAB1B;RAB43;RAB3A;RHOV;GNB3;SEPTIN9;GTPBP1;ATL1;RHOBTB1;RAB8A;GNB2;GNA15;TBCC;RIT2;GNG11;RHOT1;RAB24;NKIRAS2;DIRAS2;RAB5A;RAB38;GFM2;RAP1GAP;RAB28;DNM1L;EEF1A2;GNGT2;GNA11;GNAI3;HRAS;GNAS;RHOQ;GSPT1;RRAS2;RHOBTB2;SRPRA;RHOU;RHEBL1;CDC42;MMAA;RAP2C;DRG1;ATL2;GBP2;RHOBTB3;GNG3;RHOA;IRGM;GNAI1;RNF112;GTPBP10;DDX3X
prerank,adrenergic receptor binding (GO:0031690),0.38928388635980626,1.0558930428714532,0.3622704507512521,0.9244149597194824,1.0,7/16,26.40%,ADRA2A;APLP1;NEDD4;GNAS;MAGI2;RAPGEF2;DLG4
prerank,metal ion transmembrane transporter activity (GO:0046873),0.34825868425265305,1.0513863187822745,0.3717357910906298,0.9352118086471266,1.0,5/27,5.76%,SLC4A8;ATP2A3;ITPR2;CLDN16;SLC12A2
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.26349247228762473,-1.0513596527497213,0.3575949367088608,0.7955461999435939,1.0,20/60,19.16%,LRRC39;CDC14B;PPM1H;PPP3R1;CTDNEP1;TAB1;LCK;CDKN3;PPP3CA;PPP1R3C;LRRK2;CTDSP1;DUSP1;TIMM50;PPP2CB;RPAP2;MTMR3;PGAM5;PPM1F;PPEF1
prerank,calcium channel regulator activity (GO:0005246),-0.28673092556490776,-1.0505185403030726,0.3371757925072046,0.7922475328958122,1.0,15/37,22.28%,MCUB;ITPR1;CACNG4;NRXN2;INAFM2;PHPT1;REM1;CALM2;STIM2;SGK3;SLC30A1;NPY;NPY2R;STIMATE;CACNB3
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3010119543703663,1.0500842572192468,0.3621212121212121,0.934104083660977,1.0,12/53,13.69%,SLC25A2;SLC38A2;SLC1A1;SLC38A9;SLC25A18;SLC38A7;SFXN1;SLC1A3;CTNS;SLC1A4;SLC66A1;SLC3A1
prerank,sodium channel regulator activity (GO:0017080),0.3208335188122956,1.0497742277675688,0.38704581358609796,0.9296063382901023,1.0,7/37,10.74%,FGF14;FGF12;FGF11;COMMD1;PTPN3;NEDD4;FGF13
prerank,chemorepellent activity (GO:0045499),0.3447362172614956,1.0492658309731941,0.39008264462809916,0.925866247585764,1.0,8/25,16.54%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;NRG3;SEMA4F;SEMA4B;SEMA3C
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3983707592561082,1.0483307370750246,0.4031413612565445,0.9237945065352484,1.0,2/14,4.73%,SPOCK3;SPOCK2
prerank,hexose transmembrane transporter activity (GO:0015149),0.4202219325442058,1.0462606957322989,0.3986135181975737,0.9255578758462951,1.0,2/12,6.70%,SLC2A3;SLC2A2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.3087697163968773,-1.0445723360438717,0.3494897959183674,0.8039334908138784,1.0,11/29,16.94%,ACER3;CTBS;GANAB;HEXD;IDUA;HPSE2;HPSE;GLA;GALC;GAA;HYAL3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3872245948316305,1.0445705471251099,0.39792387543252594,0.9258090193405994,1.0,3/15,7.52%,PIK3C2G;PIK3CG;PI4K2A
prerank,pre-mRNA binding (GO:0036002),0.3385830104530987,1.044054987909965,0.38412698412698415,0.9220651533323092,1.0,4/28,6.03%,DDX5;TRA2B;SRSF6;PTBP1
prerank,glutathione transferase activity (GO:0004364),-0.32421158732676536,-1.0439247273109924,0.3695090439276486,0.8001269722118292,1.0,6/23,18.56%,MGST3;GSTA3;GSTZ1;GSTM1;GSTM5;LTC4S
prerank,protein kinase C activity (GO:0004697),0.40428314122628894,1.0430179744929096,0.3975694444444444,0.9203357211075412,1.0,7/14,17.60%,PKN1;PRKCZ;PRKCI;PRKCA;PRKD1;PRKCG;SMG1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3793974937453398,-1.042507068697196,0.3981264637002342,0.7985287172513632,1.0,2/13,2.53%,CSK;PJA2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.20929476837016733,-1.0424220454786362,0.2832369942196532,0.7930358675937945,1.0,62/228,23.07%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;TRIM14;UBE2K;DTX3L;SIAH2;SMURF2;TRIM17;UHRF2;RNF216;HECW1;ARIH2;TRIM62;RNF13;NHLRC3;ZNRF3;RNF14;RNF150;RNF6;RNF157;SH3RF1;RNF220;RC3H1;TRIM44;TRIP12;BIRC2;CBL;RNF38;PELI1;TRIM5;FBXO2;TRIM71;RC3H2;MKRN1;MUL1;TRAF3IP2;DTX4;TRIM3;RNF144A;RNFT1;RNF130;TRIM37;RNF121;RNF24;TRIM21;RNF125;NEURL4;ASB12;KCMF1;BFAR;MEFV;NEURL2;TRIM72
prerank,transcription cis-regulatory region binding (GO:0000976),-0.19742822530052873,-1.0421156960000704,0.27884615384615385,0.7882912745517239,1.0,112/406,22.97%,TRPS1;NR3C1;NFXL1;ARID4B;SOX6;SP3;ATF3;GABPB2;CDK5RAP2;HMGB2;TCF12;RUNX3;PPARG;CIITA;PEG3;ETV6;MNT;RARA;MEF2D;ENO1;SOX11;PURB;AHR;PROX1;NFKB1;ETV5;YY1;SMAD3;SP1;CEBPB;PRDM9;EGR2;BCOR;YAP1;MLXIP;TBL1X;HIF1A;BRCA1;HSF1;CRY2;SATB2;HINFP;MZF1;CTCF;CREBRF;RFX5;XRN2;ATF5;CUX2;NFE2;SMAD6;ZBTB5;FOXJ1;RXRB;AGO2;TCF7;HDAC1;NR1H3;AHRR;RB1;SCX;E2F8;CREB3L1;ZBTB20;FOS;NPM1;KMT2D;FOXP1;IRF2;LHX1;DACH1;PURG;TNF;FOXK2;DEAF1;E2F7;KLF11;ARID5B;TIPARP;SATB1;RFXANK;SMAD4;GATA3;HMGA2;GLIS2;PER2;ZFP3;FOXN2;RBBP5;TFAP2B;HOXD8;TAF7;MXI1;ESRRB;NCOR1;HMGA1;KLF4;RBAK;BASP1;ZFP90;HDAC4;PSPC1;RREB1;NPAS4;TCF24;ISL1;NR1H4;TWIST1;HOXD9;TBL1XR1;TFAP2C;ZNF3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.39122208998319297,1.0415903960066013,0.41091492776886035,0.9196299795199503,1.0,6/17,21.71%,TM7SF2;AKR1C1;MECR;TECR;DECR2;PTGR2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3205239369177681,1.041542644650378,0.3969924812030075,0.9145544991356416,1.0,15/35,28.42%,PLCL1;PLCXD1;PLD4;ENPP2;MPPED2;MPPE1;APEX1;NAPEPLD;PLCB2;PLCXD3;GPLD1;PDE11A;SMPD2;PLCXD2;SMPD4
prerank,potassium ion antiporter activity (GO:0022821),0.39131906932130583,1.0402195286646323,0.3993231810490694,0.913810862877431,1.0,6/15,23.15%,SLC24A5;SLC9A4;SLC9A5;SLC24A3;SLC24A4;SLC9A1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4098036153711191,1.0383140008509228,0.39893617021276595,0.9152006394736205,1.0,5/13,14.01%,PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.4336992835994757,1.0380645203306214,0.39679715302491103,0.9109053299820867,1.0,3/10,17.79%,SLC10A2;SLC6A1;SLC10A1
prerank,androgen receptor binding (GO:0050681),-0.3209534131052848,-1.0365835656420097,0.38701298701298703,0.7999594701303792,1.0,8/25,14.21%,SMARCA4;PRPF6;RNF14;RNF6;SNW1;EP300;PRMT2;FOXP1
prerank,acetyltransferase activity (GO:0016407),-0.3015729494487654,-1.0359666779141135,0.3879781420765027,0.7961797167650558,1.0,12/31,22.57%,PAFAH1B2;KAT6B;NAA10;NAA16;GNPNAT1;EP300;DBT;NAT14;PAFAH1B3;NAT10;ESCO2;KAT2B
prerank,SH3 domain binding (GO:0017124),-0.2602881714472931,-1.0351911675295893,0.3859060402684564,0.7929268530003659,1.0,18/62,17.23%,CBLB;SH3BP2;PTPN22;SYNJ2;CRK;SOCS7;ADAM9;WIPF1;CABYR;GRB2;DNM2;SKAP1;CYBA;CBL;VASP;GPX1;AKAP5;MICAL1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3339671004865068,1.0334309184456734,0.4166666666666667,0.9216095346159987,1.0,7/28,14.97%,RPP40;ELAC2;DROSHA;PRORP;RPP30;APEX1;FEN1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.42729470586085183,-1.0332048493498833,0.4034229828850856,0.7933202835388218,1.0,4/10,14.60%,RIOX2;KDM7A;KDM8;RIOX1
prerank,growth factor receptor binding (GO:0070851),-0.23683601296668924,-1.0331330937475853,0.3772893772893773,0.7879893554581954,1.0,37/95,27.03%,HIP1;SDCBP;CNOT9;PIBF1;FRS2;CD300LF;SNX1;IL6ST;ERN1;PDGFD;FYN;IL1B;FGF1;PSEN1;ERAP1;PDGFC;GRB2;TIMM50;SHC1;IL27RA;ADAM17;PDGFRA;ITGB3;TGFA;FGF18;TLR5;VEGFB;PLSCR1;EGF;TLR9;PGF;IL12RB1;PDGFA;TSLP;FGF22;KL;FGF20
prerank,ion gated channel activity (GO:0022839),0.34773156894561297,1.0315159681860724,0.40483870967741936,0.9227171886031863,1.0,7/24,16.74%,TMEM63C;TMEM63A;ANO2;TMEM63B;KCNT2;ANO3;KCNT1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2009395312302949,-1.028604835351698,0.3308270676691729,0.79594811887196,1.0,101/335,25.61%,MAP3K1;STK3;CSNK1G1;SLK;PRKCH;STK38;PRKCE;RAF1;STK17B;CDK6;ALPK1;MARK2;PIK3R4;MAP3K8;CDK8;FAM20A;BRAF;PRKACA;NUAK2;TBK1;STK35;GAK;MKNK1;MAPKAPK2;PIM1;LMTK2;ERN1;STK24;TAF1;PRKD3;MAP3K15;TESK2;RPS6KA6;DYRK1A;SYK;RIPK1;CIT;PRKCQ;CDKL3;TAOK3;CAMK2D;MAP3K11;UHMK1;HIPK1;MAPKAPK3;CDK1;DAPK1;LRRK2;IRAK4;RPS6KA2;FAM20C;SIK2;NLK;SIK1;CDK12;EGFR;PRKAB2;CDK14;PTK2B;MAPK7;PLK1;MAPK8;SQSTM1;HIPK2;MAP4K1;CAMK1G;CLK4;PKN3;SGK3;SGK2;CDK19;MAPK12;MYLK;NEK8;ACVR1;ACVR2A;CDC42BPG;MELK;STK38L;CDK9;MAP3K2;MAP3K20;HUNK;SBK3;BCR;EIF2AK2;MARK4;MAPK11;STKLD1;BRSK1;MASTL;PIM2;HTATIP2;RPS6KA3;STK32C;GRK5;BMPR2;ULK3;ERN2;ILK;CDK13
prerank,CARD domain binding (GO:0050700),0.3986372404497965,1.0280314214809054,0.4475043029259897,0.929326835566656,1.0,6/14,24.73%,CARD14;NOD1;CASP4;CARD16;RIPK2;IRGM
prerank,translation initiation factor activity (GO:0003743),-0.29285886556053775,-1.0280123900320526,0.40229885057471265,0.7923165311958592,1.0,14/36,24.79%,EIF2A;EIF2S2;EIF3I;EIF3G;EIF2B2;EIF2S1;EIF3K;AGO2;EIF2B4;EIF3A;EIF1B;EIF3E;EIF3L;EIF4A2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.39925673937210304,-1.0276668758138585,0.41333333333333333,0.7881462375678231,1.0,4/11,21.40%,MAP3K1;MAP3K15;EGFR;MAP3K20
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.33155718615612084,1.0275849746569297,0.42524916943521596,0.9256068608800568,1.0,7/29,14.50%,SLC1A1;SLC25A18;SLC38A7;SLC26A4;SLC26A7;SLC1A4;SLC19A1
prerank,cholesterol binding (GO:0015485),-0.2741145481997345,-1.0274673879164373,0.43478260869565216,0.7835163250601995,1.0,11/47,13.75%,OSBPL8;NPC2;STARD3NL;OSBPL1A;CAV1;ERLIN2;OSBPL2;ABCG1;OSBP2;NR1H3;GRAMD1C
prerank,mannosyltransferase activity (GO:0000030),0.35952445956024365,1.0265239768401289,0.4068965517241379,0.9241444784087287,1.0,5/21,9.94%,TMTC4;ALG1;DPY19L4;PIGB;DPY19L3
prerank,I-SMAD binding (GO:0070411),-0.378881759702382,-1.0252458094280905,0.42857142857142855,0.7844161916829134,1.0,5/13,17.73%,SMAD3;SMAD9;CTNNB1;SMAD6;SMAD4
prerank,cytokine receptor binding (GO:0005126),-0.2376695224664198,-1.0252321805780857,0.40070921985815605,0.7792513099305586,1.0,30/83,27.53%,SDCBP;LIFR;PIBF1;CD300LF;IL6ST;KITLG;CCL25;IL27;SMAD3;SYK;IL1B;ERAP1;CCRL2;TIMM50;IL27RA;ADAM17;OSMR;USP15;EPO;CXCL12;TLR5;VEGFB;FADD;TLR9;PGF;IL12RB1;CSF1;TSLP;SPRED1;CRLF1
prerank,microtubule minus-end binding (GO:0051011),0.40836462734264456,1.0251881202035165,0.420863309352518,0.9236874286938636,1.0,6/13,25.17%,HAUS4;CAMSAP3;CAMSAP1;TUBGCP2;TUBGCP6;TUBGCP5
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.19860717174659245,-1.024609537560129,0.38235294117647056,0.7758787603755054,1.0,71/269,19.99%,BCL2;ITCH;PTPN22;MAP1LC3B;VCP;CUL3;RPL5;ARIH1;CUL4A;UBE2K;DTX3L;FBXW7;PRKACA;STAT2;PATZ1;BAG4;SMAD3;HSPD1;RIPK1;EGR2;SNX9;MID1;UBC;TXNIP;HIF1A;PSMA3;ERLIN2;BRCA1;BAG6;SPOPL;PACRG;UBE2L3;UBA52;STAT1;FOXO1;SMAD6;TNFRSF1B;RRAGA;PARP9;RB1;STAM;NLK;GPI;RALB;DBT;VCL;EGFR;UBE2L6;MAGEC2;PRKACB;AMBRA1;TRAF1;MUL1;CBS;UBE2C;ASB4;SQSTM1;RPA2;MAP1LC3A;WFS1;RNF20;LAPTM4B;TRAF4;TRIM37;PSMD1;NKD2;GPR37;HSPA1B;CUL5;NPLOC4;PA2G4
prerank,glucose transmembrane transporter activity (GO:0005355),0.3727937941564028,1.0244285720118098,0.42158516020236086,0.9211922114533797,1.0,2/17,6.70%,SLC2A3;SLC2A2
prerank,cytokine receptor activity (GO:0004896),0.2699328672169469,1.0243497163142714,0.4089012517385257,0.9164879910902994,1.0,19/83,17.90%,ACKR4;IL5RA;F3;IL2RA;CSF3R;CNTFR;PRLR;IL1RAP;CCR1;GPR17;CX3CR1;IL13RA1;GFRA1;CCR6;IFNGR1;ACKR2;CCR9;FLT3;IL1RAPL2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.350808255841815,1.02296893590692,0.4197952218430034,0.9159062492883686,1.0,12/22,29.73%,SYT1;CLU;APBB1;HSP90B1;APBB3;LANCL1;ANKRA2;SNX17;DNAJA1;CLTC;HSPG2;AP2M1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.432418102510635,1.020192013381108,0.42473118279569894,0.9201677077542996,1.0,3/10,11.05%,ANKRD13D;DNAJC2;FAN1
prerank,NF-kappaB binding (GO:0051059),-0.31998601036282215,-1.0196458941333246,0.41645244215938304,0.7849555237066523,1.0,7/24,14.13%,PSMA6;ANXA4;EP300;BRMS1;HDAC2;HDAC1;NPM1
prerank,antiporter activity (GO:0015297),0.36103841561686795,1.0187542790888733,0.4278169014084507,0.9201447419889491,1.0,9/20,28.66%,SLC35A1;SLC35C1;TMEM241;ATP1A3;SLC25A10;SLC35E2B;SLC35E2A;SLC25A16;CLCN3
prerank,ATP hydrolysis activity (GO:0140603),-0.27203706903400815,-1.0180989599947807,0.438953488372093,0.7840840123782683,1.0,9/41,11.24%,VCP;VWA8;RNF213;SMCHD1;CHD1L;KIF20B;TOR1B;ABCG4;TOR3A
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2350492074233702,1.0180091271538565,0.42840095465393796,0.9177824732626306,1.0,52/248,18.93%,TPPP;RAB6B;KLC1;RAB1B;RAB43;RAB3A;RHOV;GNB3;ABCB6;SEPTIN9;GTPBP1;ATL1;RHOBTB1;CLU;ATAD1;RAB8A;GNB2;GNA15;TBCC;RIT2;MYO6;GNG11;KIF26A;RHOT1;RAB24;NKIRAS2;MYL6;CFTR;DIRAS2;RAB5A;RAB38;GFM2;RAP1GAP;RAB28;DNM1L;EEF1A2;KIF1C;GNGT2;KIF2A;GNA11;GNAI3;KIF14;HRAS;GNAS;RHOQ;GSPT1;RRAS2;RHOBTB2;SRPRA;ABCD2;PIN1;RHOU
prerank,gap junction channel activity (GO:0005243),0.3470110240622815,1.01480009251013,0.4427001569858713,0.9230316342724251,1.0,3/22,11.76%,GJC3;GJA5;PANX1
prerank,GTPase regulator activity (GO:0030695),-0.20434490521060478,-1.0130643299194722,0.41954022988505746,0.7927939218614344,1.0,34/212,12.40%,IQGAP1;VAV3;ARHGAP15;IQGAP2;ARHGAP10;NRP1;TBC1D1;STARD8;ARHGEF10L;ARHGAP17;ARHGAP19;RANBP2;RIC8A;RASA4;RASA1;ARHGEF6;RABGAP1;ARHGAP18;TBC1D2;ASAP1;ARAP1;ARHGAP30;RACGAP1;ARHGAP24;SEC23A;ABR;AGAP2;RALGAPA2;RANBP3;ARHGAP39;ARHGAP28;TBC1D10C;LRRK2;TBC1D10A
prerank,nuclease activity (GO:0004518),0.2892683610799515,1.0124310694320968,0.4253048780487805,0.926045713142955,1.0,15/52,19.28%,ANG;RNASE1;DNASE1L2;DDX1;MAP1S;OGG1;NME1;RNASEL;RNASE7;SND1;APEX1;FEN1;WRN;RNASE12;REXO4
prerank,N-acetyltransferase activity (GO:0008080),0.3618172050165518,1.0104060316778676,0.45614035087719296,0.9278745745158811,1.0,4/19,7.13%,SAT2;SMARCE1;NAT8L;ATAT1
prerank,magnesium ion binding (GO:0000287),-0.21956278346827457,-1.0102022133415423,0.4377358490566038,0.7961706386865555,1.0,45/135,24.06%,STK3;DIS3L2;ABL2;STK38;MARK2;IDH3A;RRAGC;NUAK2;TOP2A;NLRC4;IDH1;ERN1;TKT;HMGCL;UBA2;GCLC;EYA2;CERK;NUDT5;LRRK2;CLYBL;SIK2;NLK;SIK1;TESC;PRKACB;FOXK2;ADPRH;PDE2A;PLK1;MAP2K7;MTHFD2;XYLT2;RAP2A;MAPK12;CDC42BPG;STK38L;MVK;MAP3K20;THG1L;PPA2;PLSCR1;BRSK1;PIF1;TDP2
prerank,cardiolipin binding (GO:1901612),0.4201096702247508,1.0082975517848376,0.4306049822064057,0.9299322904771133,1.0,2/10,9.22%,GSDME;UQCC3
prerank,muscle alpha-actinin binding (GO:0051371),-0.3521969565729315,-1.0073024527290508,0.4529262086513995,0.7993388335094797,1.0,3/15,4.69%,PDLIM1;PDLIM5;SYNPO2
prerank,symporter activity (GO:0015293),0.43879018069404796,1.0054372899604576,0.46935201401050786,0.9342295012295172,1.0,2/10,7.26%,SLC5A12;SLC46A2
prerank,solute:proton symporter activity (GO:0015295),0.37155435086767313,1.005010429998078,0.4628975265017668,0.9309624014484176,1.0,4/16,19.91%,SLC33A1;SLC39A8;CTNS;SLC2A9
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3268497241859797,1.0049688260429448,0.4423676012461059,0.9263727455521,1.0,12/27,27.31%,POLR2L;POLR2F;POLR3F;POLR2G;POLR3A;POLR1F;POLR3B;POLR2C;POLR3K;POLR2D;POLR1A;POLRMT
prerank,manganese ion binding (GO:0030145),0.2968976296483644,1.0040634255225882,0.45941807044410415,0.9246625594042003,1.0,20/48,27.74%,XPNPEP1;MTPAP;XPNPEP3;MPPED2;MPPE1;NEK4;MGAT5B;FEN1;POMGNT1;WRN;ARG2;GALNT4;GALNT2;LARGE1;EXD2;SOD2;GALNT3;PAPOLA;NUDT16;PPM1M
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3089767664794838,-1.0036645644215114,0.44385026737967914,0.8047836512666942,1.0,7/25,22.65%,PARP4;PARP14;PARP9;TIPARP;ZC3HAV1;SIRT2;PARP16
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.20400396952598698,-1.0017171455791947,0.48,0.8052146084769287,1.0,34/181,14.13%,RBPJ;MDFIC;PSMA6;RBBP8;PPARG;DTX3L;SMARCA4;PROX1;NCOA7;TAF1;PPARD;BBS7;NCOA1;SMAD3;SP1;EGR2;HIF1A;SNW1;MAD2L2;STAT1;ANXA4;EP300;CTNNB1;SPEN;BRMS1;PIAS2;HDAC2;CRY1;PRRX1;PARP9;HDAC1;RB1;FOS;NPM1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.33570597407122293,1.001118587905605,0.46622734761120266,0.9292574586636434,1.0,5/25,15.42%,AKR1C1;NDOR1;MICAL3;FMO1;CYP27A1
prerank,myosin binding (GO:0017022),0.2831613900935731,0.9992288617117071,0.46153846153846156,0.9307059042054306,1.0,11/55,14.91%,RAB6B;RAB3A;GIPC1;DMD;MYBPC3;RAB8A;RAB3D;CXCR4;CORO1A;ARFGEF1;HAP1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.36167490601122587,0.9977230652659397,0.45210084033613446,0.9309215379170593,1.0,7/17,23.54%,NME1;AK5;DTYMK;AK1;AK4;AK3;AK9
prerank,triglyceride lipase activity (GO:0004806),0.3426394075683853,0.9969551720235628,0.46178861788617886,0.9288338253907532,1.0,6/20,22.70%,PNPLA3;ABHD5;LIPC;PLA2G15;LIPE;DAGLB
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.32357362425644115,0.9966549101216048,0.4491803278688525,0.9252051959627644,1.0,9/26,29.25%,SLC16A6;SLC5A12;SLC6A1;MPC1;SLC16A12;ABCG2;SLC16A7;SLC16A9;MPC2
prerank,WW domain binding (GO:0050699),0.33290886345773096,0.9960251996378424,0.48878205128205127,0.9226223580913496,1.0,3/26,2.65%,TCEAL5;WBP1;SCNN1A
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.25226757215704004,-0.992212167576171,0.48546511627906974,0.8269220660518356,1.0,18/53,24.23%,CYBB;ACOX3;XDH;MTHFR;KMO;CRY2;SQOR;MTO1;CRY1;MTRR;ACADL;MICAL1;MICAL2;POR;GSR;NQO2;ACOXL;NOX4
prerank,MHC class II protein complex binding (GO:0023026),0.41302544557230636,0.9910457924250888,0.4717607973421927,0.9341658109721559,1.0,3/11,8.51%,YWHAE;ATP1B1;CD81
prerank,deoxyribonuclease activity (GO:0004536),0.3823061582070727,0.9901059930587701,0.4872665534804754,0.9327219747325999,1.0,6/14,24.18%,DNASE1L2;MAP1S;NME1;APEX1;APLF;ERCC4
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.39863067291123044,0.9896870897432285,0.4658493870402802,0.9297027386774189,1.0,5/11,26.71%,NUDT10;NUDT3;NUDT16L1;NUDT4;NUDT16
prerank,phosphatidate phosphatase activity (GO:0008195),0.3929958671309105,0.9887778868219314,0.4682274247491639,0.9283120145661681,1.0,5/13,25.25%,PLPP5;PLPPR4;PLPP1;PLPP2;PLPPR1
prerank,anion transmembrane transporter activity (GO:0008509),0.3979514823769723,0.987679357057258,0.4963898916967509,0.9271114685762514,1.0,7/12,28.61%,SLCO2B1;MFSD10;SLC39A8;SLC19A1;ABCG2;ABCC5;SLC4A2
prerank,metal ion binding (GO:0046872),0.214759861933946,0.9844839042552949,0.5303687635574837,0.9323473608266042,1.0,94/477,18.56%,TPPP;AGRN;NUDT12;SYT4;ANXA8;ANXA8L1;ATP2A2;HMGCLL1;CAPN3;ITPR2;CDH23;EFHD1;NIM1K;DCHS1;STK26;TRIM26;SYT13;SYT1;TNNC1;SPOCK2;NT5C3A;SYT6;STK11;LRP2;SMOC2;DNASE1L2;PLA2G4C;ASPH;PRNP;GSS;NRXN1;TRPM2;ESYT2;MTPAP;KCNIP4;S100A2;FKBP9;S100A13;CDH18;CDC42BPA;PI4K2A;MICU2;NUDT3;ADGRL3;NME1;S100G;OTOF;ENPP2;CPNE6;PKD2;GRIN1;SLC8A1;HPRT1;BGLAP;HSP90B1;PPA1;PDCD6;ADPRS;CCDC47;CISD3;FAN1;CDH4;ITPR3;CSGALNACT1;HSPE1;NUCB1;CLGN;RCN2;BAIAP3;AOC1;APEX1;FEN1;TCHH;NDUFAB1;SLC25A23;HPCA;POSTN;MT2A;SDF4;CDC42BPB;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;CANT1;MAST2;SNCB;WRN;LTBP4;DXO
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.37582146583869686,0.9838497708823706,0.4780316344463972,0.9299477553466035,1.0,6/15,18.16%,PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5;ABHD8
prerank,kinase activity (GO:0016301),-0.2200690547583788,-0.9837161889147973,0.5056179775280899,0.8471388809993284,1.0,27/109,15.98%,PIK3C3;FCSK;PAPSS2;DGKK;NADK;TAF1;PRKD3;PANK1;CERKL;LYN;PSTK;IPPK;PIK3CA;TRRAP;CERK;LRRK2;PANK3;SHPK;GK;SPHK2;GK5;FN3KRP;PGM2L1;ITPKA;DGKA;PI4KA;POMK
prerank,cysteine-type endopeptidase activity (GO:0004197),0.26035553981160997,0.9808335065711941,0.5121602288984263,0.9349159925886721,1.0,15/78,12.50%,USP10;CAPN3;CAPN12;USP35;LGMN;USP11;USP30;CAPNS1;CAPN11;USP12;CASP3;SFRP1;CASP4;USP33;CASP7
prerank,cytokine activity (GO:0005125),0.2457737616253241,0.9796372606817753,0.5287817938420348,0.9343274224971103,1.0,24/131,20.16%,WNT4;GDF11;IL17F;SLURP1;WNT3;IL6;NDP;IL2;BMP4;TNFRSF11B;TGFB1;WNT8B;CLCF1;FGF2;INHA;HMGB1;WNT7A;GDF1;IL7;IL18;IL1A;CCL15;CCL5;IL34
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3041333852050463,0.977285844255222,0.5101404056162246,0.9368838532279143,1.0,8/34,15.50%,CNOT2;ERI3;REXO2;ANGEL1;ERI2;EXOSC5;CNOT8;ANGEL2
prerank,nuclear localization sequence binding (GO:0008139),-0.32503190785617514,-0.9756101474289917,0.4621212121212121,0.8657671287270261,1.0,3/18,8.22%,KPNB1;KPNA2;NUP153
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.36715742089253334,0.9752560757449821,0.48932676518883417,0.9387072760498858,1.0,2/15,5.39%,PLA2G3;PLA2G4C
prerank,ATPase regulator activity (GO:0060590),-0.26503016172653615,-0.9749322553304137,0.49271137026239065,0.8624102311210429,1.0,9/38,17.24%,FNIP2;DNAJC1;TOR1AIP1;BAG4;DNAJC10;FXYD2;DNAJB6;DNAJC15;DNAJB1
prerank,translation elongation factor activity (GO:0003746),0.3669857311784597,0.9748393186631931,0.46568627450980393,0.9356877274955193,1.0,6/14,20.79%,GTPBP1;GFM2;EEF1A2;EIF5AL1;EIF5A;EIF5A2
prerank,DNA-binding transcription factor binding (GO:0140297),0.23078021629357504,0.9740957132841029,0.5211970074812967,0.9338075374940255,1.0,37/189,16.58%,HHEX;TLE3;ZFPM1;TLE2;LDB2;LDB1;USF2;RELA;PPARA;ZFPM2;CRTC1;CTBP1;MEF2C;AR;MAP3K10;GTF2I;LHX3;LMO2;DGKQ;BBS5;TCF7L2;HDAC5;TAF9;NFE2L2;IFI27;USF1;GABPA;TBX6;PRDM16;RBL2;DMAP1;HMGB1;ZBTB49;RBL1;TCF3;RERE;BHLHE41
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.30536608427659384,0.9740601081343774,0.5069551777434312,0.9296596709151954,1.0,16/35,31.83%,NT5C3A;ELAC2;DTWD2;FTSJ1;TARS2;DUS4L;TRIT1;DUS1L;MRPL58;BCDIN3D;FTO;AARS1;QTRT2;GATB;TRPT1;ALKBH1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.22534394815464384,-0.9737551238654085,0.5359712230215827,0.8609060233964402,1.0,12/91,6.28%,SVIL;HIP1;KIF16B;SDCBP;SESTD1;PLA2G4E;SH3PXD2B;GBF1;FCHO2;HIP1R;LDLRAP1;PICALM
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.36080390326878903,0.9733136506625316,0.4931506849315068,0.9277524397285435,1.0,6/16,22.22%,SLC1A1;SLC25A18;SLC38A7;SLC1A4;SLC13A3;SLC25A10
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.3463276313230985,-0.972738387521672,0.47641509433962265,0.8587353443901159,1.0,4/14,8.22%,BLVRB;MTHFR;PYCR2;MTHFD1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3419509758152065,0.9726413041961992,0.496742671009772,0.9255222938129017,1.0,7/20,28.39%,OTULINL;USP50;OTUB1;OTUD5;COPS5;USP7;SENP2
prerank,ion channel inhibitor activity (GO:0008200),-0.2732750471121578,-0.9718916693054858,0.48314606741573035,0.8561348299588963,1.0,10/35,18.12%,MCUB;ENSA;RASA1;ITPR1;CAMK2D;PHPT1;CALM2;RACK1;RSC1A1;SLC30A1
prerank,miRNA binding (GO:0035198),-0.28748550782330823,-0.9714330736815213,0.5272727272727272,0.8523883423600036,1.0,10/30,21.03%,PUM2;ZNF346;ZC3H12A;RC3H1;HNRNPA2B1;AGO2;DDX21;TRIM71;PUM1;ZC3H7A
prerank,mRNA 3'-UTR binding (GO:0003730),-0.2316181506339852,-0.9707334970580674,0.5526315789473685,0.8492916853232402,1.0,24/79,21.57%,CELF1;CPSF1;RPL5;PUM2;RPS7;EXOSC8;CPEB4;ZC3H12A;CRYZ;RC3H1;HNRNPA2B1;LARP1;RPL41;EXOSC9;LARP4B;FXR2;CPEB2;RNF20;MEX3D;CELF2;HNRNPC;HNRNPU;PUM1;CPEB3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.36867844197099675,0.9704470288985362,0.5051369863013698,0.9278745095161521,1.0,2/14,11.66%,RDH10;RDH5
prerank,5'-3' exonuclease activity (GO:0008409),0.3722115788436762,0.9680134878339822,0.5189003436426117,0.9308008163410509,1.0,4/14,18.56%,CPSF3;FAN1;FEN1;DXO
prerank,microtubule binding (GO:0008017),0.2258058458342914,0.9673697499993351,0.5538089480048367,0.9285579935186179,1.0,63/222,22.75%,TPPP;GAPDH;MAP6;DST;HAUS4;MID2;PSRC1;REEP2;PRNP;NAV3;MAP1S;CLASP2;CCDC181;MAPRE2;KIF26A;FSD1;MAP4K4;CKAP5;RAE1;LRPPRC;CAMSAP3;FGF13;PEX14;RMDN3;CAMSAP1;DNM1L;DCTN1;KIF1C;MTCL1;VASH2;SYBU;HOOK2;KIF2A;NEFM;RCC2;NDRG1;APC2;UXT;TUBGCP2;MAP9;CLIP1;KIF14;HDGFL3;STARD9;ALMS1;EML4;MAST2;HOOK1;ABRAXAS2;EML6;TPGS1;CEP57;KIF1B;KIF9;TUBGCP6;MAP2;KIF17;MAPRE3;DRG1;SPAST;MAP7D3;TOGARAM2;KIF21B
prerank,zinc ion binding (GO:0008270),0.21948421276519262,0.9665057089694591,0.5734104046242775,0.9268178963641254,1.0,73/293,20.43%,POLR2L;QPCTL;NUDT12;TET1;IKZF4;MMP16;MYCBP2;AFP;NSD1;ZFPM2;ADA;KDM1B;GALT;S100A13;ZNF205;SHANK3;WDFY1;ENPP2;PHEX;CHORDC1;GRIN2B;TRHDE;PRKN;KLF7;ITGB1BP2;KDM2B;SUV39H2;THAP1;RNF8;USP33;PHF8;CHMP1A;PITRM1;TIMM13;SEC24D;FBXL19;TRIM8;SEC24B;KDM4A;MSRB3;PGGT1B;ACR;ZBTB32;RNF2;AOC1;ENPEP;RPS27;TRAF7;NAPEPLD;SIAH1;EPRS1;SEC24C;CLIP1;TK1;ESCO1;MT2A;ZEB1;PHF2;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;ADAMTS3;ALAD;RABGGTB;CDADC1;PLA2G15;CYLD;CALB1
prerank,solute:sodium symporter activity (GO:0015370),0.3146345592341234,0.9652197894792295,0.49522292993630573,0.9265801125229347,1.0,4/27,13.42%,SLC4A8;SLC20A1;SLC4A10;SLC4A7
prerank,wide pore channel activity (GO:0022829),0.32556088978955167,0.9628903105619612,0.5193798449612403,0.9292845209280197,1.0,3/23,11.76%,GJC3;GJA5;PANX1
prerank,protein heterodimerization activity (GO:0046982),-0.20065087215084834,-0.9620387120156403,0.5660377358490566,0.8693215990873514,1.0,46/178,22.20%,BCL2;CYBB;HIP1;EXT1;BCL2L1;SDCBP;ZHX2;ATF3;PAFAH1B2;RRAGC;MCL1;BAX;SNX1;TOP2A;TCOF1;AHR;TAF1;HIF1A;HSF1;UBA2;ABCG4;ABCG1;RALGAPA2;BARD1;CYBA;RRAGA;LSM5;GCA;MICU1;FXR2;TLR4;ADRA1A;TPM4;TFAP2B;PAFAH1B3;PAFAH1B1;SDCBP2;TAF7;TUBB2B;BHLHE40;TOP2B;RCC1;VAPB;NPAS4;FZD4;CD3E
prerank,transcription coactivator binding (GO:0001223),-0.3061642407104823,-0.9616422467827902,0.48641975308641977,0.8653177674190643,1.0,5/20,7.25%,ESR1;AHR;PPARD;SMAD3;CIT
prerank,mannose binding (GO:0005537),0.3860769856812727,0.9606421745022503,0.5137457044673539,0.9318673950410694,1.0,3/12,18.47%,MBL2;ACR;LMAN2L
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36385095412892643,-0.9604795209591817,0.4674698795180723,0.8635740401721977,1.0,7/13,26.94%,SLC9B2;SLC9A9;SLC9A2;SLC11A1;SLC9A6;LETM1;SLC9A3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3587275753182336,0.9593910866964118,0.533106960950764,0.9313957699520322,1.0,5/15,13.79%,SLA2;SOCS3;SOCS2;SOCS6;SOCS4
prerank,O-methyltransferase activity (GO:0008171),0.3993296448581688,0.9592164021933989,0.5116666666666667,0.9278087717991004,1.0,6/10,27.14%,LRTOMT;MEPCE;COMT;ASMT;BCDIN3D;CMTR2
prerank,calcium ion binding (GO:0005509),0.2159422819220833,0.9590152124243988,0.6055045871559633,0.92435743344071,1.0,44/323,11.86%,AGRN;SYT4;ANXA8;ANXA8L1;ATP2A2;CAPN3;ITPR2;CDH23;EFHD1;DCHS1;SYT13;SYT1;TNNC1;SPOCK2;SYT6;LRP2;SMOC2;DNASE1L2;PLA2G4C;ASPH;PRNP;NRXN1;TRPM2;ESYT2;KCNIP4;S100A2;FKBP9;S100A13;CDH18;MICU2;ADGRL3;S100G;OTOF;ENPP2;CPNE6;PKD2;GRIN1;SLC8A1;BGLAP;HSP90B1;PDCD6;CCDC47;CDH4;ITPR3
prerank,filamin binding (GO:0031005),0.3916871919387415,0.9584051514862573,0.5166374781085814,0.9220001431687845,1.0,2/11,4.60%,NEBL;CRMP1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.23094490156776398,-0.9569677286678714,0.546875,0.8686751381162043,1.0,18/72,19.24%,SVIL;HIP1;SDCBP;SESTD1;PLA2G4E;FCHO2;HIP1R;LDLRAP1;PICALM;OSBPL2;PLEKHA4;VILL;STXBP6;SNX21;PFN2;GSN;KCNQ1;SDCBP2
prerank,sequence-specific DNA binding (GO:0043565),0.20790208092782475,0.9567512760914786,0.6196120689655172,0.9229136135646412,1.0,102/590,18.41%,HOXA5;HHEX;SCRT2;TET1;HSF4;ONECUT2;MYRFL;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;TFAM;PPARGC1A;MEOX2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXB7;E2F1;XRCC6;FOXD1;NR2F6;MEF2C;RXRG;ZNF35;HOXC10;LHX3;SP4;ZBTB22;TCF7L2;FOXC1;HEY1;TBX2;ZNF23;SNAI2;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;KDM2B;ZFP41;HOXB2;POU3F4;THAP1;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;TBX6;TEF;FBXL19;LHX5;MYRF;PRDM16;ZBTB32;BARX2;LMX1B;UPF1;ZBTB49;ZNF740;IRF5;PRDM1;BATF;ERG;TCF7L1;CALCOCO1;BHLHE41;EN2;KLF16;KLF12;ZIC5;SMG1;BACH2;XBP1;POU3F3;MAX;CHTOP;ZBTB7B
prerank,ATPase binding (GO:0051117),-0.2273955892504819,-0.9564195556635683,0.5794392523364486,0.8651297682997473,1.0,22/71,19.82%,CHMP4A;ATP6V0A1;TOR1AIP1;ESR1;TRPC1;CAV1;NR1H2;PSEN1;CLPP;DNAJC10;VCPKMT;LCK;S100A1;PPP3CA;NOP58;RALB;EGFR;FBL;DNAJB1;WFS1;NKD2;ATP6V0A4
prerank,motor activity (GO:0003774),-0.2398306718348327,-0.9556385252166204,0.5439739413680782,0.8624107887920383,1.0,20/60,21.31%,KIF3A;KIF16B;KIF23;KIF11;KIFC2;KIF20B;KIF13B;KIFC1;KIF24;KIF21A;KIF4A;MYH9;GPR88;KIF20A;DNAH8;KIF18B;KIF19;KIF27;KIF7;MYO1E
prerank,RNA polymerase II complex binding (GO:0000993),0.29945199876804224,0.9553995901994563,0.5254237288135594,0.923022019664567,1.0,10/32,23.51%,CTR9;SMYD2;ELP2;BRD4;CCAR2;PAF1;ELOF1;SCAF8;ELP4;GTF2B
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.30846252850828243,0.9540678559257261,0.5048231511254019,0.9227029709958262,1.0,7/27,18.00%,RNF19A;PPARA;RNF180;DCUN1D2;PRKN;SIAH1;SIAH3
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2530863667054558,0.9510625003075641,0.5561569688768606,0.9272393792789743,1.0,21/83,21.39%,MPND;OTUD7A;USP32;USP10;USP35;USP11;USP50;USP30;USP51;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;COPS5;CYLD;USP49
prerank,pyrophosphatase activity (GO:0016462),0.2735858634180494,0.9496287023449634,0.5662100456621004,0.9274807966104417,1.0,17/50,26.71%,PLPP5;NUDT10;NUDT9;TRPM2;NUDT3;ENTPD6;ALPL;PPA1;FITM2;DXO;PLPP1;NUDT16L1;ENTPD1;DDX3X;ENTPD2;NUDT4;NUDT16
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.24840712661980127,-0.9478729898826306,0.5434782608695652,0.880032772057674,1.0,14/48,17.58%,TMEM165;ATP6V1B2;TRPC1;SLC46A1;RHD;TRPM4;TRPV2;TRPM6;PIEZO2;CALHM6;SLC12A7;PKD1L3;MCOLN1;CALHM5
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.29875992581939337,-0.9456974088275659,0.5171568627450981,0.8813874958052959,1.0,7/24,17.56%,MKNK1;MAPKAPK2;CAMK2D;MAPKAPK3;DAPK1;PTK2B;CAMK1G
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3127428783908994,-0.945088953618749,0.547911547911548,0.8780099969821159,1.0,7/18,13.40%,SOCS7;SOCS5;AGAP2;WDR91;WDR81;PIK3R6;PIK3R5
prerank,protein homodimerization activity (GO:0042803),0.20463982950588258,0.9443159168478612,0.6599147121535182,0.9385642517469374,1.0,153/590,23.39%,TPPP;MYOM1;HHEX;TSC2;HOGA1;STARD3;MKLN1;TYW5;ADCY8;ANG;SRGAP2;KCNH2;RAB11FIP3;NACC2;LDB1;DGAT2;F11R;ADD2;USF2;STK26;MID2;DUSP29;NTRK1;FLT4;IL17F;CADM1;RELA;TENM1;TNNC1;PTPRT;PTPRO;SYT6;XPNPEP1;DEFA6;GSS;MTHFD1L;MTPAP;XPNPEP3;COMMD1;SPPL2B;NDP;MAP3K10;ADRA2A;S100A13;PSMF1;DAB2IP;NOD1;ACSL6;BAK1;PSMD7;NAGA;ACHE;ERBB4;PKD2;NECTIN3;TENM3;GGCT;PAXX;GUCY2D;INPP5F;RBPMS2;PDCD6;RAP1GAP;TRIM9;ZDHHC2;EXD1;TRPC6;STK25;DROSHA;RDH5;KYAT1;THAP1;USF1;RNF8;DNM1L;DCK;CHMP1A;MTCL1;PDGFB;CORO1A;TARS2;MTMR1;CADM3;TRIM8;GADD45A;ACOX1;MAP3K13;NUDT21;MIGA1;TPST2;CRYL1;AOC1;SNX6;DSCAML1;NTRK2;OXA1L;HM13;NAA60;TCF3;PGRMC1;PPCS;EPRS1;BHLHE41;AGXT;GALE;HARS1;SCARB2;TRIM68;UXS1;MFF;ASMT;ALS2;POU3F3;CANT1;ABCD2;ZBTB7B;CHRNA7;WRN;NADK2;HOOK1;CCL5;CAV2;CDADC1;ERP29;SNF8;SRF;CLN6;CR2;HSP90AB1;ABCG2;ABCB7;CEP57;PSPH;SSBP1;MMAA;PEX11B;HPGDS;AXIN1;RAB11FIP2;PIP4K2B;UGT1A6;EXD2;EXT2;KCNN2;FXR1;SPPL2A;CAMK2B;PEX11A;IRF3;GBP2;IL6R;RIPK2;NUDT16L1
prerank,double-stranded DNA binding (GO:0003690),0.2063216578843326,0.9439443075658287,0.6663019693654267,0.9356807525488646,1.0,88/531,18.41%,HOXA5;NUCKS1;SCRT2;HSF4;PQBP1;ONECUT2;POU2F2;USF2;HOXD4;TFCP2;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;MEOX2;SOX4;BCL11B;ZBTB12;HOXB9;HOXB7;E2F1;HDGFL2;XRCC6;NR2F6;MEF2C;GTF2H4;RXRG;HOXC10;ZBTB22;HEY1;TBX2;ZNF23;SNAI2;DMRTA1;CGAS;HSF2;ZNF32;ZFP1;DMC1;ZFP41;HOXB2;POU3F4;POLR3F;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;LHX5;ZBTB32;BARX2;HMGB1;LMX1B;APEX1;FEN1;ZNF740;IRF5;HMGB3;PRDM1;BATF;ERG;TCF7L1;BHLHE41;EN2;KLF16;CENPS;HDGFL3;KLF12;ZIC5;BACH2;XBP1;MAX;PSIP1;ZBTB7B
prerank,disordered domain specific binding (GO:0097718),0.32129476090305475,0.9435678606036083,0.5514469453376206,0.9328252497644927,1.0,3/23,4.72%,GAPDH;HSPA2;PPIL1
prerank,amino acid binding (GO:0016597),0.3027149845408348,0.9423806628240361,0.5440931780366056,0.9320882703210503,1.0,7/31,16.81%,GLRA3;GLRB;GRIN1;GRIN2B;GLRA2;DDAH2;AGXT
prerank,single-stranded RNA binding (GO:0003727),-0.25204985567464827,-0.9422052166794351,0.5523809523809524,0.8814934470335357,1.0,9/43,12.50%,DDX60;IFIH1;EIF4B;TLR7;JMJD6;TLR8;AQR;EXOSC10;AGO2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3252350405066089,0.9412477784518416,0.5419354838709678,0.9313459030164117,1.0,3/21,6.73%,PDE8B;PDE4A;PDE3B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.3745966642618785,-0.9392552062205902,0.5284738041002278,0.8848369915630998,1.0,3/10,6.22%,NSD2;SETD3;PRDM9
prerank,endopeptidase activator activity (GO:0061133),0.39129852689273653,0.938642125056957,0.523725834797891,0.9346079324204639,1.0,4/10,12.51%,VSIR;PSME3;PSENEN;PSMD14
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.35474536119931244,0.9364751778671555,0.5627118644067797,0.9367021947367353,1.0,6/14,23.54%,NME1;AK5;DTYMK;AK1;AK4;AK9
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3692620537650768,-0.936191700836148,0.522248243559719,0.8882689146833724,1.0,3/10,19.10%,CLCN1;CLCN5;ANO1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.37332890056863266,-0.9347186335770331,0.5496535796766744,0.8875558262541351,1.0,1/10,2.04%,CD47
prerank,deubiquitinase activity (GO:0101005),0.2477480741242484,0.9344402758130254,0.5863013698630137,0.9383816058445417,1.0,16/88,15.27%,MPND;OTUD7A;USP32;USP10;USP35;USP11;USP50;USP30;USP51;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5
prerank,phospholipase inhibitor activity (GO:0004859),-0.3743249021708851,-0.9327662894746336,0.5506912442396313,0.888340369701262,1.0,3/10,12.97%,ANXA1;ANXA4;APOC1
prerank,protein kinase C binding (GO:0005080),0.28096974749055553,0.9325222078571969,0.5625942684766214,0.9396587895911578,1.0,8/43,11.47%,PKN1;PARD6B;AVPR1A;PARD6G;TWF2;PRKD2;HDAC5;IRS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.35961284705351926,0.9319214412047787,0.5366269165247018,0.9374919797574532,1.0,4/14,10.33%,CAPN3;CAPN12;CAPNS1;CAPN11
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.377611802878807,-0.9302072708388839,0.5424528301886793,0.8903572247808563,1.0,2/10,9.63%,DPP4;PRCP
prerank,R-SMAD binding (GO:0070412),0.32776859908562217,0.92935461265297,0.5645695364238411,0.9408015278738123,1.0,4/18,11.56%,LDLRAD4;DDX5;PPM1A;DROSHA
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.2431819125197739,-0.9282411762403783,0.5949008498583569,0.8908110151090287,1.0,7/42,10.06%,EMB;PDLIM1;CD47;PDLIM5;NPTN;ANXA1;RAB10
prerank,metalloexopeptidase activity (GO:0008235),0.26777432659166417,0.9231858974220883,0.5905044510385756,0.9534301697628181,1.0,14/51,19.05%,MMP16;RNPEPL1;XPNPEP1;METAP1D;XPNPEP3;VASH1;AEBP1;TRHDE;LAP3;VASH2;ENPEP;AGBL4;MMP17;FOLH1
prerank,tau-protein kinase activity (GO:0050321),-0.30902031709647115,-0.9229151882852413,0.5675675675675675,0.9003895960560966,1.0,3/20,6.99%,MARK2;DYRK1A;FYN
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2987211460757163,-0.9218364284360232,0.5826771653543307,0.8983853441755705,1.0,8/22,22.80%,CPSF1;EXOSC8;ZC3H12A;EXOSC9;CPEB2;MEX3D;CPEB3;ILF3
prerank,endoribonuclease activity (GO:0004521),-0.26005213119768367,-0.9189953693032136,0.6185286103542235,0.9012719826150606,1.0,11/32,25.45%,ZC3H12D;ERN1;ZC3H12A;ZC3H12B;PIWIL2;AGO2;ENDOG;SMG6;RNASEK;RIDA;ERN2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.19769651111724945,0.9186333456667615,0.7675392670157068,0.9614962456003169,1.0,163/730,23.78%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;SALL3;IKZF4;NACC2;ONECUT2;BPTF;POU2F2;USF2;HOXD4;TFCP2;ZNF394;ESRRG;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;SP2;KCNIP3;SOX10;TFCP2L1;NSD1;MEOX2;WBP2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;FOXD1;NR2F6;RFX6;MEF2C;AR;RXRG;ZNF205;MAZ;HOXC10;SP4;EBF1;TCF7L2;FOXC1;HEY1;HDAC5;ZFP82;TBX2;ZNF23;ZKSCAN8;SNAI2;KLF7;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;POU3F4;PBX3;ZNF383;THAP1;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;PLAG1;PRDM16;ZSCAN12;ZBTB32;MYNN;ZBTB49;NKX2-2;IKZF2;ZNF740;IRF5;PRDM1;BATF;ERG;REST;TCF3;TCF7L1;PRDM15;CALCOCO1;BHLHE41;EN2;KLF16;BACH1;KLF12;ZIC5;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;XBP1;POU3F3;TEAD3;MAX;ZFP92;ZBTB7B;FOSL2;SNAPC3;REL;RORA;POU5F2;SRF;DHX36;PRDM5;IRX5;SMAD2;SMAD1;GLI3;GRHL2;KLF5;HOXC5;PRMT5;NFE2L3;ZNF467;ZFAT;TOP1;TEAD2;EBF3;ZNF628;NFYB;ZSCAN18;NPAS2;SKOR2;CC2D1A;ZIK1;HDX;CREB3L4;IRF3;SOX13;EBF4;HOXB3;NKRF;CREB3;HES6;MEF2A;MAFB
prerank,fibroblast growth factor binding (GO:0017134),0.32819169547397953,0.9182107850689332,0.5396039603960396,0.9587888066153152,1.0,3/21,7.10%,KLB;GPC1;S100A13
prerank,solute:anion antiporter activity (GO:0140323),-0.33562666104522454,-0.9173438413034345,0.5497737556561086,0.9005883925491476,1.0,2/14,4.50%,SLC26A11;SLC7A11
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.3397793235245191,-0.9168615634529395,0.5801886792452831,0.8972938581719341,1.0,4/13,20.01%,BMP5;BMP2;BMP3;BMP7
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3798587545097369,0.9147916866980597,0.5721739130434783,0.9640925564594646,1.0,2/10,6.58%,PIK3C2G;PIK3CG
prerank,ubiquitin-specific protease binding (GO:1990381),0.32091852401282445,0.9123686031625824,0.5750853242320819,0.9665817796156565,1.0,8/19,28.40%,SELENOS;PRKN;DERL1;RHBDD2;AMFR;CLTC;SUMO1;PTEN
prerank,intracellular chloride channel activity (GO:0061778),-0.31615488962219573,-0.9078074014270818,0.5671641791044776,0.9114042537477631,1.0,6/16,26.65%,TTYH2;ANO5;ANO8;ANO1;ANO10;ANO4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.31615488962219573,-0.9078074014270818,0.5671641791044776,0.9114042537477631,1.0,6/16,26.65%,TTYH2;ANO5;ANO8;ANO1;ANO10;ANO4
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3211705278442333,0.906621554699869,0.6214876033057851,0.9782598951977616,1.0,7/20,23.54%,DLG2;LRGUK;DTYMK;AK1;AK4;AK3;AK9
prerank,vitamin D receptor binding (GO:0042809),-0.32864897565782386,-0.9062863681190788,0.6,0.910658596192546,1.0,3/14,9.36%,MED13;MED16;SNW1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.19473577993273505,0.9060425696262447,0.799791449426486,0.9759547830250292,1.0,161/731,23.78%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;SALL3;IKZF4;NACC2;ONECUT2;BPTF;POU2F2;USF2;HOXD4;TFCP2;ZNF394;ESRRG;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;SP2;KCNIP3;SOX10;TFCP2L1;NSD1;MEOX2;WBP2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;FOXD1;NR2F6;RFX6;MEF2C;AR;RXRG;ZNF205;MAZ;HOXC10;SP4;EBF1;TCF7L2;FOXC1;HEY1;HDAC5;ZFP82;TBX2;ZNF23;ZKSCAN8;SNAI2;KLF7;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;POU3F4;PBX3;ZNF383;THAP1;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;PLAG1;PRDM16;ZSCAN12;ZBTB32;MYNN;ZBTB49;NKX2-2;IKZF2;ZNF740;IRF5;PRDM1;BATF;ERG;REST;TCF3;TCF7L1;PRDM15;CALCOCO1;BHLHE41;EN2;KLF16;BACH1;KLF12;ZIC5;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;XBP1;POU3F3;TEAD3;ZFP92;ZBTB7B;FOSL2;SNAPC3;REL;RORA;POU5F2;SRF;DHX36;PRDM5;IRX5;SMAD2;SMAD1;GLI3;GRHL2;KLF5;HOXC5;NFE2L3;ZNF467;ZFAT;TOP1;TEAD2;EBF3;ZNF628;NFYB;ZSCAN18;NPAS2;SKOR2;CC2D1A;ZIK1;HDX;CREB3L4;IRF3;SOX13;EBF4;HOXB3;NKRF;CREB3;HES6;MEF2A;MAFB
prerank,peptidase inhibitor activity (GO:0030414),0.28124203573386736,0.9046381582582513,0.6066565809379728,0.9758712005276612,1.0,4/33,10.34%,CST3;PSMF1;SPINT2;SIMC1
prerank,thyroid hormone receptor binding (GO:0046966),0.29445856195827225,0.9039382386708739,0.6232558139534884,0.9737053360027655,1.0,5/28,6.24%,MED24;NSD1;MED4;BRD8;TRIP6
prerank,proton transmembrane transporter activity (GO:0015078),0.2758371215745764,0.9039230467359906,0.6430769230769231,0.9699705376804829,1.0,10/39,23.98%,UQCRC1;SLC33A1;NDUFA4;CTNS;UQCR11;COX4I1;COX6B1;SLC9A1;UQCR10;COX10
prerank,TBP-class protein binding (GO:0017025),0.3114531849720235,0.9015476916944932,0.6138933764135702,0.9725116214007947,1.0,2/21,1.61%,HHEX;DRAP1
prerank,tRNA methyltransferase activity (GO:0008175),-0.32002514487347516,-0.9014616436261308,0.5815789473684211,0.9182621709503299,1.0,7/16,15.31%,TARBP1;THUMPD3;LCMT2;ALKBH8;TRDMT1;TRMT13;TRMT9B
prerank,neuropeptide receptor binding (GO:0071855),0.35155115711895546,0.9010711575349959,0.5820379965457686,0.9699306635320523,1.0,3/14,17.85%,PPY;GAL;SHANK1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2841445025617154,0.8995124044331014,0.6423017107309487,0.9699571637249214,1.0,11/34,18.51%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4;TTLL12;SMYD1;N6AMT1;KMT2E;SETDB1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.21662648393947595,-0.8994168197045381,0.6993243243243243,0.9188573763523342,1.0,24/71,22.19%,PTPN22;PTPN23;PTPRC;PTPN1;CDC14B;PTPN21;EYA1;PTPN7;DUSP18;EYA3;EYA2;CDKN3;DUSP1;TIMM50;TNS2;CDC25A;MTMR3;HACD2;PTP4A3;PTPRZ1;PTPRH;CDC25C;PTPN4;CDC14A
prerank,phospholipase activity (GO:0004620),0.2460177415489426,0.8985977570208993,0.653179190751445,0.9686238000093818,1.0,9/67,8.83%,PLCL1;PRDX6;PLAAT5;PLA2G4C;PNPLA3;ABHD12;LYPLA1;PLD4;ENPP2
prerank,SUMO binding (GO:0032183),0.3552539366581282,0.8975902513113686,0.6086235489220564,0.9673147237188219,1.0,3/13,11.19%,HERC2;SIMC1;CBX4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.1944332708276912,0.8965149784476977,0.8221512247071352,0.9664478068329214,1.0,90/597,16.66%,HOXA5;HHEX;SCRT2;MCM5;HSF4;KCNH2;ONECUT2;POU2F2;USF2;HOXD4;TFCP2;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;RELA;SP2;SOX10;TFCP2L1;TFAM;MEOX2;SOX4;BCL11B;ZBTB12;HOXB9;HOXB7;E2F1;GABPB1;XRCC6;NR2F6;RFX6;MEF2C;AR;RXRG;MCM3;HOXC10;ZBTB22;TCF7L2;ERBB4;FOXC1;HEY1;HDAC5;TAF9;ZW10;TBX2;ZNF23;SNAI2;DMRTA1;HSF2;NFE2L2;ZNF32;ZFP1;ZFP41;HOXB2;POU3F4;SUV39H2;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;LHX5;PRDM16;ZBTB32;BARX2;HMGB1;LMX1B;MLH3;ZNF740;IRF5;PRDM1;BATF;ERG;REST;TCF7L1;CALCOCO1;BHLHE41;EN2;KLF16
prerank,ATP binding (GO:0005524),-0.17652780260538303,-0.8960405048773818,0.8609271523178808,0.9230153655446196,1.0,41/266,13.61%,PEAK1;STK3;OAS2;STK38;STK17B;CDK6;HSPA4;MARK2;OLA1;ATP7A;RUNX3;P2RX4;RRM1;NUAK2;MKNK1;PTPA;NLRC4;MYO1F;RTEL1;PIM1;LMTK2;ERN1;PRKAG2;IGHMBP2;KIFC1;EIF2B2;UBA2;HASPIN;ABCG1;YARS2;UHMK1;AGAP2;CAD;LIG4;DAPK1;PANK3;OAS3;N4BP2;SIK2;FICD;NLK
prerank,BMP receptor binding (GO:0070700),-0.33979187293427254,-0.8958160798843042,0.6036866359447005,0.9188248716349019,1.0,4/12,20.01%,BMP5;BMP2;BMP3;BMP7
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.19111489368781656,0.8948354384007129,0.8404145077720208,0.9670226818785338,1.0,184/830,23.78%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;ZFP57;SALL3;IKZF4;NACC2;ONECUT2;BPTF;POU2F2;USF2;HOXD4;TFCP2;ZNF394;ESRRG;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;SP2;KCNIP3;SOX10;TFCP2L1;NSD1;MEOX2;WBP2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;FOXD1;NR2F6;RFX6;MEF2C;AR;RXRG;ZNF35;ZNF205;MAZ;HOXC10;LHX3;SP4;EBF1;ZBTB22;TCF7L2;FOXC1;HEY1;HDAC5;ZFP82;TBX2;ZNF23;AEBP1;ZKSCAN8;SNAI2;KLF7;DMRTA1;GBX1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;ZFP69;ZFP41;HOXB2;RFXAP;POU3F4;PBX3;ZNF383;THAP1;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;TBX6;TEF;LHX5;PLAG1;PRDM16;ZSCAN12;RBL2;ZBTB32;MYNN;BARX2;LMX1B;ZBTB49;RBL1;NKX2-2;IKZF2;ZNF740;IRF5;PRDM1;BATF;ERG;BHLHA9;REST;TCF3;TCF7L1;PRDM15;LHX2;CALCOCO1;BHLHE41;EN2;KLF16;BACH1;KLF12;ZIC5;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;XBP1;POU3F3;TEAD3;MAX;ZFP92;ZBTB7B;FOSL2;SNAPC3;REL;RORA;POU5F2;SRF;DHX36;PRDM5;IRX5;SMAD2;SMAD1;GLI3;GRHL2;KLF5;HOXC5;NFE2L3;ZNF467;TFDP2;LHX4;ZFAT;TOP1;TEAD2;NPAS3;EBF3;ZNF628;ZBTB46;NFYB;ZSCAN18;NPAS2;SKOR2;CC2D1A;ZIK1;HDX;CREB3L4;IRF3;SOX13;EBF4;HOXB3;GTF2B;NKRF;CREB3;HES6;MEF2A;MAFB
prerank,lipoprotein particle receptor binding (GO:0070325),0.29059306754582404,0.8939728635018188,0.6124794745484401,0.9655217396778593,1.0,12/27,29.73%,SYT1;CLU;APBB1;HSP90B1;APBB3;LANCL1;ANKRA2;SNX17;DNAJA1;CLTC;HSPG2;AP2M1
prerank,lysophospholipase activity (GO:0004622),0.3155182897104093,0.8910473207171687,0.6127946127946128,0.9692086815269229,1.0,4/20,8.83%,PLA2G4C;ABHD12;LYPLA1;ENPP2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.24435895049151599,0.8904575082734076,0.6690856313497823,0.9669700950055496,1.0,15/69,17.18%,DGAT2;PLAAT5;AWAT2;PLA2G4C;SOAT2;ZDHHC8;CERS4;ZDHHC1;ZDHHC2;KAT8;CERS5;CERS6;CERS1;ESCO1;NMT1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3641105338389759,0.8897463472124343,0.6252220248667851,0.9651033892838738,1.0,4/11,21.18%,FBXO11;PRMT9;PRMT3;PRMT5
prerank,damaged DNA binding (GO:0003684),-0.23785353541460255,-0.8890208390454893,0.6617210682492581,0.9315373248808025,1.0,11/44,19.68%,RBBP8;HMGB2;PCNA;NBN;CRY2;EP300;RPA1;NTHL1;RPA2;XPC;NEIL3
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.33062410730493375,-0.8878446664034777,0.6047745358090185,0.9297996420281364,1.0,5/13,19.21%,ERN1;PDGFD;PDGFC;PDGFRA;ITGB3
prerank,BMP binding (GO:0036122),0.3602956181380633,0.880183487710334,0.6432246998284734,0.9848219497011264,1.0,3/11,22.62%,GREM2;ENG;UCMA
prerank,exonuclease activity (GO:0004527),0.256953288074607,0.8787861994308905,0.6737160120845922,0.9847204375897572,1.0,13/46,19.73%,REXO2;POLG;ENPP2;CPSF3;FAN1;EXD1;EXOSC5;APEX1;FEN1;WRN;DXO;REXO4;APLF
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3747762806326049,0.8787819533195208,0.6440972222222222,0.9811004233474098,1.0,3/10,24.57%,ECHDC1;ECHS1;ECHDC2
prerank,metalloendopeptidase activity (GO:0004222),0.23304092985677258,0.8784521269885814,0.6757142857142857,0.9783598219453761,1.0,15/76,18.61%,MMP16;MEP1B;ADAMTS20;PHEX;ADAMTSL1;ADAMTS15;ADAMTS19;THSD4;ADAMTS14;PITRM1;MMP1;THOP1;ADAMTS4;MMP17;ADAMTS3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3071812860581683,-0.875337391063159,0.6497584541062802,0.9560623165962994,1.0,6/16,15.83%,MTMR14;MTMR2;MTMR4;MTM1;MTMR12;MTMR3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2561912695778003,-0.8752006951900102,0.7060439560439561,0.9516209335441176,1.0,4/30,6.09%,TMEM165;SLC39A10;ATP7A;SLC30A5
prerank,CCR chemokine receptor binding (GO:0048020),-0.25780349685176174,-0.8751167128916991,0.6786703601108033,0.9471338120730057,1.0,7/28,27.31%,CCR2;CCL25;CCRL2;NARS1;NES;CCL7;CCL24
prerank,retinoic acid receptor binding (GO:0042974),-0.30293803237791955,-0.8747949521317043,0.6306532663316583,0.9431776981111718,1.0,8/17,28.56%,PPARG;SNW1;PRMT2;TACC1;NRIP1;HMGA1;ARID5A;ACTN4
prerank,methyl-CpG binding (GO:0008327),-0.2737418141701404,-0.8717779891963855,0.654228855721393,0.9457386034962671,1.0,5/22,12.33%,MECP2;ZCWPW1;MBD2;MBD1;TET3
prerank,phosphatase activity (GO:0016791),0.23721040017454678,0.8712726729347979,0.7144927536231884,0.992368682869716,1.0,24/73,27.15%,PLPP5;PTPRO;ENOPH1;SACM1L;PPP1CC;ALPL;OCRL;PPP5C;PTPMT1;PLPPR4;FRA10AC1;NT5C;PLPP1;PSPH;PPP1CA;NUDT16L1;DUSP28;DUSP26;ACP4;PLPP2;PLPPR1;MDP1;NUDT16;ACP2
prerank,peptidoglycan binding (GO:0042834),0.361950516295544,0.8704736840022949,0.6445993031358885,0.9906154250528135,1.0,3/10,10.19%,PGLYRP2;NOD1;RNASE7
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.2907357554187725,0.8689452255060364,0.6719492868462758,0.9906123098212605,1.0,3/23,6.73%,PDE8B;PDE4A;PDE3B
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.35851070811953734,-0.8687669035496467,0.6255813953488372,0.9437148055719988,1.0,7/10,37.97%,DUSP16;DUSP1;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.35851070811953734,-0.8687669035496467,0.6255813953488372,0.9437148055719988,1.0,7/10,37.97%,DUSP16;DUSP1;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,ATPase activator activity (GO:0001671),-0.28028752313784944,-0.8669916755582806,0.6902887139107612,0.9435485114882155,1.0,7/20,17.24%,DNAJC1;TOR1AIP1;DNAJC10;FXYD2;DNAJB6;DNAJC15;DNAJB1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3131973105477206,0.8661786664871431,0.6501766784452296,0.9936562152629504,1.0,5/18,20.59%,TGFBR3;TGFBR1;TGFB1;ENG;SMAD2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.27571882412918736,0.8657809319814722,0.6502463054187192,0.9910265158046124,1.0,11/32,22.87%,SLC38A2;SLC1A1;SLC38A9;SLC38A7;SFXN1;SLC1A4;SFXN2;SLC25A38;SLC6A9;SLC38A3;SLC6A7
prerank,5'-nucleotidase activity (GO:0008253),-0.32254513717965916,-0.8653075104205086,0.6370192307692307,0.9427670942557992,1.0,3/13,13.41%,NT5DC1;NT5E;NT5DC2
prerank,GDP binding (GO:0019003),-0.2132167991068475,-0.8634730234738921,0.7234726688102894,0.9422050209823677,1.0,14/63,18.62%,RAB8B;RRAGC;RAB7A;KRAS;RAB10;RAB21;RALB;RASL12;RAP1B;RAP1A;NRAS;MIEF1;RAB31;RAP2A
prerank,telomerase RNA binding (GO:0070034),-0.2784436988756105,-0.8628688641363897,0.6724137931034483,0.9392374472181446,1.0,14/22,30.44%,SNRPB;EXOSC10;NOP10;SMG6;TENT4B;DKC1;TEP1;HNRNPC;HNRNPU;NAF1;NHP2;TERT;PINX1;SMG5
prerank,retinoid binding (GO:0005501),0.294899517706407,0.862758227701993,0.6820276497695853,0.9944891593713443,1.0,2/22,3.95%,PTGDS;CYP26C1
prerank,transforming growth factor beta binding (GO:0050431),0.2976502649112298,0.8626122651280582,0.6733333333333333,0.9912724784066904,1.0,5/23,18.50%,LTBP3;TGFBR3;TGFBR1;ENG;LTBP4
prerank,methylation-dependent protein binding (GO:0140034),0.24326569198533596,0.8621234909669054,0.6925329428989752,0.9887916851894136,1.0,22/57,27.48%,BPTF;CBX2;SPIN1;NCAPD3;KAT8;PHF8;KDM4A;MORC4;KMT2E;PHF1;PHF2;CBX5;TDRD3;MPHOSPH8;ING2;ING3;WDR5;MBTD1;PHF13;CHD1;CHD8;LRWD1
prerank,nucleotidase activity (GO:0008252),-0.3102567253955401,-0.8616321021334626,0.6535626535626535,0.9374494171023292,1.0,4/15,18.92%,NT5DC1;NT5E;NT5DC2;BPNT2
prerank,kinase activator activity (GO:0019209),0.27412229315189796,0.8600536514163662,0.694620253164557,0.9901237898885719,1.0,5/30,10.74%,RPTOR;NCKAP1L;STK11;IL2;FGF13
prerank,methylated histone binding (GO:0035064),0.2375111238650347,0.858302407745972,0.7294964028776978,0.9905583507471375,1.0,24/62,27.48%,BPTF;CBX2;DPF2;SPIN1;NCAPD3;KAT8;PHF8;KDM4A;TTLL12;MORC4;KMT2E;PHF1;PHF2;CBX5;TDRD3;MPHOSPH8;ING2;ING3;WDR5;MBTD1;PHF13;CHD1;CHD8;LRWD1
prerank,MHC class I protein binding (GO:0042288),-0.31634101920470414,-0.8579621094950702,0.6550925925925926,0.9416805291839229,1.0,6/13,31.91%,TAPBP;LILRB1;PILRA;TUBB4B;CD8B;CD8A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3415358055187291,0.8579267558704553,0.668918918918919,0.9879169784753156,1.0,3/12,12.25%,PIK3C2G;PIK3CG;IPMK
prerank,single-stranded DNA binding (GO:0003697),0.22280344045028388,0.8578159493996593,0.7607192254495159,0.9847312602520109,1.0,23/93,24.18%,TOP3A;NUCKS1;MCM5;RTF1;RNF138;FUBP3;MCM3;DMC1;POLR2G;RAD52;MLH1;SUB1;HMGB1;HNRNPA1;REXO4;DHX36;SSBP1;NABP1;TOP1;POLA1;SSBP2;POLR2D;ERCC4
prerank,nuclear export signal receptor activity (GO:0005049),-0.33676049490800364,-0.855032075237934,0.6740196078431373,0.9438626676277734,1.0,2/11,9.99%,EIF4ENIF1;XPO1
prerank,cation transmembrane transporter activity (GO:0008324),0.24980933500096342,0.8542133504020294,0.7090352220520674,0.9892334331985476,1.0,9/48,13.34%,SLC25A2;SLC38A2;SLC1A1;SLC38A9;SLC38A7;SFXN1;SLC1A4;SLC66A1;SFXN2
prerank,E-box binding (GO:0070888),0.26573410294771527,0.8509940227025774,0.7044410413476263,0.9929738544037788,1.0,8/34,18.32%,SCRT2;NEUROG2;NEUROD2;SNAI2;TCF3;BHLHE41;ZEB1;MAX
prerank,U6 snRNA binding (GO:0017070),0.33365144089313215,0.8500475261822121,0.6650082918739635,0.9916939657538797,1.0,6/14,22.72%,METTL16;LSM8;DDX39B;EIF5A;LSM4;LSM3
prerank,transaminase activity (GO:0008483),0.3511214773211764,0.8496338182524358,0.6916058394160584,0.989235696271649,1.0,3/11,19.90%,BCAT1;AGXT;ABAT
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3287622702652815,-0.8483734526400062,0.6594202898550725,0.9540069055362138,1.0,4/11,19.68%,APEX2;NTHL1;HMGA2;NEIL3
prerank,frizzled binding (GO:0005109),0.2652514110037276,0.848313437856505,0.7119741100323624,0.9887578463351189,1.0,6/34,11.54%,WNT4;WNT3;RYK;NDP;WNT8B;SFRP1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3301739569223312,-0.8475912040641836,0.6607929515418502,0.9511591038264484,1.0,5/10,26.42%,EP300;HAT1;MSL3;NAA40;ATF2
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.1616707297803584,-0.8472158332545395,0.98,0.9476546815278751,1.0,90/431,20.14%,PEAK1;STK3;PSMA6;OAS2;STK38;STK17B;CDK6;HSPA4;MARK2;OLA1;ATP7A;RUNX3;P2RX4;RRAGC;TUBB6;RRM1;NUAK2;EEF1A1;RAB7A;MKNK1;PTPA;NLRC4;MYO1F;RTEL1;PIM1;LMTK2;TUBA4A;ERN1;TUBD1;ARF3;MTG2;PRKAG2;GBP3;IGHMBP2;KIFC1;RAB6A;EIF2B2;TUBE1;UBA2;HASPIN;ABCG1;KRAS;GNL2;RHOJ;RAB10;YARS2;UHMK1;AGAP2;DNM2;CAD;LIG4;DAPK1;TSR1;LRRK2;RRAGA;RAB21;PANK3;REM1;OAS3;N4BP2;SIK2;FICD;NLK;GBP4;RALB;SIK1;RASL12;PRKACB;RAP1B;RAP1A;MYH9;ARHGEF5;PLK1;NRAS;PFKL;RAB31;ZAP70;MAP4K1;TBCK;TRIP13;RAP2A;LANCL2;TUBB2B;HSPA13;MYO9B;ACVR1;HSPA1B;GBP6;HNRNPU;CDC42BPG
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.34072453386206714,0.8472075891881772,0.6482142857142857,0.9878467133169717,1.0,4/12,19.48%,SLC25A5;SLC19A1;SLC25A23;SLC35B2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2636317770177121,0.8455395484971222,0.7024922118380063,0.9880660593757764,1.0,7/33,15.50%,ERI3;REXO2;ANGEL1;ERI2;EXOSC5;CNOT8;ANGEL2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2832330034777364,0.8449623841744102,0.6875,0.9859102443012793,1.0,8/24,23.54%,IP6K1;NME1;AK5;DTYMK;AK1;AK4;AK3;AK9
prerank,endopeptidase activity (GO:0004175),0.1931649355725723,0.8439842047625518,0.8532219570405728,0.9847122136267588,1.0,51/257,21.54%,F3;USP10;PSMB1;PLAT;MMP16;RHBDL3;PRSS56;ASPRV1;MEP1B;GZMM;ADAMTS20;USP35;BACE1;LGMN;USP11;USP30;PSMA1;PHEX;ADAMTSL1;ADAMTS15;PSMA8;USP12;CASP3;SFRP1;ADAMTS19;CASP4;THSD4;USP33;CASP7;ADAMTS14;PITRM1;MMP1;ACR;PIK3IP1;KLK2;HPN;THOP1;ADAMTS4;MMP17;PSMB4;PCSK2;ADAMTS3;CTSK;USP48;CASP8;TYSND1;OMA1;USP49;APEH;CASP2;CTSS
prerank,ribonuclease P activity (GO:0004526),0.34835297491460165,0.8436832479288934,0.6509598603839442,0.9819883787205568,1.0,3/11,13.22%,RPP40;PRORP;RPP30
prerank,G protein-coupled receptor binding (GO:0001664),0.20850736124356284,0.8421356358036665,0.7997364953886693,0.9818580842586405,1.0,37/132,27.43%,WNT4;INSL3;REEP2;WNT3;RYK;NDP;ARRB2;GNA15;PPY;UTS2B;WNT8B;PRKN;HOMER2;SFRP1;USP33;GNA11;WNT7A;GNAI3;ADM;GNAS;BICD1;GHRL;RSPO1;DVL2;CCL5;ARRB1;RNF43;TULP3;TAFA5;GNAI1;ITGB4;WNT5B;STUB1;PSMC5;GNAQ;HSPA8;DNAJA1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3570114384636244,0.8412480060337371,0.6832191780821918,0.9804205061902062,1.0,2/10,15.68%,NAA30;NAA60
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.19446001169140595,0.8404580384282391,0.855072463768116,0.9787996897328006,1.0,40/254,16.00%,HOXA5;HHEX;ONECUT2;HOXD4;TFCP2;NR1I2;NRL;NR1I3;NFIB;RELA;SOX10;TFCP2L1;MEOX2;SOX4;PPARA;PBX2;HOXB7;RFX6;MEF2C;AR;GTF2I;HOXC10;LHX3;FOXC1;KLF7;GRHL3;HSF2;SMARCD3;HOXB2;RFXAP;GABPA;HLF;PLAG1;PRDM16;BARX2;NKX2-2;IRF5;ERG;TCF3;PRDM15
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.27431928548143397,0.8392037152126556,0.7208538587848933,0.9780518725972486,1.0,5/27,12.62%,SLC22A8;SLC26A4;SLC26A7;SLC39A8;GET3
prerank,bHLH transcription factor binding (GO:0043425),0.30852763501039115,0.8386115198173951,0.6872909698996655,0.9760418360574277,1.0,6/19,16.58%,USF2;MAP3K10;LMO2;USF1;TCF3;BHLHE41
prerank,actin binding (GO:0003779),0.20295854879484745,0.8382323977455395,0.8193224592220828,0.9734814716293759,1.0,34/170,17.44%,KCNMA1;ADCY8;FSCN1;ANG;ADD2;EPS8L3;GIPC1;TNNI3;CORO2B;DMD;MYH10;RUSC1;MAP1S;MICAL3;MYO6;TWF2;VASH1;LDB3;PRKN;EMD;CXCR4;KLHL2;CORO1A;LMOD3;VASH2;EPS8L2;PHACTR3;PAWR;TWF1;SSH1;HPCA;PTK2;SSH2;SSH3
prerank,protein phosphatase 1 binding (GO:0008157),-0.27083340401474654,-0.835464412274981,0.6974358974358974,0.968891015909504,1.0,9/21,22.18%,SHOC2;AKAP11;PPP1R3C;PPP1R3F;PPP1R3E;LILRB1;PPP1R15A;KCNQ1;SMTNL2
prerank,ADP binding (GO:0043531),-0.24892319094662974,-0.8350835516863176,0.7364130434782609,0.9653267660025224,1.0,7/25,19.44%,ERN1;PRKAG2;ABCG1;GCLC;MYH9;MIEF1;MYO9B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.22483419344231992,0.8345769462161012,0.7680115273775217,0.9778062631051664,1.0,16/75,21.32%,RDH10;AKR1C1;PRXL2B;NSDHL;CBR4;HSD17B11;MDH1;RDH5;SDR42E1;CRYL1;LDHD;KDSR;HSD17B10;HPGD;PHGDH;PGD
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.22332830699465012,0.8329163077588881,0.7624633431085044,0.9779804843976188,1.0,8/73,11.76%,AVPR2;NMUR1;AVPR1A;LTB4R2;SORCS1;ADCYAP1R1;CX3CR1;MC4R
prerank,histone methyltransferase activity (GO:0042054),-0.23323742582443577,-0.8322377183709819,0.7461139896373057,0.9669361499257784,1.0,10/32,20.71%,SETD7;DOT1L;PRDM9;KMT2C;PRMT2;EHMT1;FBL;SMYD3;EED;SETD2
prerank,ubiquitin protein ligase binding (GO:0031625),0.1906885119060001,0.8312174877349021,0.8855780691299165,0.9782694550220664,1.0,43/254,16.03%,WRAP53;YWHAE;PRDX6;FHIT;UBE2B;UQCRC1;KCNH2;RELA;CASC3;PPARGC1A;HERC2;CLU;UBE2G1;FBXO7;TRIB1;TRIB2;ARRB2;APBB1;FAF1;PRKN;SUMO2;LRPPRC;UBE2N;HSPA9;BECN1;CXCR4;ACVR1B;MC4R;CUL2;RNF8;DERL1;SLC25A5;DNM1L;OTUB1;ARRDC1;KDM4A;BLZF1;RFFL;HSPBP1;JKAMP;HM13;UBXN1;HLTF
prerank,alkali metal ion binding (GO:0031420),0.32908312751872315,0.8309811171473735,0.6712095400340715,0.9754952959392559,1.0,3/13,22.19%,CAPN3;ATP1A1;DRG1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.2330112664824046,0.8304534650004068,0.7812041116005873,0.9734816736281691,1.0,16/60,20.52%,MERTK;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;TEK;EPHA4;INSR;EPHB2;NTRK2;FLT3;PDGFRB;ROR1;EPHA5
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.25743677386145897,0.8300707183947085,0.734472049689441,0.9710553809679536,1.0,5/33,9.79%,RNF19A;PPARA;RNF180;DCUN1D2;PRKN
prerank,N-methyltransferase activity (GO:0008170),-0.2675801521714706,-0.8296757510270547,0.7038043478260869,0.9679169474636595,1.0,10/20,32.12%,SETD3;TRMT1L;PEMT;ZCCHC4;METTL15;GNMT;RNMT;TRMT1;PRMT1;TFB1M
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3220553643026082,-0.8289783572177152,0.6538461538461539,0.9647857393253026,1.0,6/12,26.94%,SLC9B2;SLC9A9;SLC9A2;SLC9A6;LETM1;SLC9A3
prerank,rRNA binding (GO:0019843),-0.2203145247959633,-0.8286793832624126,0.7913043478260869,0.9611154310054107,1.0,20/42,32.28%,RCC1L;RPL5;RPS14;RPS13;RPS5;RPF2;DDX21;NOP53;GTF3A;EMG1;FASTKD5;RPL11;MRPS27;DDX28;MRPS18C;MRPL11;MDM2;RPL23;RPS3;CAVIN1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3193303073480215,0.8276495079996172,0.6921797004991681,0.9728291319895248,1.0,5/14,18.44%,RPP40;ELAC2;PRORP;RPP30;TSEN34
prerank,store-operated calcium channel activity (GO:0015279),-0.34396497814768057,-0.8274621434056323,0.6821345707656613,0.9593000566047117,1.0,4/10,16.39%,TRPC5;TRPC1;ORAI2;STIM2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.23532357966069936,-0.8273367997871379,0.7365439093484419,0.9509214899629969,1.0,7/34,11.44%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB10;NDUFS7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.23532357966069936,-0.8273367997871379,0.7365439093484419,0.9509214899629969,1.0,7/34,11.44%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB10;NDUFS7
prerank,NADP binding (GO:0050661),-0.23528833417644818,-0.8269831583106649,0.773936170212766,0.9475136218671666,1.0,11/32,20.95%,DECR1;CRYZ;CBR3;HSD17B1;MTRR;GMDS;HSD11B1;DUS2;KCNAB1;GRHPR;DHFR
prerank,DNA binding (GO:0003677),0.17753304524940194,0.8257075031694106,0.956020942408377,0.9735592037818239,1.0,141/694,22.10%,CCDC25;TOP3A;HOXA5;HHEX;NUCKS1;TET1;MCM5;ANG;DRAP1;SURF6;DENND4A;RTF1;PQBP1;MYRFL;BPTF;CSRNP3;POU2F2;USF2;RNF138;TFCP2;DNASE1;NRL;TRIM26;SOX21;HIC1;NFIB;RELA;SOX10;TFAM;PPARGC1A;MEOX2;POLG;PPARA;DNASE1L2;E2F1;HDGFL2;XRCC6;FOXD1;NR2F6;MAP1S;GTF2H4;RBM5;BCLAF3;SMC1A;FUBP3;ZNF35;MCM3;OGG1;REPIN1;TIMELESS;LHX3;SP4;ZBTB22;TCF7L2;FOXC1;TAF9;TSHZ2;TBX2;SNAI2;CGAS;GRHL3;ZDHHC1;TRNP1;NFE2L2;FAN1;KDM2B;DMC1;HOXB2;POLR3F;POLR2G;RAD52;THAP1;USF1;MBD6;EPAS1;HLF;MLH1;TSN;TBX6;SUB1;MYRF;DDB2;ACR;PRDM16;ZBTB32;BARX2;HMGB1;SPTY2D1;ZBTB49;APEX1;FEN1;RPS27;ERCC6;IRF5;HMGB3;BATF;ERG;APLP2;HNRNPA1;TCF3;TCF7L1;CALCOCO1;SETX;CENPS;BRIP1;HDGFL3;KLF12;PHF1;XBP1;POU3F3;TSNAX;TFPT;MAX;PSIP1;WRN;ZMYM6;POGK;SNAPC3;ARID4A;REXO4;ZMYM3;RORA;DHX36;CENPC;CR2;PRDM5;SMAD2;XRCC5;SSBP1;NABP1;GRHL2;UNG;MPG;LHX4;XRCC4;TOP1;ING2;CXXC5;TAF4;NFYB;NPAS2
prerank,acylglycerol lipase activity (GO:0047372),0.3410270383176639,0.8255441299810049,0.7067137809187279,0.9707405009770393,1.0,5/11,29.72%,ABHD12;ABHD2;LIPE;MGLL;FAAH
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.32841390312685514,-0.8249327291765721,0.6952380952380952,0.9474202193405536,1.0,2/10,7.35%,PKIB;PRKAG2
prerank,estrogen receptor binding (GO:0030331),0.26531142709602173,0.8245798077964062,0.7555555555555555,0.9696630656371896,1.0,3/32,4.37%,DCAF1;NSD1;WBP2
prerank,iron ion binding (GO:0005506),-0.21772627066682412,-0.8234839463968822,0.8287461773700305,0.9458992625287195,1.0,16/48,26.34%,ALOX5;TET2;KDM7A;JMJD6;ALKBH8;NFU1;LCN2;RIOX1;FTL;LTF;HEPH;DOHH;FBXL5;ALOX15;PHYH;EGLN1
prerank,ankyrin binding (GO:0030506),0.2939617147546403,0.8232786239183167,0.7123050259965338,0.9690204588361521,1.0,4/19,14.32%,SLC8A1;CACNA1D;NRCAM;SPTBN1
prerank,ribonuclease activity (GO:0004540),-0.20844911973246993,-0.8216566389773787,0.8441558441558441,0.9454024869211287,1.0,15/56,18.88%,DIS3L2;RNASE3;ZC3H12D;ERN1;EXOSC8;ZC3H12A;EXOSC10;ZC3H12B;PIWIL2;AGO2;ENDOG;EXOSC9;RNASEH2A;SMG6;RNASEH1
prerank,methyltransferase activity (GO:0008168),0.23880298367679448,0.820736154942623,0.7739628040057225,0.9709707606496377,1.0,12/46,22.29%,LRTOMT;EEF1AKMT2;MEPCE;FTSJ1;METTL4;AMT;COMT;N6AMT1;ASMT;PRMT3;PRMT5;BCDIN3D
prerank,carbohydrate kinase activity (GO:0019200),0.329502668528737,0.8170167513758676,0.6935201401050788,0.9750905262519959,1.0,4/11,16.02%,FGGY;KHK;HK2;GALK1
prerank,hexosaminidase activity (GO:0015929),0.3261884510466093,0.8162846707255139,0.7108843537414966,0.9734949708098675,1.0,6/12,27.58%,HEXB;NAGA;HYAL4;OGA;SPAM1;CEMIP
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.26073653553715176,-0.8157002807860748,0.7371134020618557,0.9525766429325678,1.0,7/22,17.12%,ZRANB3;ATRIP;WDR81;FAAP20;OPTN;SQSTM1;UIMC1
prerank,ribosomal large subunit binding (GO:0043023),-0.3192693668426221,-0.8148130627389447,0.7149220489977728,0.9501738560778334,1.0,5/11,17.18%,MALSU1;DHX33;NPM1;NMD3;CPEB2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.21825038138531716,-0.8133450177103857,0.8205882352941176,0.948887399136692,1.0,14/42,27.43%,CCND1;CDKN2C;CCNH;CCNA2;CCNL1;CCND2;CDKN2A;CNPPD1;CCNY;KAT2B;CCNB1;CCNJ;CCNF;INCA1
prerank,death receptor binding (GO:0005123),-0.28977609053118497,-0.8128905830875248,0.7195402298850575,0.9456836458732516,1.0,6/15,25.80%,RIPK1;PIDD1;EDA;MYD88;FADD;TMBIM1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3367552893308111,0.8125371013140442,0.7220216606498195,0.9774397437889603,1.0,4/11,29.51%,SLC22A4;SLC22A5;SLC25A45;SLC25A29
prerank,FAD binding (GO:0071949),-0.24576052400260967,-0.8124153060742363,0.7837150127226463,0.9424298124304874,1.0,8/24,17.51%,MTHFR;KMO;CRY2;SQOR;CRY1;MTRR;MICAL1;MICAL2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3106070006028896,-0.806767778886642,0.7183098591549296,0.9491736957422405,1.0,5/12,23.12%,TENT2;TENT5A;TENT4B;TENT4A;TENT5C
prerank,ligand-gated calcium channel activity (GO:0099604),0.2816747193528092,0.8061034058658799,0.7147707979626485,0.9866704560934713,1.0,4/19,11.86%,TRPM2;GRIN1;GRIN2B;ITPR3
prerank,cation:chloride symporter activity (GO:0015377),0.3354290487155729,0.8044570011299136,0.7314487632508834,0.986610231528173,1.0,3/10,14.20%,SLC12A2;SLC12A6;SLC6A1
prerank,phospholipase binding (GO:0043274),-0.30206678793134184,-0.8030922830497413,0.7066974595842956,0.9518507318954967,1.0,4/13,10.61%,SYK;FYN;BLNK;LCK
prerank,glutamate receptor binding (GO:0035254),0.29136787680434617,0.8027783430299752,0.7346600331674958,0.9865329490454539,1.0,5/17,17.85%,IGSF11;SHANK3;HOMER2;GNAS;SHANK1
prerank,protein kinase regulator activity (GO:0019887),-0.18207937577428074,-0.8022447513720415,0.9319727891156463,0.9495073216102377,1.0,31/95,25.88%,GMFG;MARK2;NCK1;CCND1;PRKAG2;TAOK3;SMCR8;GPRC5B;CCNH;AGAP2;CCNA2;CCNL1;CCND2;NPM1;QARS1;PRKRIP1;SPRY4;DUS2;RGCC;TPX2;SOCS1;EPO;CNPPD1;GSKIP;DUSP19;CCNY;CCNB1;ITPRIP;KIDINS220;CCNJ;CCNF
prerank,ubiquitin binding (GO:0043130),0.21741694734912576,0.8020615686724045,0.8521617852161785,0.9847005662838937,1.0,15/73,16.32%,GGA3;FBXO7;OTULINL;FAF1;PRKN;RAE1;NEDD4;UBE2N;CXCR4;RNF168;USP33;OTUB1;TOM1L1;UBXN1;UBAP1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.28998731015430085,0.8007598855974146,0.7571669477234402,0.9839683936282186,1.0,4/18,17.86%,HSD17B2;AKR1C1;RDH5;HSD17B10
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.336942409823246,0.799502094292253,0.7092819614711033,0.9831688089269087,1.0,2/10,14.38%,CRMP1;DPYSL2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.22980579889604452,-0.7978721036800823,0.8160919540229885,0.9531804814785261,1.0,5/30,11.76%,GAS6;TNFAIP8;BIRC6;BIRC5;BIRC2
prerank,hormone receptor binding (GO:0051427),0.3066178031784059,0.7976871403072018,0.7551369863013698,0.9831720544566551,1.0,2/14,8.74%,SOCS2;ADCYAP1
prerank,tau protein binding (GO:0048156),0.23951497910333364,0.796884316715118,0.7990506329113924,0.9815987981329568,1.0,12/40,21.28%,BIN1;CLU;LGMN;DCTN1;PPP5C;ROCK1;TAOK1;PIN1;ACTB;SMAD2;HSP90AB1;MAP2
prerank,adenyl ribonucleotide binding (GO:0032559),0.1818135272712944,0.7959453256850805,0.927144535840188,0.9801664589655985,1.0,68/291,22.52%,HCN1;NIM1K;STK26;ABCG8;KCNJ8;HSPA2;ABCB6;DDX25;PDE4A;MYH10;STK11;GSS;MTHFD1L;TRIB1;MTPAP;PRKCI;CDC42BPA;PI4K2A;TGFBR1;PRAG1;MYO6;NME1;STK36;TWF2;CDKL5;MAP4K4;MPPED2;HSPA9;BTK;MINK1;ACVR1B;P2RY1;COQ8A;PFKM;PPP5C;ABCA2;SLC19A1;INSR;ERCC6;ACLY;HSPA14;GALK1;TWF1;DMPK;KIF14;TAOK1;HARS1;CDC42BPB;AKT3;MAST2;PEX6;ABCD2;MAP4K2;WNK1;BMPR1B;ABCC6;ATP1A3;ATP1A1;PFKP;DHX36;HSP90AB1;TOP1;LATS1;SIK3;TRNT1;PNPLA8;PIP4K2B;TLK2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.2975093368890194,-0.7947860867104986,0.7403846153846154,0.954330652907167,1.0,6/12,20.60%,CDK6;CDK8;CDK1;CDK12;CDK19;CDK9
prerank,monocarboxylic acid binding (GO:0033293),0.28757202673612603,0.7909608700981865,0.7569659442724458,0.9859398870388164,1.0,2/18,3.95%,AKR1C1;CYP26C1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.25889747773381777,0.79071318002329,0.7896341463414634,0.9834144561834824,1.0,7/27,19.87%,SLC4A8;SLC9A4;SLC8A1;SLC9A5;SLC8A3;ASIC3;CNNM4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.22882548445447615,-0.7885704027110624,0.8379120879120879,0.9613469060781632,1.0,12/37,21.77%,FARS2;IARS2;YARS2;PARS2;EARS2;QARS1;NARS1;WARS2;VARS2;WARS1;FARSA;LARS1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.252583597208735,-0.7878865535397458,0.8014705882352942,0.9584898851016589,1.0,2/20,4.99%,RBBP8;ZRANB3
prerank,nuclear receptor coactivator activity (GO:0030374),0.2292673482933143,0.7875856936725834,0.8208955223880597,0.9856721525354456,1.0,7/52,10.75%,MED24;PKN1;PPARGC1A;MED4;BRD8;SS18;FGF2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.29239853182725495,-0.7863689089172089,0.7780373831775701,0.9568144624611634,1.0,5/12,20.48%,IGF1;YWHAG;IGF2;SHC1;SOCS1
prerank,CoA-ligase activity (GO:0016405),0.3035818273821558,0.7852140799173227,0.7658119658119659,0.9866707414113095,1.0,4/14,19.16%,ACSS3;ACSF3;ACSBG1;ACSS1
prerank,sulfotransferase activity (GO:0008146),0.24723801634391412,0.7830099545755753,0.8032520325203252,0.9872896695170211,1.0,6/33,14.67%,CHST10;CHST1;HS6ST1;GAL3ST4;GAL3ST1;TPST2
prerank,protease binding (GO:0002020),0.2000351375820558,0.7786478583415957,0.8904299583911235,0.9915622183275522,1.0,8/99,5.53%,SELENOS;F3;BIN1;ATP9A;CST3;INSL3;POLG;PRNP
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2015125240729422,0.7774940889588484,0.8801128349788434,0.990467898603893,1.0,19/85,22.70%,PRDX6;CA1;PLAAT5;PLA2G4C;PNPLA3;ABHD12;LYPLA1;ENPP2;ACHE;TARS2;ABHD5;LYPLAL1;LIPC;ABHD8;ABHD2;PLA2G15;MRPL58;LIPE;DAGLB
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.2977661078273272,-0.7719099416919754,0.7530266343825666,0.9761841952591958,1.0,3/11,15.09%,GNPTAB;PIGF;PIGO
prerank,guanyl ribonucleotide binding (GO:0032561),0.18219272419358676,0.7706384772615307,0.9530284301606922,0.9982875878270868,1.0,64/196,29.52%,RAB1B;RHOV;RAB26;ATL1;ARL5A;RHOBTB1;RAB8A;ARL4C;ARL4A;RIT2;CNGB1;NME1;RHOT1;MPPED2;DIRAS2;ARL4D;RAB5A;RAB38;RAB28;RAB39A;RAB12;TUBB2A;SLC19A1;INSR;GNAI3;HRAS;RHOQ;RRAS2;RHOBTB2;RHOU;RHEBL1;CDC42;MMAA;TUBA8;RAP2C;DRG1;PIP4K2B;ARF1;ARL5B;RANBP17;ATL2;GBP2;RHOBTB3;PDE11A;RHOA;GNAI1;RNF112;RAPGEF2;GTPBP10;RRAGD;TUBA1B;NUDT16;TGM2;TUBA1A;MRAS;RAB13;ARL11;RRAD;GBP5;BMS1;ADSS1;RRAS;TUBA1C;RND3
prerank,leucine zipper domain binding (GO:0043522),0.33529050579309644,0.7689309445148527,0.781981981981982,0.9981204400197289,1.0,5/10,30.26%,NRL;PAWR;MRTFA;ATF4;DDIT3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.32523433539096,0.7681701703159439,0.7535460992907801,0.9961862442300702,1.0,2/10,11.05%,ANKRD13D;FAN1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.21738306540070512,0.7664609634139247,0.8658718330849479,0.9958222276102033,1.0,14/55,24.47%,SLC16A6;SLC38A2;SLC38A9;SLC38A7;SLC3A1;SLC19A1;SLC22A4;SLC16A12;SLC13A3;SLC38A3;SLC25A10;SLC19A2;SLC38A10;SLC16A7
prerank,histone acetyltransferase binding (GO:0035035),-0.24534547231532494,-0.7656977394245318,0.8261964735516373,0.9821488632571281,1.0,10/21,31.06%,PCNA;HIF1A;STAT1;TAF7;BCAS3;SIRT2;PAX6;EGR1;KANSL1;EID1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.31353817062683653,0.7609333952323324,0.8078231292517006,1.0,1.0,2/11,15.68%,NAA30;NAA60
prerank,Notch binding (GO:0005112),0.2594761503796027,0.7606398394828501,0.8167202572347267,0.9986272326462939,1.0,4/22,11.08%,TCIM;NCOR2;AAK1;KCTD10
prerank,exopeptidase activity (GO:0008238),0.22327305487123164,0.7596814808792036,0.8788321167883212,0.9970069819741554,1.0,18/50,26.71%,XPNPEP1;CNDP1;METAP1D;XPNPEP3;GGH;TRHDE;LAP3;ENPEP;DPP8;FOLH1;NAALAD2;METAP2;DPEP3;NPEPPS;RCE1;CTSH;DPP3;NUDT16
prerank,phosphatidylglycerol binding (GO:1901611),0.29527383844437133,0.7581805823983973,0.7827648114901257,0.9963122565117206,1.0,2/13,9.22%,GSDME;UQCC3
prerank,MAP kinase kinase activity (GO:0004708),-0.26802094495344675,-0.7579639332426029,0.824945295404814,0.9896435289081201,1.0,6/15,24.77%,MAPKAPK3;LRRK2;MAP2K4;MAP2K7;MAP2K3;SBK2
prerank,hormone activity (GO:0005179),-0.1935659053053933,-0.7576725895352707,0.9088145896656535,0.9861021849986499,1.0,23/54,36.81%,IGF1;METRNL;CCL25;AGRP;PTHLH;NPY;GNRH1;CRH;NMB;VIP;SPX;INHBB;PNOC;NPPC;EDN3;CORT;EDN2;NPPA;POMC;EDN1;GHRH;C1QTNF12;CALCB
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.24062615264345324,-0.7541699141286548,0.8273195876288659,0.9870719393602667,1.0,7/21,21.11%,PJA2;PRKACA;WASF1;AKAP5;KCNQ1;AKAP9;GSKIP
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2569250354853737,0.7520993691884619,0.8119800332778702,1.0,1.0,10/24,26.99%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;GLUL;ZDHHC19;ZDHHC12
prerank,GTP binding (GO:0005525),0.17926432951992116,0.7516131640314861,0.9500624219725343,1.0,1.0,58/172,29.85%,RAB1B;RHOV;RAB26;ATL1;ARL5A;RHOBTB1;RAB8A;ARL4C;ARL4A;RIT2;NME1;RHOT1;DIRAS2;ARL4D;RAB5A;RAB38;RAB28;RAB39A;TUBB2A;INSR;HRAS;RHOQ;RRAS2;RHOBTB2;RHOU;RHEBL1;CDC42;MMAA;TUBA8;RAP2C;DRG1;PIP4K2B;ARF1;ARL5B;RANBP17;ATL2;GBP2;RHOBTB3;RHOA;GNAI1;RNF112;GTPBP10;RRAGD;TUBA1B;NUDT16;TGM2;TUBA1A;MRAS;RAB13;ARL11;RRAD;GBP5;BMS1;ADSS1;RRAS;TUBA1C;RND3;ARF5
prerank,pseudouridine synthase activity (GO:0009982),-0.2784749085193899,-0.7515296840475728,0.7820823244552058,0.9867943052675825,1.0,10/13,45.41%,TRUB2;DKC1;PUS3;RPUSD3;RPUSD2;RPUSD1;PUSL1;PUS10;TRUB1;PUS1
prerank,signal sequence binding (GO:0005048),0.23317613329468934,0.7499782191602801,0.8452950558213717,0.9996081709482626,1.0,8/35,15.65%,KDELR3;PEX5;CABP1;SEC61A2;TIMM22;IPO5;TOMM70;KDELR2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.23830668990778486,0.7473247056535255,0.8388157894736842,1.0,1.0,11/32,25.06%,TYW5;TET1;PHYHD1;KDM2B;PHF8;KDM4A;ALKBH4;ALKBH5;ALKBH3;HIF1AN;FTO
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3098142100531953,0.7471138237493312,0.7868561278863233,0.997839627628811,1.0,2/11,11.86%,TRPM2;ITPR3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.23588210507730337,-0.7465725734465674,0.8636363636363636,0.9819166251505368,1.0,3/22,11.78%,HRH1;CHRM2;HTR1B
prerank,serotonin receptor activity (GO:0099589),-0.23588210507730337,-0.7465725734465674,0.8636363636363636,0.9819166251505368,1.0,3/22,11.78%,HRH1;CHRM2;HTR1B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.23588210507730337,-0.7465725734465674,0.8636363636363636,0.9819166251505368,1.0,3/22,11.78%,HRH1;CHRM2;HTR1B
prerank,phosphatidylcholine transporter activity (GO:0008525),0.27376266790483095,0.7452137863403019,0.8046744574290484,0.9976233398209892,1.0,10/17,33.69%,ABCB4;MTTP;ATP8B1;ABCA7;ATP8B2;ATP10B;ABCA3;PITPNA;PITPNC1;PITPNM1
prerank,peptidase activator activity (GO:0016504),0.2526120485936795,0.7436867095631624,0.83,0.9966978327772105,1.0,9/22,25.68%,VSIR;EBAG9;PSME3;PSENEN;PSMD14;PSME1;MAL;PCOLCE2;CLPX
prerank,AMP binding (GO:0016208),-0.2912413281453145,-0.7418658793301305,0.795045045045045,0.9842565553196693,1.0,2/11,7.35%,ACSS2;PRKAG2
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3059609979545944,0.741013484821298,0.7972270363951474,0.9975886636567907,1.0,2/11,9.40%,SRRM2;TAF9
prerank,potassium channel regulator activity (GO:0015459),0.21400329733418358,0.7406515477126607,0.9032738095238095,0.9952053465056804,1.0,4/49,6.35%,YWHAE;KCNE2;KCNIP3;KCNIP4
prerank,sodium:proton antiporter activity (GO:0015385),-0.2950231016583798,-0.7394116491969991,0.7928571428571428,0.9834307211141603,1.0,3/11,11.79%,SLC9B2;SLC9A9;SLC9A2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.2883739005181293,-0.7387631627206481,0.8056206088992974,0.9804054772420931,1.0,3/11,15.27%,PPP1R1A;PPP1R2;PPP1R14C
prerank,cytochrome-c oxidase activity (GO:0004129),0.2805033296122984,0.7381405365014532,0.8170940170940171,0.9957352237332514,1.0,4/15,23.98%,NDUFA4;COX4I1;COX6B1;COX10
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.29656200246329234,0.7377207929750499,0.8183391003460208,0.9934553142893833,1.0,2/12,8.07%,AKR1C1;CBR4
prerank,galactosyltransferase activity (GO:0008378),0.30264566894236894,0.7370477824055718,0.7989130434782609,0.9914753808199721,1.0,3/11,18.86%,B3GNT6;A3GALT2;B4GALT2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.2714238143843174,0.7345451780283344,0.8462837837837838,0.9918564393253183,1.0,3/15,14.39%,ALDH9A1;ALDH1L1;ALDH4A1
prerank,dynactin binding (GO:0034452),0.29664789081873477,0.7336481249875179,0.8460111317254174,0.9901357244915865,1.0,3/12,17.35%,BICD2;SNX6;BICD1
prerank,cGMP binding (GO:0030553),0.303678803621373,0.732041556809878,0.8184873949579832,0.989296664136544,1.0,4/11,31.67%,CNGB1;PDE11A;RAPGEF2;PDE10A
prerank,transcription coregulator binding (GO:0001221),0.2094456756946985,0.7303361458526774,0.9030303030303031,0.9885117921358675,1.0,14/50,21.91%,CNOT2;RELA;CTBP1;AR;USP11;LMO2;ZBTB49;UBE2I;MED25;PHF1;HDAC3;RORA;TEAD2;CHD6
prerank,GABA receptor binding (GO:0050811),0.3053254783689444,0.7287604939465561,0.8138297872340425,0.9877261377055404,1.0,2/11,9.48%,LHFPL4;JAKMIP1
prerank,snRNA binding (GO:0017069),0.21594311442749944,0.7280163081162869,0.889937106918239,0.9858524786224746,1.0,14/42,25.29%,SNRNP70;MEPCE;HEXIM2;LSM8;SF3B3;DDX39B;GEMIN5;SNRPD3;EIF5A;LSM4;SNRPB2;SNU13;HEXIM1;COIL
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.29788128637280964,-0.7272479601424322,0.8136020151133502,0.9906676352751186,1.0,5/10,30.59%,CDKN2C;CDKN2A;KAT2B;INCA1;CDKN2D
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.29643617912124326,0.7243178868231517,0.8296041308089501,0.9877271673687438,1.0,3/12,15.54%,DAB2IP;ITGA5;CADM4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.24609439729341537,-0.721796272541095,0.8402948402948403,0.9935302217042097,1.0,7/18,28.50%,HSD17B12;ALDH1A1;ALDH3A2;ALDH1A2;ALDH2;ALDH1A3;ALDH8A1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2905697348527281,0.7208780994858662,0.8540268456375839,0.9889015215810127,1.0,2/12,13.34%,CNOT2;CNOT8
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.26752991955031424,-0.7162742910515002,0.8444444444444444,0.9961806795046309,1.0,3/12,13.47%,NCBP1;AGO2;LARP1
prerank,palmitoyltransferase activity (GO:0016409),0.23655540397666638,0.714307566776947,0.8667763157894737,0.9938942829166274,1.0,11/28,27.25%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;GLUL;ZDHHC19;ZDHHC12;ZDHHC5
prerank,lipid phosphatase activity (GO:0042577),-0.25577799718170474,-0.7117820886429331,0.866504854368932,0.9971576301421343,1.0,6/14,31.16%,PLPP7;SGPP1;INPP5K;PLPPR3;PLPP3;PLPPR5
prerank,sialyltransferase activity (GO:0008373),0.25017718184013327,0.7089716822953234,0.8659966499162479,0.9970085346107996,1.0,5/20,22.65%,ST3GAL5;ST6GALNAC2;ST3GAL6;ST3GAL3;ST6GALNAC4
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3034160680756478,0.7080616618518113,0.8495726495726496,0.9952040407195214,1.0,3/10,20.40%,OTUD5;STAMBP;CYLD
prerank,sulfuric ester hydrolase activity (GO:0008484),0.28869299669913395,0.706598452506159,0.8470790378006873,0.9939899433264794,1.0,2/12,5.79%,ARSB;ARSG
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.24773961948969653,0.7031967618704993,0.8783570300157978,0.9921792353383752,1.0,2/21,1.65%,CDK7;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.24773961948969653,0.7031967618704993,0.8783570300157978,0.9921792353383752,1.0,2/21,1.65%,CDK7;CDK15
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.2686090172113115,0.7019075216789583,0.8503401360544217,0.9908167050545825,1.0,3/13,14.39%,ALDH9A1;ALDH1L1;ALDH4A1
prerank,acetylation-dependent protein binding (GO:0140033),-0.23013518367016794,-0.6999975729578078,0.8851674641148325,1.0,1.0,3/20,6.01%,SMARCA4;TAF1;MLLT3
prerank,lysine-acetylated histone binding (GO:0070577),-0.23013518367016794,-0.6999975729578078,0.8851674641148325,1.0,1.0,3/20,6.01%,SMARCA4;TAF1;MLLT3
prerank,single-stranded DNA helicase activity (GO:0017116),0.24472165051132053,0.6914626847873495,0.8808373590982287,0.9982094962382544,1.0,1/19,1.07%,MCM5
prerank,RNA stem-loop binding (GO:0035613),-0.2655926332581082,-0.6913642009550703,0.8455882352941176,1.0,1.0,6/12,24.48%,LARP6;ZC3H12A;RC3H1;RC3H2;CPEB3;CSDE1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.2936186967297587,0.6909796835265531,0.8545454545454545,0.9959489976237852,1.0,2/10,13.00%,B3GALT2;A3GALT2
prerank,G protein-coupled receptor activity (GO:0004930),0.1574975841026004,0.6861908053403721,0.9963811821471653,0.997705377107431,1.0,34/239,19.57%,GPR34;P2RY12;AVPR2;GABBR1;NTSR2;ADGRG4;NMUR1;AVPR1A;GPR12;LTB4R2;GRM3;ADRA2A;ADGRL3;GPR17;ADCYAP1R1;CXCR6;CX3CR1;CXCR4;MC4R;LPAR4;P2RY1;GPR171;GABBR2;ELOVL4;P2RY10;OPRM1;MTNR1B;MTNR1A;ADGRL1;OPRD1;GPR174;PDGFRB;GPR63;HCAR2
prerank,phosphatidic acid binding (GO:0070300),-0.22786897377824972,-0.6857984500882185,0.9088729016786571,1.0,1.0,4/19,16.15%,SESTD1;PLTP;PACSIN2;GRAMD1B
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.19192744852906463,0.683948569664668,0.9563318777292577,0.9970145193751466,1.0,14/57,23.98%,NDUFA6;UQCRC1;NDUFA4;NDUFS1;UQCR11;NDUFA8;NDUFS6;CYB561A3;NDUFS2;NDUFB6;COX4I1;COX6B1;UQCR10;COX10
prerank,serine-type endopeptidase activity (GO:0004252),0.18214864651044121,0.6798544604172503,0.9693593314763231,0.998088491458764,1.0,5/80,4.46%,F3;PLAT;RHBDL3;PRSS56;GZMM
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2340338912593507,0.6780676400763566,0.9025641025641026,0.9969680570110767,1.0,3/21,18.42%,GRIA1;CHRNA7;CHRFAM7A
prerank,protein phosphatase 2A binding (GO:0051721),-0.21560627581712338,-0.6770366271986307,0.900523560209424,1.0,1.0,5/23,14.69%,ENSA;PTPA;BOD1;FOXO1;ARPP19
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.19394170622891532,0.6749061976814436,0.9410898379970545,0.9970998626211239,1.0,18/54,30.64%,PM20D1;ACY1;HDAC5;NTAQ1;AGA;ACR;HDAC3;ASPA;HDAC8;NIT1;GLS2;TGM2;NTAN1;NADSYN1;AMDHD2;HINT3;FAAH;ACER2
prerank,telomeric DNA binding (GO:0042162),-0.1930773798990924,-0.6601646402575179,0.9619565217391305,1.0,1.0,11/32,26.20%,UPF3A;RPA1;HNRNPA2B1;TERF2;UPF2;HNRNPD;SMG6;TINF2;PIF1;TERT;PURA
prerank,phosphoric ester hydrolase activity (GO:0042578),0.18962960468020032,0.6600681612702992,0.9636913767019667,1.0,1.0,18/49,31.26%,PLCXD1;PTPRO;SACM1L;PPP1CC;MPPED2;PPP5C;APEX1;FRA10AC1;PLCXD3;PPP1CA;DUSP28;ACP4;ACP2;PLCXD2;DUSP10;DUSP5;DUSP11;EPHX2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.2616280070338711,-0.6585027021425547,0.9028436018957346,1.0,1.0,2/10,12.27%,SETDB2;EHMT1
prerank,retinoid X receptor binding (GO:0046965),-0.2586150157332583,-0.6559613137859519,0.9134615384615384,1.0,1.0,9/11,41.02%,PPARG;TACC1;NRIP1;HMGA1;ARID5A;NCOA6;VDR;NR4A2;RARG
prerank,serine-type peptidase activity (GO:0008236),0.17001161627223912,0.6554439716207874,0.9850746268656716,1.0,1.0,22/96,26.57%,F3;PLAT;RHBDL3;PRSS56;GZMM;TMPRSS7;ACR;PIK3IP1;KLK2;HPN;PCSK2;NAALAD2;TYSND1;APEH;RHBDD3;PCSK7;HTRA3;TPP1;CTSH;TMPRSS4;MASP2;RHBDL2
prerank,lipase activity (GO:0016298),0.19100380436795444,0.6541820095849948,0.9593984962406015,1.0,1.0,16/43,30.22%,PNPLA3;ABHD12;LYPLA1;ABHD5;LIPC;LDAH;ABHD2;PLA2G15;LIPE;PNPLA8;DAGLB;SMPD2;MGLL;FAAH;CEL;LIPA
prerank,neuropeptide hormone activity (GO:0005184),0.2248342541372834,0.6521220334810442,0.9278523489932886,1.0,1.0,5/22,23.34%,PPY;ADCYAP1;GAL;GRP;CCK
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.2568349975214973,-0.6509618892121187,0.8923444976076556,1.0,1.0,2/11,14.00%,SLC17A5;SLC5A3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.22454061665556174,0.648577403736275,0.9388429752066115,1.0,1.0,2/21,7.67%,GLRB;GRIK2
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.21872447672127424,-0.6474666465133293,0.9403341288782816,1.0,1.0,2/17,7.34%,ACOT8;ACAA2
prerank,ribonuclease P RNA binding (GO:0033204),0.27509481903884153,0.6469511972430324,0.8960573476702509,1.0,1.0,2/10,13.22%,RPP40;RPP30
prerank,retinoic acid binding (GO:0001972),0.260270101283879,0.6451650485085251,0.9141004862236629,1.0,1.0,1/12,3.95%,CYP26C1
prerank,peptide hormone receptor binding (GO:0051428),0.26371795987585334,0.6397008060715196,0.9052823315118397,1.0,1.0,3/11,25.75%,ADCYAP1;CCK;PSMC5
prerank,endonuclease activity (GO:0004519),0.18401269605620807,0.6390458868720109,0.9741641337386018,1.0,1.0,13/49,24.18%,ANG;OGG1;RNASEL;CPSF3;SND1;APEX1;FEN1;TSNAX;REXO4;APLF;INTS11;LACTB2;ERCC4
prerank,NAD+ binding (GO:0070403),0.2632590803751938,0.6389907799669498,0.9166666666666666,0.9976947969227101,1.0,3/12,19.03%,CRYL1;UXS1;HPGD
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.2383713624013173,-0.6388393924741601,0.9248291571753986,1.0,1.0,1/14,0.98%,SLC26A11
prerank,mRNA methyltransferase activity (GO:0008174),-0.24140813375309633,-0.6343777764942886,0.9313725490196079,1.0,1.0,3/12,12.69%,TRMT10C;METTL8;NSUN2
prerank,acid-thiol ligase activity (GO:0016878),-0.2316900295937026,-0.630601093627219,0.9367396593673966,1.0,1.0,1/13,1.97%,ACSS2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.18655704647209764,-0.629349228349078,0.9712230215827338,1.0,1.0,6/28,17.21%,PRKACA;MAPKAPK3;LRRK2;RPS6KA2;MAP2K4;MAP2K7
prerank,transcription corepressor binding (GO:0001222),0.20368623687667023,0.6276859176424208,0.9624796084828712,1.0,1.0,6/27,19.61%,CNOT2;CTBP1;USP11;PHF1;HDAC3;RORA
prerank,MHC protein binding (GO:0042287),-0.2032498099960548,-0.6267564822785611,0.958128078817734,1.0,1.0,9/20,31.91%,CD74;TAPBP;LILRB1;PILRA;TUBB4B;KIR3DL2;CD8B;CD4;CD8A
prerank,receptor antagonist activity (GO:0048019),0.23098073335313016,0.6264897962414062,0.9369817578772802,1.0,1.0,3/17,19.32%,PXDN;IL18BP;CCL5
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.24240547670599608,0.6245580706983402,0.9574105621805792,0.9985500797040304,1.0,3/13,13.69%,SLC38A7;SLC66A1;SLC3A1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2553704198440599,0.6231947385784132,0.9137323943661971,0.9967769808771522,1.0,3/11,19.48%,SLC19A1;SLC25A23;SLC35B2
prerank,LRR domain binding (GO:0030275),0.24242458669077066,0.6162528473812214,0.9405594405594405,0.9979950549487829,1.0,6/14,30.26%,NRL;PAWR;MRTFA;ATF4;ROBO1;DDIT3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2399579298986432,-0.6146229590276286,0.9287410926365796,1.0,1.0,1/11,5.51%,BAG4
prerank,adenyl nucleotide binding (GO:0030554),-0.2399579298986432,-0.6146229590276286,0.9287410926365796,1.0,1.0,1/11,5.51%,BAG4
prerank,CoA hydrolase activity (GO:0016289),-0.21450421828836835,-0.6116942497105793,0.9537037037037037,1.0,1.0,2/16,7.34%,ACOT8;ACAA2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.2375881576064271,-0.6110278943670044,0.9334916864608076,1.0,1.0,6/11,40.04%,PADI4;DDAH1;ARG1;AGMAT;PADI1;PADI2
prerank,phospholipase activator activity (GO:0016004),-0.24322259326473744,-0.6110211891610702,0.9455782312925171,1.0,1.0,2/10,10.61%,FYN;LCK
prerank,protein tyrosine kinase activator activity (GO:0030296),0.2174932503325438,0.6048307802980326,0.955810147299509,1.0,1.0,5/19,19.32%,DGKQ;NRG3;ERCC6;GHRL;CCL5
prerank,neuropeptide receptor activity (GO:0008188),0.1963644816825551,0.6033609960770938,0.9762308998302207,0.9991328788285303,1.0,4/29,16.91%,NMUR1;SORCS1;GAL;OPRM1
prerank,pentosyltransferase activity (GO:0016763),-0.1700418962129169,-0.6029906945573866,0.990990990990991,1.0,1.0,2/36,1.44%,PARP4;PARP14
prerank,phospholipid transfer activity (GO:0120014),-0.19572014520268174,-0.5949385124117472,0.9826302729528535,1.0,1.0,3/21,9.14%,PLEKHA3;PLTP;OSBPL2
prerank,transferrin receptor binding (GO:1990459),0.2524173614052679,0.5935511688624423,0.9397810218978102,1.0,1.0,4/10,29.17%,CD81;RGMA;HFE;CHUK
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.21237877958732365,-0.5863739088887222,0.9563218390804598,1.0,1.0,4/13,37.24%,IDI1;HSD3B2;EBP;DDT
prerank,kinesin binding (GO:0019894),-0.17628086509089397,-0.5822137602262345,0.9869451697127938,0.9998954529224677,1.0,4/27,17.87%,PRC1;TOR1B;MAPK8IP3;KIF18B
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.20649594467576224,0.5796199572665751,0.9695431472081218,1.0,1.0,4/20,17.78%,SLC39A4;SLC39A8;SLC30A3;SLC39A3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.20718459415509266,0.5780920093122368,0.983633387888707,1.0,1.0,3/21,12.92%,POLG;POLD3;POLM
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.15938128276155278,-0.5776978060769754,1.0,0.998012317040732,1.0,14/38,35.77%,SERPINC1;SERPIND1;SERPING1;SERPINF2;APP;TFPI2;SERPINB2;SPINK5;SLPI;SERPINB9;SERPINB5;HRG;SERPINA10;WFDC3
prerank,lipase activator activity (GO:0060229),-0.2299373907681338,-0.5773918034508154,0.9681818181818181,0.9945895661183359,1.0,2/10,10.61%,FYN;LCK
prerank,neurexin family protein binding (GO:0042043),0.24479337592953243,0.5747381065855514,0.9554030874785592,1.0,1.0,1/10,3.46%,SYTL4
prerank,MAP kinase activity (GO:0004707),0.224799511119704,0.573353584138786,0.955,0.9980619990437802,1.0,3/14,15.76%,MAPK15;MAPK10;MAPK3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.2204662364789282,-0.5675488992625048,0.975669099756691,0.9940948841869872,1.0,8/12,37.97%,DUSP16;DUSP1;DUSP3;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,potassium:proton antiporter activity (GO:0015386),0.24035607107891677,0.5673648360064005,0.9614035087719298,0.9973735935299093,1.0,3/10,23.15%,SLC9A4;SLC9A5;SLC9A1
prerank,histone deacetylase activity (GO:0004407),-0.190973681718125,-0.5669187660660738,0.9766839378238342,0.9908089998573345,1.0,7/19,32.73%,HDAC2;HDAC1;SIRT2;HDAC4;MIER1;HDAC11;HDAC6
prerank,nucleoside-diphosphatase activity (GO:0017110),0.22022579453502827,0.560015652050682,0.9634146341463414,0.997075074148138,1.0,7/12,35.31%,ENTPD6;CANT1;ENTPD1;ENTPD2;ENTPD3;ENTPD7;NUDT18
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.22154410914058043,0.5571618286946097,0.968013468013468,0.9953105691593547,1.0,3/12,17.88%,PHF8;KDM4A;PHF2
prerank,DNA polymerase activity (GO:0034061),0.19385436287837285,0.5496976592328557,0.9869918699186991,0.9947616237776603,1.0,3/22,12.92%,POLG;POLD3;POLM
prerank,ferrous iron binding (GO:0008198),-0.17694723618090455,-0.5468384111673369,0.9895561357702349,0.9927524783970506,1.0,21/21,82.33%,TET2;FTL;HEPH;PHYH;EGLN1;ALKBH2;FECH;SNCA;EGLN3;EGLN2;FXN;CDO1;ACP5;FTH1;DNAJC24;ALKBH1;HAAO;FTO;HIF1AN;ALKBH3;ISCU
prerank,alanine transmembrane transporter activity (GO:0022858),0.21561717358812732,0.5393143014793569,0.9912891986062717,0.9946058741650022,1.0,2/12,11.61%,SLC38A7;SLC1A4
prerank,pyridoxal phosphate binding (GO:0030170),-0.16512781860435902,-0.5141234899489302,0.9926470588235294,0.9956389714066912,1.0,20/20,83.51%,CBS;THNSL2;CTH;GLDC;SDS;SHMT2;PDXK;OAT;PLPBP;PNPO;ALB;SHMT1;PYGB;ACCS;PYGL;PSAT1;SRR;ABAT;AGXT;PYGM
prerank,Wnt-activated receptor activity (GO:0042813),0.1928597935391013,0.5064289066168998,0.9933554817275747,0.9980092032902204,1.0,3/15,19.62%,RYK;PKD1;ROR1
prerank,thioesterase binding (GO:0031996),0.20644259936797965,0.5006581963400966,0.9827288428324698,0.9963334956002483,1.0,1/11,6.94%,ADRA2A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.17892643291907706,-0.4999117192195327,0.9806763285024155,0.994194279796486,1.0,6/14,35.68%,USP9X;MINDY3;USP15;YOD1;ATXN3;USP27X
prerank,myosin II binding (GO:0045159),0.2095364289558559,0.4853705627470946,0.9876325088339223,0.9955948348808358,1.0,5/10,28.13%,STXBP5;LLGL2;SHROOM1;LLGL1;STXBP5L
